<SEC-DOCUMENT>0001999371-25-004421.txt : 20250418
<SEC-HEADER>0001999371-25-004421.hdr.sgml : 20250418
<ACCEPTANCE-DATETIME>20250418151000
ACCESSION NUMBER:		0001999371-25-004421
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20250418
DATE AS OF CHANGE:		20250418

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NUVEEN ARIZONA QUALITY MUNICIPAL INCOME FUND
		CENTRAL INDEX KEY:			0000892992
		ORGANIZATION NAME:           	
		EIN:				363847197
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0228

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-285472
		FILM NUMBER:		25850280

	BUSINESS ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-917-8146

	MAIL ADDRESS:	
		STREET 1:		333 WEST WACKER DRIVE
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVEEN ARIZONA PREMIUM INCOME MUNICIPAL FUND
		DATE OF NAME CHANGE:	20130410

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVEEN ARIZONA PREMIUM INCOME MUNICIPAL FUND INC
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>naz_424b5-041825.htm
<DESCRIPTION>PROSPECTUS
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:naz="http://nuveen.com/20250418">
<head>
     <title>Nuveen Municipal High Income Opportunity Fund</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_CEF%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_naz_nuveen.com_20250418 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20250418_20250418 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DDocumentType_424B5 -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000892992 -->
<!-- Field: Set; Name: xdx; ID: xdx_078_XDX_naz__424b2.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="line-height: normal">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-04-18" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-04-18" id="Fact000004" name="dei:DocumentType">424B5</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-04-18" id="Fact000005" name="dei:EntityCentralIndexKey">0000892992</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="naz-20250418.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-04-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-18</xbrli:startDate>
        <xbrli:endDate>2025-04-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-04-14_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-04-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-012025-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-05-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012024-02-29_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-08-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-03-012023-05-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-01</xbrli:startDate>
        <xbrli:endDate>2023-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-12-012023-02-28_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-12-01</xbrli:startDate>
        <xbrli:endDate>2023-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-09-012022-11-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-09-01</xbrli:startDate>
        <xbrli:endDate>2022-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-142025-04-14_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-14</xbrli:startDate>
        <xbrli:endDate>2025-04-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-04-142025-04-14_custom_CommonStockAdjustedForOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naz:CommonStockAdjustedForOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-14</xbrli:startDate>
        <xbrli:endDate>2025-04-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2025-04-14_custom_CommonStockAdjustedForOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000892992</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naz:CommonStockAdjustedForOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2025-04-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000020" toRefs="Footnote000023"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000024"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000025"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000035"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000035 Footnote000036"/>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000035 Footnote000037"/>
  <ix:relationship fromRefs="Fact000032" toRefs="Footnote000035"/>
  <ix:relationship fromRefs="Fact000041" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000042" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000043" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000044" toRefs="Footnote000045"/>
  </ix:resources>
 </ix:header>
</div>


<div style="line-height: normal; display: inline">

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><div style="text-align: right; font-weight: bold; display: inline">Filed Pursuant to Rule 424(b)(5)<br/> Registration Statement No. 333-285472</div></div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<div style="margin-top: 0pt; margin-bottom: 0pt; text-align: right"> <img alt="LOGO" src="nuveenlogo.jpg"/> </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt"><div style="font-weight: bold; display: inline">PROSPECTUS SUPPLEMENT </div></div>

<div style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><div style="font-weight: bold; display: inline">(To Prospectus dated April 17, 2025) </div></div>

<div style="font: 12pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline">1,200,000 COMMON SHARES </div></div>

<div style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline">$0.01 PAR VALUE PER SHARE </div></div>

<div style="font: 18pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: center"><div style="text-align: center; font-weight: bold; display: inline"><span id="xdx_901_edei--EntityRegistrantName_c20250418__20250418_zwAXiSfXc4Je"><ix:nonNumeric contextRef="AsOf2025-04-18" id="Fact000011" name="dei:EntityRegistrantName">Nuveen Arizona Quality Municipal Income  Fund</ix:nonNumeric></span> </div></div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<div style="text-align: center">

<div style="border-bottom: #000000 1pt solid; margin: 0pt auto 2pt; line-height: 6pt; width: 21%; text-align: center">&#160;</div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 11pt; margin-bottom: 0pt; text-indent: 0.5in">Nuveen Arizona Quality Municipal Income  Fund (the &#8220;Fund&#8221;), a diversified, closed-end management investment company, is offering up to 1,200,000 of its common shares, $0.01 par value per share (the &#8220;Common Shares&#8221;), pursuant to this prospectus supplement. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The minimum price on any day at which Common Shares may be sold will not be less than the current net asset value (&#8220;NAV&#8221;) per share plus the per share amount of the commission to be paid to the Fund&#8217;s distributor, Nuveen Securities, LLC (&#8220;Nuveen Securities&#8221;). The Fund and Nuveen Securities will suspend the sale of Common Shares if the per share price of the shares is less than such minimum price. The Fund currently intends to distribute the shares offered pursuant to this prospectus supplement primarily through transactions deemed &#8220;at the market,&#8221; as defined in Rule 415 under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), including sales made directly on the New York Stock Exchange (the &#8220;NYSE&#8221;) or sales made to or through a market maker other than on an exchange. For information on how Common Shares may be sold, see the &#8220;Plan of Distribution&#8221; section of this prospectus supplement. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund will compensate Nuveen Securities with respect to sales of Common Shares at a variable commission rate. The variable commission rate shall be equal to the sum of (i) seventy-five percent (75%) of the premium to net asset value with respect to the sale of any Common Shares sold until such compensation is equal to 0.80% of the aggregate gross sales proceeds and (ii) twenty-five percent (25%) of the premium to net asset value with respect to the sale of any Common Shares sold until such compensation is equal to 0.20% of the aggregate gross sales proceeds. Out of this commission, Nuveen Securities will compensate the applicable dealer at a variable commission rate equal to seventy-five percent (75%) of the premium to net asset value with respect to the sale of any Common Shares sold until such compensation is equal to 0.80% of the aggregate gross sales proceeds. In connection with the sale of the Common Shares on the Fund&#8217;s behalf, Nuveen Securities may be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act and the compensation of Nuveen Securities may be deemed to be underwriting commissions or discounts. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">Common Shares are
listed on the NYSE under the symbol &#8220;NAZ&#8221;. The closing price for the Common Shares on the NYSE on April 14,
2025 was <span id="xdx_90B_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zRbrqbVDAqr">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-04-14_us-gaap_CommonStockMember" id="Fact000012" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.79</ix:nonFraction></span>. The NAV of the Common Shares at the close of business on April 14, 2025 was <span id="xdx_903_eus-gaap--NetAssetValuePerShare_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7FHxXbGEDE1">$<ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-04-14_us-gaap_CommonStockMember" id="Fact000013" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.31</ix:nonFraction> </span>
per Common Share.</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"><div style="font-weight: bold; display: inline">Common shares of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">closed-end</div> investment companies, such as the Fund, often trade at a discount to their NAV. This creates a risk of loss for an investor purchasing common shares in a public offering. </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"><div style="font-weight: bold; display: inline">Investing in the Common Shares involves risks. See &#8220;Risk Factors&#8221;
                                                                                                                beginning on page 14, of the accompanying prospectus. You should consider carefully these risks together with all of the other
                                                                                                                information in this prospectus supplement and the accompanying prospectus before making a decision to purchase Common Shares. </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: center"><div style="text-align: center; font-weight: bold; display: inline">The date of this prospectus supplement is April 18, 2025. </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: right"><div style="font-style: normal; letter-spacing: 0px; top: 0px; display: inline"><div style="text-align: right; font-style: italic; display: inline"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(continued on next page)</i></span></div></div></div></div>

<div>

<div><div style="line-height: normal; background-color: white; display: inline">

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: right"><div style="font-style: normal; letter-spacing: 0px; top: 0px; display: inline"><div style="font-style: italic; display: inline"></div></div></div></div></div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><div style="font-style: normal; letter-spacing: 0px; top: 0px; display: inline"><div style="font-style: italic; display: inline">(continued from previous page) </div></div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">You should read this prospectus supplement, together with the accompanying prospectus, which contains important information about the Fund, before deciding whether to invest in Common Shares and retain it for future reference. A <a href="https://www.sec.gov/Archives/edgar/data/892992/000199937125004231/naz-n2a_041525.htm#toc780884_24">statement of additional information</a>, dated April 17, 2025, and as it may be supplemented (the &#8220;SAI&#8221;), containing additional information about the Fund, has been filed with the SEC and is incorporated by reference in its entirety into this prospectus supplement and the accompanying prospectus. This prospectus supplement, the accompanying prospectus and the SAI are part of a &#8220;shelf&#8221; registration statement filed with the SEC. This prospectus supplement describes the specific details regarding this offering, including the method of distribution. If information in this prospectus supplement is inconsistent with the accompanying prospectus or the SAI, you should rely on this prospectus supplement. You may request a free copy of the SAI, annual and semi-annual reports to shareholders, and other information about the Fund, and make shareholder inquiries by calling (800) 257-8787 or by writing to the Fund at 333 West Wacker Drive, Chicago, Illinois 60606, or from the Fund&#8217;s website (www.nuveen.com). The information contained in, or that can be accessed through, the Fund&#8217;s website is not part of this prospectus supplement, the accompanying prospectus or the SAI, except to the extent specifically incorporated by reference herein. You also may obtain a copy of the SAI (and other information regarding the Fund) from the SEC&#8217;s website (www.sec.gov). </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">You should not construe the contents of this prospectus supplement and the accompanying prospectus as legal, tax or financial advice. You should consult with your own professional advisors as to the legal, tax, financial or other matters relevant to the suitability of an investment in the Common Shares. </div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<div style="text-align: center">

<div style="border-bottom: #000000 1pt solid; margin: 0pt auto 2pt; line-height: 6pt; width: 21%; text-align: center">&#160;</div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"><div style="font-weight: bold; display: inline">Common Shares do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency. </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"><div style="font-weight: bold; display: inline">Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.</div> <div style="font-weight: bold; display: inline"></div></div>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline">TABLE OF CONTENTS </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline">Prospectus Supplement </div></div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%">
  <tr>
    <td style="padding: 0; width: 95%; text-indent: 0"/>
    <td style="padding: 0; vertical-align: bottom; width: 1%; text-indent: 0"/>
    <td style="padding: 0; text-indent: 0"/>
    <td style="padding: 0; text-indent: 0"/></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td colspan="2" style="border-bottom: #000000 1pt solid; padding: 0; vertical-align: bottom; text-align: center; text-indent: 0"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">Page</div></div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#fls">Forward-Looking Statements</a></div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-align: right; text-indent: 0">ii</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#pss">Prospectus Supplement Summary</a></div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-align: right; text-indent: 0"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">S-1</div></td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#sfe">Summary of Fund Expenses</a></div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-align: right; text-indent: 0"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">S-3</div></td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#trading">Trading and Net Asset Value Information</a></div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-align: right; text-indent: 0"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">S-5</div></td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#proceeds">Use of Proceeds</a></div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-align: right; text-indent: 0"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">S-5</div></td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#pod">Plan of Distribution</a></div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-align: right; text-indent: 0"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">S-6</div></td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#cap">Capitalization</a> </div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-align: right; text-indent: 0"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">S-7</div></td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#legmatt">Legal Matters</a></div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-align: right; text-indent: 0"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">S-8</div></td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#avinfo">Available Information</a></div></td>
    <td style="padding: 0; vertical-align: bottom; text-indent: 0">&#160;&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-align: right; text-indent: 0"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">S-8</div></td>
    <td style="padding: 0; white-space: nowrap; vertical-align: bottom; text-indent: 0">&#160;</td></tr>
  </table>

<p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 10pt">&#160;</p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: -6pt; font-size: 10pt"><b>Prospectus</b></p>

<p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; width: 90%; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_1">PROSPECTUS SUMMARY</a></span></td>
    <td style="padding-right: 0.05in; width: 10%; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_2">SUMMARY OF FUND EXPENSES</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_3">FINANCIAL HIGHLIGHTS</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_4">TRADING AND NET ASSET VALUE INFORMATION</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_5">THE FUND</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_6">USE OF PROCEEDS</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_7">THE FUND&#8217;S INVESTMENTS</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_8">USE OF LEVERAGE</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_9">RISK FACTORS</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_10">MANAGEMENT OF THE FUND</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_11">NET ASSET VALUE</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_12">DISTRIBUTIONS</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_13">DIVIDEND REINVESTMENT PLAN</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_14">PLAN OF DISTRIBUTION</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_15">DESCRIPTION OF SHARES</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_16">RIGHTS OFFERINGS</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_17">CERTAIN PROVISIONS IN THE DECLARATION OF TRUST AND BY-LAWS</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_18">REPURCHASE OF FUND SHARES; CONVERSION TO OPEN-END FUND</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_19">TAX MATTERS</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_20">CUSTODIAN AND TRANSFER AGENT</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_21">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_22">LEGAL MATTERS</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_23">AVAILABLE INFORMATION</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom">
    <td style="padding: 0; text-align: left; text-indent: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#toc780884_24">INCORPORATION BY REFERENCE</a></span></td>
    <td style="padding-right: 0.05in; text-align: right; padding-top: 0in; padding-bottom: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<div style="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-indent: 0.5in"><div style="font-weight: bold; display: inline">You should rely only on the information contained or incorporated by reference into this prospectus supplement and the accompanying prospectus. The Fund has not authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. The Fund is not making an offer of Common Shares in any state where the offer is not permitted. You should not assume that the information contained in this prospectus supplement and the accompanying prospectus is accurate as of any date other than the respective dates on the front covers. The Fund&#8217;s business, financial condition and prospects may have changed since that date. </div></div>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt">&#160;</div>

<div style="font: 11pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></div>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline"><span id="fls"></span>FORWARD-LOOKING STATEMENTS </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">Any projections, forecasts and estimates contained or incorporated by reference herein are forward looking statements and are based upon certain assumptions. Projections, forecasts and estimates are necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying any projections, forecasts or estimates will not materialize or will vary significantly from actual results. Actual results may vary from any projections, forecasts and estimates and the variations may be material. Some important factors that could cause actual results to differ materially from those in any forward-looking statements include changes in interest rates, market, financial or legal uncertainties, including changes in tax law, and the timing and frequency of defaults on underlying investments. Consequently, the inclusion of any projections, forecasts and estimates herein should not be regarded as a representation by the Fund or any of its affiliates or any other person or entity of the results that will actually be achieved by the Fund. Neither the Fund nor its affiliates has any obligation to update or otherwise revise any projections, forecasts and estimates including any revisions to reflect changes in economic conditions or other circumstances arising after the date hereof or to reflect the occurrence of unanticipated events, even if the underlying assumptions do not come to fruition. The Fund acknowledges that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995 does not apply to investment companies such as the Fund.</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"></div>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt"></div>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline"><span id="pss"></span>PROSPECTUS SUPPLEMENT SUMMARY </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"><div style="font-style: normal; letter-spacing: 0px; top: 0px; display: inline"><div style="font-style: italic; display: inline">This is only a summary. You should review the more detailed information contained elsewhere in this prospectus supplement (&#8220;Prospectus Supplement&#8221;), in the accompanying prospectus and in the statement of additional information (&#8220;SAI&#8221;). </div></div></div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 20%">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">The Fund </div></div> </div></td>
    <td style="width: 80%">Nuveen Arizona Quality Municipal Income Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company. The Fund&#8217;s common shares, $.01 par value per share (the &#8220;Common Shares&#8221;), are traded on the NYSE under the symbol &#8220;NAZ&#8221;. See &#8220;Description of Shares&#8212;Common Shares&#8221; in the accompanying  prospectus. </td></tr>
  </table>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 20%">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">Investment Adviser </div></div> </div></td>
    <td style="width: 80%">Nuveen Fund Advisors, LLC (&#8220;Nuveen Fund Advisors&#8221;) is the Fund&#8217;s investment adviser, responsible for overseeing the Fund&#8217;s overall investment strategy and its implementation. </td></tr>
  </table>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr>
    <td style="width: 20%">&#160;</td>
    <td style="vertical-align: top; text-align: left; width: 80%">Nuveen Fund Advisors, a registered investment adviser, offers advisory and investment management services to a broad range of investment company clients. Nuveen Fund Advisors has overall responsibility for management of the Fund, oversees the management of the Fund&#8217;s portfolio, manages the Fund&#8217;s business affairs and provides certain clerical, bookkeeping and other administrative services. Nuveen Fund Advisors is located at 333 West Wacker Drive, Chicago, Illinois 60606. Nuveen Fund Advisors is an indirect subsidiary of Nuveen, LLC (&#8220;Nuveen&#8221;), the investment management arm of Teachers Insurance and Annuity Association of America (&#8220;TIAA&#8221;). TIAA is a life insurance company founded in 1918 by the Carnegie Foundation for the Advancement of Teaching and is the companion organization of College Retirement Equities Fund. As of March 31, 2025, Nuveen managed approximately $1.3 trillion in assets, of which approximately $147.1&#160;billion was managed by Nuveen Fund Advisors. </td></tr>
  </table>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 20%">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">Sub-Adviser</div> </div></div> </div></td>
    <td style="width: 80%">Nuveen Asset Management, LLC (&#8220;Nuveen Asset Management&#8221;), located at 333 West Wacker Drive, Chicago, Illinois 60606, serves as the Fund&#8217;s investment <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">sub-adviser</div> and is an affiliate of Nuveen Fund Advisors. Nuveen Asset Management is a registered investment adviser. Nuveen Asset Management oversees the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">day-to-day</div></div> investment operations of the Fund. </td></tr>
  </table>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 20%">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">The Offering </div></div> </div></td>
    <td style="width: 80%">
        <div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 0%">The Fund has entered into a distribution agreement (the &#8220;Distribution Agreement&#8221;) with Nuveen Securities, LLC (&#8220;Nuveen Securities&#8221;), a registered broker-dealer affiliate of Nuveen Fund Advisors and Nuveen Asset Management, to provide for distribution of the Common Shares. Nuveen Securities has entered into a selected dealer agreement with Virtu Americas LLC (&#8220;Virtu Americas&#8221;) pursuant to which Virtu Americas will be acting as Nuveen Securities&#8217; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">sub-placement</div> agent with respect</div>
        <div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 0%"></div></td></tr>
  </table>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt"></div>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr>
    <td style="width: 20%">&#160;</td>
    <td style="vertical-align: top; text-align: left; width: 80%">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 0%">to the Common Shares offered pursuant to this Prospectus Supplement and the accompanying prospectus. The minimum price on any day at which Common Shares may be sold will not be less than the then current NAV per Common Share plus the per Common Share amount of the commission to be paid to Nuveen Securities (the &#8220;Minimum Price&#8221;). The Fund and Nuveen Securities will determine whether any sales of Common Shares will be authorized on a particular day. The Fund and Nuveen Securities, however, will not authorize sales of Common Shares if the price per Common Share is less than the Minimum Price. The Fund and Nuveen Securities may elect not to authorize sales of Common Shares on a particular day even if the price per Common Share is equal to or greater than the Minimum Price, or may only authorize a fixed number of Common Shares to be sold on any particular day. The Fund and Nuveen Securities will have full discretion regarding whether sales of Common Shares will be authorized on a particular day and, if so, in what amounts. </div></td></tr>
  </table>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr>
    <td style="width: 20%">&#160;</td>
    <td style="vertical-align: top; text-align: left; width: 80%">The Fund will compensate Nuveen Securities with respect to sales of Common Shares at a variable commission rate. The variable commission rate shall be equal to the sum of (i) seventy-five percent (75%) of the premium to net asset value with respect to the sale of any Common Shares sold until such compensation is equal to 0.80% of the aggregate gross sales proceeds and (ii) twenty-five percent (25%) of the premium to net asset value with respect to the sale of any Common Shares sold until such compensation is equal to 0.20% of the aggregate gross sales proceeds. &#8220;Gross sales proceeds&#8221; with respect to each sale of Common Shares shall be the gross sales price per Common Share multiplied by the number of Common Shares sold. The gross sales price with respect to each sale of Common Shares sold pursuant to the Distribution Agreement shall be the gross sales price per Common Share of such Common Shares. Nuveen Securities will compensate Virtu Americas as sub-placement agent at a variable commission rate equal to seventy-five percent (75%) of the premium to net asset value with respect to the sale of any Common Shares sold until such compensation is equal to 0.80% of the aggregate gross sales proceeds. Settlements of sales of Common Shares will occur on the first business day following the date on which any such sales are made.</td></tr>
  </table>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr>
    <td style="width: 20%">&#160;</td>
    <td style="vertical-align: top; text-align: left; width: 80%">In connection with the sale of the Common Shares on behalf of the Fund, Nuveen Securities may be deemed to be an underwriter within the meaning of the Securities Act of 1933, as amended (the &#8220;1933 Act&#8221;), and the compensation of Nuveen Securities may be deemed to be underwriting commissions or discounts. Unless otherwise indicated in a further prospectus supplement, Nuveen Securities will act as underwriter on a reasonable efforts basis. </td></tr>
  </table>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr>
    <td style="width: 20%">&#160;</td>
    <td style="vertical-align: top; text-align: left; width: 80%">The offering of Common Shares pursuant to the Distribution Agreement will terminate upon the earlier of (i)&#160;the sale of all Common Shares subject thereto or (ii)&#160;termination of the Distribution Agreement. The Fund and Nuveen Securities each have the right to terminate the Distribution Agreement in its discretion at any time. See &#8220;Plan of Distribution.&#8221; </td></tr>
  </table>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 20%"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px; display: inline">&#160;</div></td>
    <td style="width: 80%">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 0%">The principal business address of Nuveen Securities is 333 West Wacker Drive, Chicago, Illinois 60606. </div></td></tr>
  </table>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 20%">
        <div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">Risk Factors</div></div> </div></td>
    <td style="width: 80%">See &#8220;Risk Factors&#8221; in the accompanying prospectus, for a discussion of the principal risks you should carefully consider before deciding to invest in the Common Shares. </td></tr>
  </table>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt"></div>

<!-- Field: Page; Sequence: 6 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline"><span id="sfe"></span>SUMMARY OF FUND EXPENSES </div></div>

<ix:nonNumeric contextRef="AsOf2025-04-18" escape="true" id="Fact000015" name="cef:PurposeOfFeeTableNoteTextBlock"><div id="xdx_804_ecef--PurposeOfFeeTableNoteTextBlock_dU_zzkWLXa6cqS3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The
purpose of the table and the example below is to help you understand all fees and expenses that you, as a shareholder of Common
Shares (&#8220;Common Shareholder&#8221;), would bear directly or indirectly. The table shows the expenses of the Fund as a
percentage of the average net assets applicable to Common Shares, and not as a percentage of total assets or Managed Assets (as defined in the accompanying prospectus).</div>

</ix:nonNumeric><ix:nonNumeric contextRef="AsOf2025-04-18" continuedAt="ConU000018-01" escape="true" id="Fact000018" name="cef:ShareholderTransactionExpensesTableTextBlock"><div id="xdx_801_ecef--ShareholderTransactionExpensesTableTextBlock_dU_gL1STETTB-DVDSMW_zE5OaxVhJPke" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%">
  <tr>
    <td style="width: 94%"/>
    <td style="vertical-align: bottom; width: 4%"/>
    <td/>
    <td/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: #cceeff">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">Shareholder Transaction Expenses </div></div><span id="xdx_906_ecef--BasisOfTransactionFeesNoteTextBlock_c20250418__20250418_zMvvcOQCKtS9"><ix:nonNumeric contextRef="AsOf2025-04-18" escape="true" id="Fact000019" name="cef:BasisOfTransactionFeesNoteTextBlock">(as a percentage of offering price)</ix:nonNumeric></span><div style="letter-spacing: 0px; top: 0px; display: inline"></div></div></td>
    <td style="vertical-align: bottom">&#160;&#160;</td>
    <td style="vertical-align: bottom"/>
    <td style="vertical-align: bottom"/>
    <td style="vertical-align: bottom"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em">Maximum Sales Charge</div></td>
    <td style="vertical-align: bottom">&#160;&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_987_ecef--SalesLoadPercent_dp_c20250418__20250418_fKg_____zTjtjQmXxTug" style="vertical-align: bottom; text-align: right"><ix:nonFraction name="cef:SalesLoadPercent" contextRef="AsOf2025-04-18" id="Fact000020" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.00</ix:nonFraction>%</td>
    <td style="white-space: nowrap; vertical-align: bottom"><sup>*</sup>&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: #cceeff">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em">Offering Costs<div style="font-size: 75%; vertical-align: top; display: inline; font-size: 8.3px">(1) </div></div></td>
    <td style="vertical-align: bottom">&#160;&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_984_ecef--OtherTransactionExpensesPercent_dp_c20250418__20250418_fKDEp_zDpNuVt0D1X3" style="vertical-align: bottom; text-align: right"><ix:nonFraction name="cef:OtherTransactionExpensesPercent" contextRef="AsOf2025-04-18" id="Fact000021" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.49</ix:nonFraction>%</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em">Dividend Reinvestment Plan Fees<div style="font-size: 75%; vertical-align: top; display: inline; font-size: 8.3px">(2) </div></div></td>
    <td style="vertical-align: bottom">&#160;&#160;</td>
    <td style="vertical-align: bottom">$</td>
    <td id="xdx_98C_ecef--DividendReinvestmentAndCashPurchaseFees_pp2p0_c20250418__20250418_fKDIp_z9cJXEp4Pe99" style="vertical-align: bottom; text-align: right"><ix:nonFraction name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="AsOf2025-04-18" id="Fact000022" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">2.50</ix:nonFraction></td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  </table>

<div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F04_z0HYTuXwT2p3" style="width: 2%; vertical-align: top; text-align: left">*</td>
    <td style="vertical-align: top; text-align: left; width: 98%">
        <div id="xdx_F1E_zwFGXYf0Jnc1" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><ix:footnote id="Footnote000023" xml:lang="en-US">
    The maximum sales charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters in an offering that is not made at-the-market, the applicable prospectus supplement will set forth any other applicable sales load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering. </ix:footnote></div></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; display: none; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F08_zhChSEFH60Nf" style="width: 4%; vertical-align: top; text-align: left">(1)</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F19_zDBcWxvIeML6" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><ix:footnote id="Footnote000024" xml:lang="en-US">Assuming
        a Common Share offering price of $11.79
        (the closing price of the Common Shares on the NYSE on April 14, 2025). </ix:footnote></div></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; display: none; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F08_zRmKNlk0Fm4g" style="width: 4%; vertical-align: top; text-align: left">(2)</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F15_zfKUWE2NZFvg" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><ix:footnote id="Footnote000025" xml:lang="en-US">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account.</ix:footnote></div></td></tr>
  </table>

</ix:nonNumeric><div id="xdx_817_zk3cw9nU1XW9"></div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><br/></div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"></div>

<ix:nonNumeric contextRef="AsOf2025-04-18" continuedAt="ConU000028-01" escape="true" id="Fact000028" name="cef:AnnualExpensesTableTextBlock"><div id="xdx_808_ecef--AnnualExpensesTableTextBlock_dU_gL1AETTB-TW_zOYuGDr7ExJ6"></div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%">
  <tr>
    <td/>
    <td style="vertical-align: bottom"/>
    <td/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: White">
    <td style="vertical-align: top; width: 82%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom; width: 11%"><span style="font-family: Times New Roman, Times, Serif"><b>As a Percentage of Net Assets Attributable to Common Shares<sup>(3)</sup></b></span></td>
    <td style="vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: White">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><div style="font-weight: bold; display: inline"><span style="font-family: Times New Roman, Times, Serif">Annual Expenses</span></div></div></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td style="vertical-align: bottom"/>
    <td style="vertical-align: bottom"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 20pt; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif">Management Fees</span></div></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td id="xdx_987_ecef--ManagementFeesPercent_dp_c20250418__20250418_fKDMp_zfUN1oQiP816" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="cef:ManagementFeesPercent" contextRef="AsOf2025-04-18" id="Fact000029" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.97</ix:nonFraction>%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="text-align: left; vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 20pt; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif">Interest
        and Other Related Expenses <sup>(4)</sup></span></div></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td id="xdx_98C_ecef--InterestExpensesOnBorrowingsPercent_dp_c20250418__20250418_fKDMpKDQp_zzoXe64zI6I4" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="cef:InterestExpensesOnBorrowingsPercent" contextRef="AsOf2025-04-18" id="Fact000030" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.61</ix:nonFraction>%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255); page-break-inside: avoid">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt; vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other Expenses <sup>(5)</sup></span></div></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td id="xdx_988_ecef--OtherAnnualExpensesPercent_dp_c20250418__20250418_fKDMpKDUp_zRn8W0NsUF8i" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="cef:OtherAnnualExpensesPercent" contextRef="AsOf2025-04-18" id="Fact000031" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.14</ix:nonFraction>%</span></td>
    <td style="padding-bottom: 1pt; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="text-align: left; vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif">Total Annual Expenses</span></div></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td id="xdx_980_ecef--TotalAnnualExpensesPercent_dp_c20250418__20250418_fKDMp_znySGzqOK879" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><ix:nonFraction name="cef:TotalAnnualExpensesPercent" contextRef="AsOf2025-04-18" id="Fact000032" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">3.72</ix:nonFraction>%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%">&#160;</div>

</ix:nonNumeric><div id="xdx_818_z9d9nPwuHQSe"></div>

<div id="xdx_C0E_gL1STETTB-DVDSMW_znqufkUrUd65"><ix:continuation id="ConU000018-01">

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td style="width: 4%; vertical-align: top; text-align: left">(1)</td>
    <td style="vertical-align: top; text-align: left">
        <div style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span id="xdx_906_ecef--OtherTransactionFeesNoteTextBlock_c20250418__20250418_z6YgRTEszduc"><ix:nonNumeric contextRef="AsOf2025-04-18" escape="true" id="Fact000033" name="cef:OtherTransactionFeesNoteTextBlock">Assuming
        a Common Share offering price of <span id="xdx_90C_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z02esFTRIWml">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-04-14_us-gaap_CommonStockMember" id="Fact000034" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.79</ix:nonFraction></span>
        (the closing price of the Common Shares on the NYSE on April 14, 2025). </ix:nonNumeric></span></div></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td style="width: 4%; vertical-align: top; text-align: left">(2)</td>
    <td style="vertical-align: top; text-align: left">
        <div style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account. </div></td></tr>
  </table> </ix:continuation></div>

<div id="xdx_C08_gL1AETTB-TW_zNU4Gr9P40sl"><ix:continuation id="ConU000028-01">

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F06_zx07KqSG6T4j" style="width: 4%; vertical-align: top; text-align: left">(3)</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F1B_ztsskV1elOlg" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><ix:footnote id="Footnote000035" xml:lang="en-US">
        Stated as annualized percentages of average net assets attributable to Common Shares for the six-month fiscal year ended August 31,
        2024 (annualized).</ix:footnote></div></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F00_zOB1JzvPsoB5" style="width: 4%; vertical-align: top; text-align: left">(4)</td>
    <td id="xdx_F10_zlLMyWzYPXH9" style="vertical-align: top; text-align: left"><ix:footnote id="Footnote000036" xml:lang="en-US">Interest and Other Related Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month fiscal year ended August 31, 2024 (annualized). The types of leverage used by the Fund during the six-month fiscal year ended August 31, 2024 (annualized) are described in the Fund Leverage and the Notes to Financial Statements sections of the Fund's annual report. Actual Interest and Other Related Expenses incurred in the future maybe higher or lower. If short-term market interest rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates, the Fund&#146;s interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund&#8217;s use of leverage will increase the amount of management fees paid to the Fund&#8217;s adviser and sub-advisor(s).</ix:footnote></td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F04_zZc5hFyPmWd6" style="width: 4%; vertical-align: top; text-align: left">(5)</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F14_z96hsuJvXrke" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><ix:footnote id="Footnote000037" xml:lang="en-US">
    <span id="xdx_90D_ecef--OtherExpensesNoteTextBlock_c20250418__20250418_zmVchX1UmQih"><ix:nonNumeric contextRef="AsOf2025-04-18" escape="true" id="Fact000038" name="cef:OtherExpensesNoteTextBlock">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#8217;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#8220;The Fund&#8217;s Investments&#8212;Other Investment Companies&#8221; in the SAI. </ix:nonNumeric></span></ix:footnote></div></td></tr>
  <tr style="page-break-inside: avoid">
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td></tr>
  </table>
</ix:continuation></div>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt">&#160;</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></div>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><ix:nonNumeric contextRef="AsOf2025-04-18" continuedAt="Con000040-01" escape="true" id="Fact000040" name="cef:ExpenseExampleTableTextBlock"><div id="xdx_809_ecef--ExpenseExampleTableTextBlock_dU_zrESIo3FGNH1" style="font: bold 10pt Times New Roman, Times, Serif; display: inline">Example </div></ix:nonNumeric></div>

<ix:continuation id="Con000040-01"><div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The following example illustrates the expenses including the applicable transaction fees (referred to as the &#8220;Maximum Sales Charge&#8221; in the fee table above), if any, and estimated offering costs, that a Common Shareholder would pay on a $1,000 investment that is held for the time periods provided in the table. The example assumes that all dividends and other distributions are reinvested in the Fund and that the Fund&#8217;s Annual Total Expenses, as provided above, remain the same. The example also assumes a transaction fee of 1.00%, as a percentage of the offering price, and a 5% annual return.<div style="font-size: 75%; vertical-align: top; display: inline; font-size: 9.1px">1</div> </div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 60%">
  <tr>
    <td/>
    <td style="vertical-align: bottom; width: 25%"/>
    <td/>
    <td style="vertical-align: bottom; width: 25%"/>
    <td/>
    <td style="vertical-align: bottom; width: 25%"/></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="border-bottom: #000000 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">1&#160;Year</div></div></td>
    <td style="vertical-align: bottom; padding-bottom: 0.5pt">&#160;</td>
    <td style="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">3&#160;Years</div></div></td>
    <td style="vertical-align: bottom; padding-bottom: 0.5pt">&#160;</td>
    <td style="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">5&#160;Years</div></div></td>
    <td style="vertical-align: bottom; padding-bottom: 0.5pt">&#160;</td>
    <td style="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">10&#160;Years</div></div></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: #cceeff">
    <td id="xdx_98A_ecef--ExpenseExampleYear01_c20250418__20250418_fKDEp_zuIuIR6z1VJ4" style="vertical-align: bottom; text-align: center">$<ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="AsOf2025-04-18" id="Fact000041" format="ixt:numdotdecimal" decimals="0" unitRef="USD">52</ix:nonFraction></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_983_ecef--ExpenseExampleYears1to3_c20250418__20250418_fKDEp_z04Xyt8cWdgg" style="vertical-align: bottom; text-align: center">$<ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="AsOf2025-04-18" id="Fact000042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">127</ix:nonFraction></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_98E_ecef--ExpenseExampleYears1to5_c20250418__20250418_fKDEp_zdRw44Fs9R7l" style="vertical-align: bottom; text-align: center">$<ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="AsOf2025-04-18" id="Fact000043" format="ixt:numdotdecimal" decimals="0" unitRef="USD">204</ix:nonFraction></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_98F_ecef--ExpenseExampleYears1to10_c20250418__20250418_fKDEp_zGaCCLJzEUlf" style="vertical-align: bottom; text-align: center">$<ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="AsOf2025-04-18" id="Fact000044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">406</ix:nonFraction></td></tr>
  </table>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"><div style="font-weight: bold; display: inline">The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those shown above. </div></div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td style="width: 2%; vertical-align: top; text-align: left"><div id="xdx_F0E_zX9gNnjs15O1" style="font-size: 75%; vertical-align: top; display: inline; font-size: 9.1px">(1)</div>&#160;</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F13_zlfieIQghqla" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><ix:footnote id="Footnote000045" xml:lang="en-US">
    The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example. </ix:footnote></div></td></tr>
  </table>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt">&#160;</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></div>

<ix:exclude><!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

</ix:continuation><div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="AsOf2025-04-18" continuedAt="Con000047-01" escape="true" id="Fact000047" name="cef:SharePriceTableTextBlock"><div id="xdx_808_ecef--SharePriceTableTextBlock_dU_zeFXUFAqjOjh" style="text-align: center; font-weight: bold; display: inline"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="trading"></span>TRADING AND NET ASSET VALUE INFORMATION</span></div></ix:nonNumeric></div>

<ix:continuation id="Con000047-01"><div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The following table shows for the periods indicated: (i)&#160;the high and low sales prices for the Common Shares reported as of the end of the day on the NYSE, (ii)&#160;the corresponding NAV per share, and (iii)&#160;the premium/(discount) to NAV per share at which the Common Shares were trading as of such date. The Fund&#8217;s Common Shares have historically traded both at premiums and discounts in relation to the Fund&#8217;s NAV per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might be taken to reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of such shares in the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion of the Fund to an open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of these actions, or that share repurchases or tender offers will actually reduce market discount.</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%">
  <tr style="border-bottom: Black 1pt solid; display: none; visibility: hidden; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 0pt">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_488_ecef--HighestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMj3CmfwFjti" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_481_ecef--LowestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zDkzjJ0gZfR7" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_48E_ecef--HighestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3ShTHTlK4ab" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_481_ecef--LowestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0aTUt17m3d9" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_483_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zuuuYg3cHfU1" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_485_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsVaUze4oI8" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold">&#160;</td>
    <td colspan="7" style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold">&#160;</td>
    <td colspan="7" style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif">&#160;</td>
    <td colspan="7" style="white-space: nowrap; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Closing Market Price<br/>per Common Share</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">NAV per Common Share<br/>on Date of Market Price</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; padding-bottom: 0pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; text-align: center">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Premium/(Discount) on</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Date of Market Price</b></p></td></tr>
  <tr style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 0pt">Fiscal Quarter End</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;High&#8199;&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;Low&#8199;&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;High&#8199;&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;Low&#8199;&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;High&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;Low&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr id="xdx_41C_20241201__20250228_z5MFGj29r6Tl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">February 2025</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember" id="Fact000048" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.70</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember" id="Fact000049" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.28</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember" id="Fact000050" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.17</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember" id="Fact000051" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.09</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember" id="Fact000052" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.35</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember" id="Fact000053" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.70</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_413_20240901__20241130_zqukCJjPhKb9" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">November 2024</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="Fact000054" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.29</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="Fact000055" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.54</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="Fact000056" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.49</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="Fact000057" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.35</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="Fact000058" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">1.60</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember" id="Fact000059" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.56</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_410_20240601__20240831_z3JFofs0Jxjf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Times New Roman, Times, Serif; text-align: left">August 2024</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="width: 5%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="Fact000060" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.77</ix:nonFraction></td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="width: 5%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="Fact000061" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.68</ix:nonFraction></td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="width: 9%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="Fact000062" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.73</ix:nonFraction></td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="width: 9%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="Fact000063" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.33</ix:nonFraction></td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="width: 3%; font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="Fact000064" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">7.54</ix:nonFraction></td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="width: 3%; font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember" id="Fact000065" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">13.38</ix:nonFraction></td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_410_20240301__20240531_zZe2ZswQmNyd" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">May 2024</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember" id="Fact000066" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.05</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember" id="Fact000067" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.55</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember" id="Fact000068" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.76</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember" id="Fact000069" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.33</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember" id="Fact000070" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">13.40</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember" id="Fact000071" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">14.44</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_419_20231201__20240229_zOpZ67B6tENb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">February 2024</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember" id="Fact000072" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.94</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember" id="Fact000073" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.57</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember" id="Fact000074" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.63</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember" id="Fact000075" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.39</ix:nonFraction> </td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember" id="Fact000076" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">13.38</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember" id="Fact000077" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">14.69</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_412_20230901__20231130_zkO84MC4UCd5" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">November 2023</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember" id="Fact000078" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.47</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember" id="Fact000079" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">9.26</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember" id="Fact000080" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.36</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember" id="Fact000081" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.20</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember" id="Fact000082" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">15.29</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember" id="Fact000083" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">17.32</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_41A_20230601__20230831_zwayjvCbwBwd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">August 2023</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember" id="Fact000084" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.82</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember" id="Fact000085" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.27</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember" id="Fact000086" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.60</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember" id="Fact000087" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.09</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember" id="Fact000088" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">14.13</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember" id="Fact000089" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">15.05</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_41F_20230301__20230531_zNfI1G5BuW4g" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">May 2023</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember" id="Fact000090" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.30</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember" id="Fact000091" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.56</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember" id="Fact000092" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.63</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember" id="Fact000093" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.22</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember" id="Fact000094" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">10.53</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember" id="Fact000095" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">13.58</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_419_20221201__20230228_zvAsuNSZxD9c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">February 2023</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember" id="Fact000096" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.15</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember" id="Fact000097" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.16</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember" id="Fact000098" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.96</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember" id="Fact000099" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.37</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember" id="Fact000100" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">6.25</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember" id="Fact000101" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">9.78</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_41F_20220901__20221130_z3obWbHxBRU3" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">November 2022</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember" id="Fact000102" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.94</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember" id="Fact000103" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.61</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember" id="Fact000104" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.54</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"><ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember" id="Fact000105" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.71</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember" id="Fact000106" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">11.16</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember" id="Fact000107" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">0.85</ix:nonFraction></td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  </table>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The NAV per Common
Share, the market price and percentage of premium/(discount) to NAV per Common Share on April 14, 2025 was <span id="xdx_902_eus-gaap--NetAssetValuePerShare_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zu8rIqtPAI7g">$<ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-04-14_us-gaap_CommonStockMember" id="Fact000108" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.31</ix:nonFraction></span>, <span id="xdx_90D_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zULm9teFsU01">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-04-14_us-gaap_CommonStockMember" id="Fact000109" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.79</ix:nonFraction></span>, <span id="xdx_90E_ecef--LatestPremiumDiscountToNavPercent_c20250414__20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zakmU9T7oUm7">
<ix:nonFraction name="cef:LatestPremiumDiscountToNavPercent" contextRef="From2025-04-142025-04-14_us-gaap_CommonStockMember" id="Fact000110" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">4.24</ix:nonFraction>%</span>, respectively. As of April 14, 2025, the Fund had <span id="xdx_90E_ecef--OutstandingSecurityNotHeldShares_c20250414__20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkXYJWALFg68">
<ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-04-142025-04-14_us-gaap_CommonStockMember" id="Fact000111" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,597,297</ix:nonFraction></span> Common Shares outstanding, and net assets applicable to Common Shares of $131,117,293. See &#8220;Repurchase of Fund
Shares; Conversion to Open-End Fund&#8221; in the accompanying prospectus.</div>

</ix:continuation><div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: center"><div id="xdx_818_zBSxIM66CoGf" style="font-weight: bold; display: inline"><span id="proceeds"></span>USE OF PROCEEDS </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">Assuming the sale of
all of the Common Shares offered under this Prospectus Supplement and the accompanying prospectus, at the last reported sale price of
<span id="xdx_90E_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zDuVjLopNi5f">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-04-14_us-gaap_CommonStockMember" id="Fact000112" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.79</ix:nonFraction></span>
per share for Common Shares on the NYSE as of April 14, 2025, the Fund estimates that the net proceeds of this offering will be approximately
$13,936,520 after deducting the estimated sales load and the estimated offering expenses payable by the Fund, if any. There is no guarantee
that there will be any sales of Common Shares pursuant to this Prospectus Supplement and the accompanying prospectus. Actual sales, if
any, of Common Shares under this Prospectus Supplement and the accompanying prospectus may be less than as set forth above. In addition,
the price per share of any such sale may be greater or less than the price set forth above, depending on the market price of Common Shares
at the time of any such sale. As a result, the actual net proceeds the Fund receives may be more or less than the amount of net proceeds
estimated in this Prospectus Supplement.</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The net proceeds from the issuance of Common Shares hereunder will be invested in accordance with the Fund&#8217;s investment objective and policies as set forth in the accompanying prospectus. The Fund currently anticipates that it will be able to invest substantially all of the net proceeds in investments that meet the Fund&#8217;s investment objective and policies within approximately three months of the receipt of such proceeds. Pending investment, it is anticipated that the proceeds will be invested in short-term or long-term securities issued by the U.S. Government and its agencies or instrumentalities or in high-quality, short-term money market instruments.</div>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt">&#160;</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></div>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline"><span id="pod"></span>PLAN OF DISTRIBUTION </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund will bear the expenses of this offering, including but not limited to, the expenses of preparation of the prospectus, including this Prospectus Supplement, and SAI for this offering and the expense of counsel and auditors in connection with the offering. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund has entered into a distribution agreement (the &#8220;Distribution Agreement&#8221;) with Nuveen Securities, LLC (&#8220;Nuveen Securities&#8221;). Subject to the terms and conditions of the Distribution Agreement, the Fund may from time to time issue and sell its Common Shares through Nuveen Securities to certain broker-dealers which have entered into selected dealer agreements with Nuveen Securities. Currently, Nuveen Securities has entered into a selected dealer agreement with Virtu Americas LLC (&#8220;Virtu Americas&#8221;) pursuant to which Virtu Americas will be acting as the exclusive <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">sub-placement</div> agent with respect to the Common Shares offered pursuant to this Prospectus Supplement and the accompanying prospectus. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The minimum price on any day at which Common Shares may be sold will not be less than the then current NAV per Common Share plus the per Common Share amount of the commission to be paid to Nuveen Securities (the &#8220;Minimum Price&#8221;). The Fund and Nuveen Securities will determine whether any sales of Common Shares will be authorized on a particular day. The Fund and Nuveen Securities, however, will not authorize sales of Common Shares if the price per Common Share is less than the Minimum Price. The Fund and Nuveen Securities may elect not to authorize sales of Common Shares on a particular day even if the price per Common Share is equal to or greater than the Minimum Price, or may only authorize a fixed number of Common Shares to be sold on any particular day. The Fund and Nuveen Securities will have full discretion regarding whether sales of Common Shares will be authorized on a particular day and, if so, in what amounts. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund will compensate Nuveen Securities with respect to sales of Common Shares at a variable commission rate. The variable commission rate shall be equal to the sum of (i) seventy-five percent (75%) of the premium to net asset value with respect to the sale of any Common Shares sold until such compensation is equal to 0.80% of the aggregate gross sales proceeds and (ii) twenty-five percent (25%) of the premium to net asset value with respect to the sale of any Common Shares sold until such compensation is equal to 0.20% of the aggregate gross sales proceeds. &#8220;Gross sales proceeds&#8221; with respect to each sale of Common Shares shall be the gross sales price per Common Share multiplied by the number of Common Shares sold. The gross sales price with respect to each sale of Common Shares sold pursuant to the Distribution Agreement shall be the gross sales price per Common Share of such Common Shares. Nuveen Securities will compensate Virtu Americas as sub-placement agent at a variable commission rate equal to seventy-five percent (75%) of the premium to net asset value with respect to the sale of any Common Shares sold until such compensation is equal to 0.80% of the aggregate gross sales proceeds. Settlements of sales of Common Shares will occur on the first business day following the date on which any such sales are made. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with the sale of the Common Shares on behalf of the Fund, Nuveen Securities may be deemed to be an underwriter within the meaning of the 1933 Act, and the compensation of Nuveen Securities may be deemed to be underwriting commissions or discounts. Unless otherwise indicated in a further prospectus supplement, Nuveen Securities will act as underwriter on a reasonable efforts basis. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The offering of Common Shares pursuant to the Distribution Agreement will terminate upon the earlier of (i)&#160;the sale of all Common Shares subject thereto or (ii)&#160;termination of the Distribution Agreement. The Fund and Nuveen Securities each have the right to terminate the Distribution Agreement in its discretion at any time. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">Virtu Americas, its affiliates and their respective employees hold or may hold in the future, directly or indirectly, investment interests in Nuveen, Nuveen Fund Advisors, TIAA, or any of their affiliates or funds. The interests held by employees of Virtu Americas, or its affiliates are not attributable to, and no investment discretion is held by, Virtu Americas, or its affiliates. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The principal business address of Nuveen Securities is 333 West Wacker Drive, Chicago, Illinois 60606. </div>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt">&#160;</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></div>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline"><span id="cap"></span>CAPITALIZATION </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer
and sell up to 1,200,000 of its Common Shares, $0.01 par value per share, from time to time through Virtu Americas,
as&#160;sub-placement&#160;agent under this Prospectus Supplement and the accompanying prospectus. There is no guarantee that there
will be any sales of the Common Shares pursuant to this Prospectus Supplement and the accompanying prospectus. The table below
assumes that the Fund will sell 1,200,000 of its Common Shares at a price of <span id="xdx_90B_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdcu0ko0BQff">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-04-14_us-gaap_CommonStockMember" id="Fact000113" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.79</ix:nonFraction></span>
per share (which represents the last reported sales price per share of the Common Shares on the NYSE on April 14, 2025). Actual
sales, if any, of the Common Shares under this Prospectus Supplement and the accompanying prospectus may be greater or less than
$11.79 per share, depending on the market price of the Common Shares at the time of any such sale. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The following table
sets forth the Fund&#8217;s capitalization (1)&#160;on a historical basis as of April 14, 2025; and (2)&#160;on a pro forma basis as
adjusted to reflect the assumed sale of 1,200,000 Common Shares at <span id="xdx_90B_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zQHKinTdkM2i">$<ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-04-14_us-gaap_CommonStockMember" id="Fact000114" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.79</ix:nonFraction> </span>
per share (the last reported price per share of the Common Shares on the NYSE on April 14, 2025), in an offering under this
Prospectus Supplement and the accompanying prospectus, after deducting the assumed commission of $141,480  (representing an estimated
commission to Nuveen Securities of 1.00% of the gross proceeds of the sale of Common Shares, out of which Nuveen Securities will
compensate Virtu Americas, at a rate of up to 0.80% of the gross sales proceeds of the sale of the Common Shares sold by Virtu
Americas.</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"></div>



<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">As of April 14, 2025 (unaudited)</td><td style="font-weight: bold">&#160;</td>
    <td colspan="3" style="font-weight: bold; text-align: center">As Adjusted for Offering (unaudited)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%">Common shares</td><td style="width: 5%">&#160;</td>
    <td style="width: 2%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90E_ecef--OutstandingSecurityNotHeldShares_c20250414__20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zJWbIiwx5Z8"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-04-142025-04-14_us-gaap_CommonStockMember" id="Fact000115" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">11,597,297</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 5%">&#160;</td>
    <td style="width: 2%; text-align: left">&#160;</td><td style="width: 12%; text-align: right"><span id="xdx_90F_ecef--OutstandingSecurityNotHeldShares_c20250414__20250414__us-gaap--StatementClassOfStockAxis__custom--CommonStockAdjustedForOfferingMember_zRY9UM9ZRUch"><ix:nonFraction name="cef:OutstandingSecurityNotHeldShares" contextRef="From2025-04-142025-04-14_custom_CommonStockAdjustedForOfferingMember" id="Fact000116" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">12,797,297</ix:nonFraction></span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Paid in Capital</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">156,061,973</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">170,068,493</td><td style="text-align: left">*&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Undistributed net investment income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(6,100,547</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(6,100,547</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accumulated gain/(loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,077,215</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(7,077,215</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Net appreciation/depreciation</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,766,918</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(11,766,918</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Net assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">131,117,293</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">145,123,813</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Net asset value</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_902_eus-gaap--NetAssetValuePerShare_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zmBfTj5LwFla"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-04-14_us-gaap_CommonStockMember" id="Fact000117" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.31</ix:nonFraction></span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_905_eus-gaap--NetAssetValuePerShare_iI_c20250414__us-gaap--StatementClassOfStockAxis__custom--CommonStockAdjustedForOfferingMember_zqXR1Q9cK5L5"><ix:nonFraction name="us-gaap:NetAssetValuePerShare" contextRef="AsOf2025-04-14_custom_CommonStockAdjustedForOfferingMember" id="Fact000118" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.34</ix:nonFraction></span></td><td style="text-align: left">&#160;</td></tr>
  </table>




<div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td style="width: 5%; vertical-align: top; text-align: left">*</td>
    <td style="vertical-align: top; text-align: left">
        <div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Assumes a total of $70,000
        of the estimated offering costs will be deferred over the 3 year life of the registration statement.</div></td></tr>
  </table>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt">&#160;</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></div>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline"><span id="legmatt"></span>LEGAL MATTERS </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">Certain legal matters in connection with the Common Shares will be passed upon for the Fund by Stradley Ronon Stevens &amp; Young, LLP, located at 2005 Market Street, Suite 2600, Philadelphia, Pennsylvania. Stradley Ronon Stevens &amp; Young, LLP may rely as to certain matters of Massachusetts law on the opinion of Morgan, Lewis&#160;&amp; Bockius LLP. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 24pt; margin-bottom: 0pt; text-align: center"><div style="font-weight: bold; display: inline"><span id="avinfo"></span>AVAILABLE INFORMATION </div></div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) and the 1940 Act and is required to file reports, proxy statements and other information with the SEC. Reports, proxy statements, and other information about the Fund can be inspected at the offices of the NYSE. </div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">This Prospectus Supplement does not contain all of the information in the Fund&#8217;s Registration Statement, including amendments, exhibits, and schedules. Additional information about the Fund and the Common Shares can be found in the Fund&#8217;s Registration Statement (including amendments, exhibits, and schedules) on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px; display: inline">N-2</div> filed with the SEC. The SEC maintains a website (www.sec.gov) that contains the Fund&#8217;s Registration Statement, other documents incorporated by reference, and other information the Fund has filed electronically with the SEC, including proxy statements and reports filed under the Exchange Act. </div>

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt">&#160;</h5>

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"></h5>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div>

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>





<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b><span style="text-decoration: underline">BASE PROSPECTUS</span></b></p> <p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; text-align: right">


<img src="nuveenlogo.jpg" alt="LOGO"/>
 </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>1,200,000                                         Shares</b></p>
<p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Common Shares </b></p> <p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Preferred
Shares </b></p> <p style="font: 13pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Rights to Purchase Common Shares </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 17pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Nuveen Arizona
Quality Municipal Income Fund </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt"/>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Offering</i></b><i>.</i>&#160;Nuveen Arizona Quality Municipal Income Fund (the &#147;Fund&#148;) is offering, on an immediate,
continuous or delayed basis, in one or more offerings, up to 1,200,000 common shares (&#147;Common Shares&#148;),
preferred shares (&#147;Preferred Shares&#148;), and/or subscription rights to purchase Common Shares (&#147;Rights,&#148; and
collectively with Common Shares and Preferred Shares, &#147;Securities&#148;), in any combination. The Fund may offer and sell
such Securities directly to one or more purchasers, to or through underwriters, through dealers or agents that the Fund designates
from time to time, or through a combination of these methods. The prospectus supplement relating to any offering of Securities
will describe such offering, including, as applicable, the names of any underwriters, dealers or agents and information regarding
any applicable purchase price, fee, commission or discount arrangements made with those underwriters, dealers or agents or the
basis upon which such amount may be calculated. The prospectus supplement relating to any Rights offering will set forth the number
of Common Shares issuable upon the exercise of each Right (or number of Rights) and the other terms of such Rights offering. For
more information about the manners in which the Fund may offer Securities, see &#147;Plan of Distribution.&#148;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Fund</i>.</b>&#160;The Fund is a diversified, closed-end management investment company. The Fund&#8217;s primary investment objective
is current income exempt from both regular federal income taxes and Arizona individual income taxes, and its secondary investment
objective is the enhancement of portfolio value relative to the Arizona municipal bond market through investments in tax-exempt
Arizona Municipal Obligations (as defined below) that, in the opinion of the Fund&#8217;s investment adviser, are underrated or
undervalued or that represent municipal market sectors that are undervalued. &#8220;Arizona Municipal Obligations&#8221; are various municipal
securities, including municipal bonds and notes, other securities issued to finance and refinance public projects, and other related
securities and derivative instruments creating exposure to municipal bonds, notes and securities that provide for the payment
of interest income that is exempt from federal and Arizona income tax. There can be no assurance that the Fund will achieve its
investment objectives or that the Fund&#146;s investment strategies will be successful.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>This
Prospectus, together with any related prospectus supplement, sets forth concisely information about the Fund that a prospective
investor should know before investing, and should be retained for future reference. Investing in Securities involves risks, including
the risks associated with the Fund&#146;s use of leverage. You could lose some or all of your investment. You should consider
carefully these risks together with all of the other information in this Prospectus and any related prospectus supplement before
making a decision to purchase any of the Securities. See &#147;<a href="#toc780884_9">Risk&#160;Factors</a>&#148; beginning on
page 14.</b></span><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Shares are listed on the New York Stock Exchange (the &#147;NYSE&#148;). The trading or &#147;ticker&#148; symbol of the Common
Shares is &#147;NAZ.&#148; The closing price of the Common Shares, as reported by the NYSE on April 8, 2025, was
$12.01 per Common Share. The net asset value of the Common Shares at the close of business on that same date was
$11.27 per Common Share. Preferred Shares and/or Rights issued by the Fund may also be listed on a securities exchange.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&#8195;*&#8195;*</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this Prospectus, together with any related prospectus supplement, which contains important information about the Fund,
before deciding whether to invest and retain it for future reference. A Statement of Additional Information, dated April 17,
2025 (the &#147;SAI&#148;), containing additional information about the Fund has been filed with the U.S. Securities and Exchange
Commission (the &#147;SEC&#148;) and is incorporated by reference in its entirety into this Prospectus. You may request a free
copy of the SAI, the table of contents of which is on the last page of this Prospectus, annual and semi-annual reports to shareholders
and other information about the Fund and make shareholder inquiries by calling (800)&#160;257-8787, by writing to the Fund at
333 West Wacker Drive, Chicago, Illinois 60606 or from the Fund&#146;s website (http://www.nuveen.com). The information contained
in, or that can be accessed through, the Fund&#146;s website is not part of this Prospectus, except to the extent specifically
incorporated by reference herein. You also may obtain a copy of the SAI (and other information regarding the Fund) from the SEC&#146;s
web site (http://www.sec.gov).</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>
<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt"/>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font: 10pt Times New Roman, Times, Serif"></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
date of this Prospectus is April 17, 2025.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
Securities do not represent a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution,
and are not federally insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other governmental agency.
</b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Neither
the SEC nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus is truthful
or complete. Any representation to the contrary is a criminal offense. </b></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc"></span>TABLE OF CONTENTS </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>
<p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 10pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-left: auto; border-collapse: collapse; margin-right: auto">


<tr>

<td style="width: 97%"/>

<td style="vertical-align: bottom; width: 1%"/>
<td/>
<td/>
<td/></tr>


<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_1">Prospectus
                                 Summary</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">1</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_2">Summary
                                 of Fund Expenses</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">7</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_3">Financial
                                 Highlights</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">8</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_4">Trading
                                 and Net Asset Value Information</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">9</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_5">The
                                 Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">9</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_6">Use
                                 of Proceeds</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">10</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_7">The
                                 Fund&#146;s Investments</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">10</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_8">Use
                                 of Leverage</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">11</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_9">Risk
                                 Factors</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">14</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_10">Management
                                 of the Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">14</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_11">Net
                                 Asset Value</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">17</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_12">Distributions</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">17</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_13">Dividend
                                 Reinvestment Plan</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">18</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_14">Plan
                                 of Distribution</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">18</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_15">Description
                                 of Shares</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">21</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_16">Rights
                                 Offerings</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">24</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_17">Certain
                                 Provisions in the Declaration of Trust and By-Laws</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">25</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_18">Repurchase
                                 of Fund Shares; Conversion to Open-End  Fund</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">27</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_19">Tax
                                 Matters</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">28</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_20">Custodian
                                 and Transfer Agent</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">29</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_21">Independent
                                 Registered Public Accounting Firm</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_22">Legal
                                 Matters</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_23">Available
                                 Information</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><a href="#toc780884_24">Incorporation
                                 By Reference</a></p></td>
<td style="vertical-align: bottom">&#160;&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: bottom; text-align: right">30</td>
<td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
</table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 25%; margin-top: 3pt; margin-bottom: 3pt"/>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>You should rely only on the information contained or incorporated by reference into this Prospectus and any related prospectus supplement. The Fund has not
authorized anyone to provide you with different information. The Fund is not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information contained in this Prospectus and any related
prospectus supplement is accurate as of any date other than the dates on their covers. The Fund will update this Prospectus to reflect any material changes to the disclosures herein. </b></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORWARD-LOOKING STATEMENTS </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Any projections, forecasts and estimates contained or incorporated by
reference herein are forward looking statements and are based upon certain assumptions. Projections, forecasts and estimates are necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying any
projections, forecasts or estimates will not materialize or will vary significantly from actual results. Actual results may vary from any projections, forecasts and estimates and the variations may be material. Some important factors that could
cause actual results to differ materially from those in any forward looking statements include changes in interest rates, market, financial or legal uncertainties, including changes in tax law, and the timing and frequency of defaults on underlying
investments. Consequently, the inclusion of any projections, forecasts and estimates herein should not be regarded as a representation by the Fund or any of its affiliates or any other person or entity of the results that will actually be achieved
by the Fund. Neither the Fund nor its affiliates has any obligation to update or otherwise revise any projections, forecasts and estimates including any revisions to reflect changes in economic conditions or other circumstances arising after the
date hereof or to reflect the occurrence of unanticipated events, even if the underlying assumptions do not come to fruition. The Fund acknowledges that, notwithstanding the foregoing, the safe harbor for forward-looking statements under the Private
Securities Litigation Reform Act of 1995 does not apply to investment companies such as the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_1"></span>PROSPECTUS SUMMARY </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>This is only a summary. You should review the more detailed
information contained elsewhere in this Prospectus and any related prospectus supplement and in the Statement of Additional Information (the &#147;SAI&#148;). </i></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><b>The
                        Fund </b></p></td>
<td>Nuveen Arizona Quality Municipal Income Fund (the &#147;Fund&#148;) is a diversified, closed-end management investment
company. See &#147;The Fund.&#148; The Fund&#146;s common shares, $0.01 par value per share (&#147;Common Shares&#148;), are traded
on the New&#160;York Stock Exchange (the &#147;NYSE&#148;) under the symbol &#147;NAZ.&#148; Preferred Shares and/or Rights issued
by the Fund may also be listed on a securities exchange.</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%">&#160;</td>
<td style="text-align: left; vertical-align: top">The closing price of the Common Shares, as reported by the NYSE on April 8,
2025, was $12.01 per Common Share. The net asset value (&#147;NAV&#148;) of the Common Shares at the close of business
on that same date was $11.27 per Common Share. As of April 8, 2025, the Fund had 11,597,297
Common Shares outstanding and net assets applicable to Common Shares of $130,710,725. See &#147;Description of Shares.&#148;</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><b>The
                       Offering </b></p></td>
<td>The Fund may offer, from time to time, in one or more offerings, up to 1,200,000 Common Shares, preferred shares
(&#147;Preferred Shares&#148;), and/or subscription rights to purchase Common Shares (&#147;Rights,&#148; and collectively with
Common Shares and Preferred Shares, &#147;Securities&#148;), in any combination, on terms to be determined at the time of the
offering. The Fund may offer and sell such Securities directly to one or more purchasers, to or through underwriters, through
dealers or agents that the Fund designates from time to time, or through a combination of these methods. The prospectus supplement
relating to any offering of Securities will describe such offering, including, as applicable, the names of any underwriters, dealers
or agents and information regarding any applicable purchase price, fee, commission or discount arrangements made with those underwriters,
dealers or agents or the basis upon which such amount may be calculated. For more information about the manners in which the Fund
may offer Securities, see &#147;Plan of Distribution.&#148; The prospectus supplement relating to any Rights offering will set
forth the number of Common Shares issuable upon the exercise of each Right (or number of Rights) and the other terms of such Rights
offering. The minimum price on any day at which the Common Shares may be sold will not be less than the NAV per Common Share at
the time of the offering plus the per share amount of any underwriting commission or discount; provided that Rights offerings
that meet certain conditions may be offered at a price below the then current NAV. See &#147;Rights Offerings.&#148;</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                               Fund may not sell any Securities through agents, underwriters or dealers without delivery, or deemed delivery,
                               of a prospectus, including the appropriate prospectus supplement, describing the method and terms of the
                               particular offering of such Securities. You should
                               read this Prospectus and the applicable prospectus supplement carefully before you invest in our Securities.</span></p>
                              <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr></table>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>



<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment&#160;Objectives
                 and Policies </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to the section of the Fund&#146;s most recent
<a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a> on Form N-CSR entitled &#147;Shareholder Update&#151;Current Investment Objectives, Investment Policies and Principal Risks
of the Funds&#151;Investment Objectives&#148; and &#147;&#151;Investment Policies,&#148; as such investment objectives and investment
policies may be supplemented from time to time, which are incorporated by reference herein, for a discussion of the Fund&#146;s investment
objectives and policies.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There can be no assurance that
such strategies will be successful. For a more complete discussion of the Fund&#146;s portfolio composition and its corresponding risks,
see &#147;The Fund&#146;s Investments&#148; and &#147;Risk Factors.&#148;</span></td></tr><tr>
<td>&#160;</td>
<td style="text-align: left; vertical-align: top">&#160;</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment&#160;Adviser
                       </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Fund Advisors, the Fund&#146;s investment
adviser, is responsible for overseeing the Fund&#146;s overall investment strategy and its implementation. Nuveen Fund Advisors
offers advisory and investment management services to a broad range of investment company clients. Nuveen Fund Advisors has overall
responsibility for management of the Fund, oversees the management of the Fund&#146;s portfolio,&#160;manages the Fund&#146;s
business affairs and provides certain clerical, bookkeeping and other administrative services. Nuveen Fund Advisors is located
at 333 West Wacker Drive, Chicago, Illinois 60606. Nuveen Fund Advisors is an indirect subsidiary of Nuveen, LLC (&#147;Nuveen&#148;),
the investment management arm of Teachers Insurance and Annuity Association of America (&#147;TIAA&#148;). TIAA is a life insurance
company founded in 1918 by the Carnegie Foundation for the Advancement of Teaching and is the companion organization of College
Retirement Equities Fund. As of March 31, 2025, Nuveen managed approximately $1.3 trillion in assets,
of which approximately $147.1&#160;billion was managed by Nuveen Fund Advisors.</span></td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sub-Adviser</b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nuveen Asset Management, located at 333 West Wacker
Drive, Chicago, Illinois 60606, serves as the Fund&#146;s sub-adviser. Nuveen Asset Management, a registered investment adviser, is a
wholly-owned subsidiary of Nuveen Fund Advisors. Nuveen Asset Management oversees the day-to-day investment operations of the Fund.</span></td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
                       of Leverage</b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund uses leverage to pursue its investment
objectives. The Fund may use leverage to the extent permitted by the Investment Company Act of 1940, as amended (the &#147;1940
Act&#148;). The Fund may source leverage through a number of methods, including through issuing Preferred Shares of beneficial
interest, which have seniority over the Common Shares and investments in inverse floating rate securities. In addition, the Fund
may also use other forms of leverage including, but not limited to, portfolio investments that have the economic effect of leverage,
such as by investing in residual interest certificates of tender option bond trusts, also called inverse floating rate securities.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
the Fund employs leverage through its outstanding Adjustable Rate MuniFund Term Preferred Shares (&#8220;AMTP Shares&#8221;),
which have seniority over the Common Shares.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
not currently employed by the Fund as a form of leverage, reverse repurchase agreements involve the sale of securities held by
the Fund with an agreement to repurchase the securities at an agreed-upon price, date and interest payment. Selling a portfolio
security and agreeing to buy it back under a reverse repurchase agreement is economically equivalent to borrowing.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
pursuit of its investment objectives, the Fund may reduce or increase the amount and type of leverage based upon changes in
market conditions and  composition of the Fund&#8217;s holdings.
The Fund&#8217;s leverage ratio varies from time to time based upon such changes in the amount of leverage used and
variations in the value of the Fund&#8217;s holdings. So long as the net income received on the Fund&#8217;s investments
purchased with leverage proceeds exceeds the then current expense on any leverage, the investment of leverage proceeds will
generate more net income than if the Fund had not used leverage. Under these circumstances, the excess net income will be
available to pay higher distributions to Common Shareholders. However, if the net income received from the Fund&#8217;s
portfolio investments purchased with leverage is less than the then current expense on outstanding leverage, the Fund may be
required to utilize other Fund assets to make expense payments on outstanding leverage, which may result in a decline in
Common Share NAV and reduced net investment income available for distribution to Common Shareholders.</span></td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr>
<td style="width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="text-align: left; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Fund may borrow for temporary or emergency purposes as permitted by the 1940 Act. The
                                         Fund, along with certain other funds managed by Nuveen Fund Advisors (the &#8220;Participating
                                         Funds&#8221;), are parties to a committed unsecured credit facility (the &#8220;Facility&#8221;) provided by a group of lenders, under which
                                         Participating Funds may borrow for temporary purposes only. Outstanding balances drawn
                                         by the Fund, or any other Participating Fund, will bear interest at a variable rate and
                                         is the liability of such Fund. The Facility is not intended for sustained levered investment
                                         purposes. A large portion of the Facility&#8217;s capacity (and corresponding annual
                                         costs, excluding interest cost) is currently allocated by Nuveen Fund Advisors to a small
                                         number of Participating Funds, which does not include the Fund. The Facility has a 364-day
                                         term and will expire in June 2025 unless extended or renewed. Because participation in
                                         the Facility creates a conflict of interest in determining which Participating Funds
                                         may draw upon the Facility at any point in time, Participating Funds have been allocated
                                         different first priority portions of the committed amount of the Facility based primarily
                                         on the expected likelihood and extent of the need to borrow under the Facility. There
                                         is no assurance that the Fund will continue to use leverage. The Fund&#8217;s use of leverage may
                                         not work as planned or achieve its goals.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund pays a management fee to Nuveen Fund Advisors (which in turn pays a portion of such fee to Nuveen Asset Management) based on a percentage
of Managed Assets. Managed Assets include the proceeds realized and managed from the Fund&#8217;s use of most types of leverage (excluding
the leverage exposure attributable to the use of futures, swaps and similar derivatives). Because Managed Assets include the Fund&#8217;s
net assets as well as assets that are attributable to the Fund&#8217;s investment of the proceeds of its leverage, the Fund&#8217;s Managed
Assets are greater than its net assets. Nuveen Fund Advisors and Nuveen Asset Management are responsible for using leverage to pursue
the Fund&#8217;s investment objectives. Nuveen Fund Advisors and Nuveen Asset Management base their decision regarding whether and how
much leverage to use for the Fund, and the terms of that leverage, on their assessment of whether such use of leverage is in the best
interests of the Fund. However, a decision to employ or increase leverage has the effect, all other
things being equal, of increasing Managed Assets, and in turn Nuveen Fund Advisors&#8217; and Nuveen Asset Management&#8217;s management
fees. Thus, Nuveen Fund Advisors and Nuveen Asset Management have a conflict of interest in determining whether to use or increase leverage. Nuveen Fund Advisors and Nuveen Asset Management seek to manage that conflict by recommending to the
Board of Trustees to leverage the Fund (or increase such leverage) only when they determine that such action would be in the best interests
of the Fund and its Common Shareholders, and by periodically reviewing with the Board of Trustees the Fund&#8217;s performance and the
impact of the use of leverage on that performance.</span></p>
                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

                               <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td></tr></table>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


 <p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 6pt">&#160;</p>
 <p style="margin-top: 0pt; margin-bottom: -6pt; font-size: 6pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Distributions
                       </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund pays regular monthly cash distributions
to Common Shareholders (stated in terms of a fixed cents per Common Share dividend distribution rate which may be set from time
to time). The Fund intends to distribute all or substantially all of its net investment income each year through its regular monthly
distributions and to distribute realized capital gains at least annually. In addition, in any monthly period, to maintain its
declared per common share distribution amount, the Fund may distribute more or less than its net investment income during the
period. In the event the Fund distributes more than its net investment income during any yearly period, such distributions may
also include realized gains and/or a return of capital. To the extent that a distribution includes a return of capital the NAV
per share may erode. If a distribution includes anything other than net investment income, the Fund provides a notice of the best
estimate of its distribution sources at the time. See &#147;Distributions.&#148;</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                         Fund reserves the right to change its distribution policy and the basis for establishing
                                         the rate of its monthly distributions at any time and may do so without prior notice
                                         to Common Shareholders.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 1pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 1%; vertical-align: top; text-align: left"/></tr></table>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Custodian
                 and Transfer Agent </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">State Street Bank and Trust Company serves as the Fund&#146;s
custodian, and Computershare Inc. and Computershare Trust Company, N.A. serves as the Fund&#146;s transfer agent for the Common Shares.
The corresponding agent for any Preferred Shares will be identified in the related prospectus supplement. See &#147;Custodian and Transfer
Agent.&#148;</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk
                 Factors </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in the Fund involves risk. The Fund is designed
as a long-term investment and not as a trading vehicle. The Fund is not intended to be a complete investment program. Please refer to
the section of the Fund&#146;s most recent <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a> on Form N-CSR entitled &#147;Shareholder Update&#151;Current Investment Objectives,
Investment Policies and Principal Risks of the Funds&#151;Principal Risks of the Funds,&#148; as such principal risks may be supplemented
from time to time, which is incorporated by reference herein, for a discussion of the principal risks you should consider before making
an investment in the Fund. Any additional risks applicable to a particular offering of Securities will be set forth in the related prospectus
supplement.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use
                 of Proceeds </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise specified in a prospectus supplement,
the Fund will use the net proceeds from any offering of Securities, pursuant to this Prospectus, to make investments in accordance with
the Fund&#146;s investment objectives. See &#147;Use of Proceeds.&#148;</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Federal
                       Income Tax </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund has elected to be treated, and intends
to qualify each year, as a regulated investment company (&#147;RIC&#148;) under Subchapter M of the Internal Revenue Code of 1986,
as amended (the &#147;Code&#148;). To qualify for the favorable U.S. federal income tax treatment generally accorded to a RIC
under Subchapter M of the Code the Fund must, among other requirements, derive in each taxable year at least 90% of its gross
income from certain prescribed sources and satisfy a diversification test on a quarterly basis. If the Fund fails to satisfy the
qualifying income or diversification requirements in any taxable year, the Fund may be eligible for relief provisions if the failures
are due to reasonable cause and not willful neglect and if a penalty tax is paid with respect to each failure to satisfy the applicable
requirements. Additionally, relief is provided for certain <i>de minimis</i> failures of the diversification requirements where
the Fund corrects the failure within a specified period. In order to be eligible for the relief provisions with respect to a failure
to meet the diversification requirements, the Fund may be required to dispose of certain assets. If these relief provisions were
not available to the Fund and it were to fail to qualify for treatment as a RIC for a taxable year, all of its taxable income
(including its net capital gain) would be subject to tax at the 21% regular corporate rate without any deduction for distributions
to shareholders, and such distributions would be taxable as ordinary dividends to the extent of the Fund&#146;s current and accumulated
earnings and profits. To qualify to pay exempt-interest dividends, which are treated as items of interest excludable from gross
income for federal income tax purposes, at least 50% of the value of the total assets of the Fund must consist of obligations
exempt from regular income tax as of the close of each quarter of the Fund&#146;s taxable year. If the proportion of taxable investments
held by the Fund exceeds 50% of the Fund&#146;s total assets as of the close of any quarter of any Fund taxable year, the Fund
will not for that taxable year satisfy the general eligibility test that otherwise permits it to pay exempt-interest dividends.</span></td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
                                         &#147;Fund Tax Risk,&#148; as contained in the section of the Fund&#146;s most recent
                                         <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a> on Form N-CSR entitled &#147;Shareholder Update&#151;Current Investment Objectives,
                                         Investment Policies and Principal Risks of the Funds&#151;Principal Risks of the Funds&#151;Fund
                                         Level and Other Risks.&#148;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 2%; vertical-align: top; text-align: left"/></tr></table>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
<td style="width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 1pt; margin-left: 2%; text-indent: -2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governing
                       Law </b></span></p></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#146;s Declaration of Trust (the &#147;Declaration
of Trust&#148;) is, and each Statement and Statement Supplement for Preferred Shares will be, governed by the laws of the Commonwealth
of Massachusetts.</span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_2"></span>SUMMARY OF
 FUND EXPENSES</b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purpose of the table below and the Examples below are to help you understand all fees and expenses that you, as a Common Shareholder,
would bear directly or indirectly. The table shows the expenses of the Fund as a percentage of the average net assets applicable
to Common Shares, and not as a percentage of total assets or Managed Assets.</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr>
    <td style="vertical-align: top; font-size: 8pt; width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shareholder
    Transaction Expenses</b></span></td>
    <td style="width: 1%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 12%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 8pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maximum
    Sales Charge (as a percentage of offering price)</span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%<sup>*</sup></span></td></tr>
<tr style="background-color: White">
    <td style="vertical-align: top; font-size: 8pt">&#160;</td>
    <td>&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom; text-align: right">&#160;</td>
    <td style="white-space: nowrap; vertical-align: bottom; font-size: 8pt">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend
    Reinvestment Plan Fees <sup>(1)</sup></span></td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="vertical-align: bottom; font-size: 8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in; font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The maximum sales
    charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters
    in an offering that is not made at-the-market, the applicable Prospectus Supplement will set forth any other applicable sales
    load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering.</span></td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; display: none; visibility: hidden; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify"><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare Inc. and Computershare Trust Company,
N.A., as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment
account.</span></td></tr></table>


<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<div></div>
<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td style="font-size: 8pt; font-weight: bold; text-align: right; padding-bottom: 1pt; padding-left: 10pt"><p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right">&#160;</p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>As
    a Percentage of Net Assets</b></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Attributable
    to</b></span><br/> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common Shares<sup>(2)</sup></b></span></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Annual Expenses</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 75%; text-align: left">Management Fees</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.97%</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Interest and Other Related Expenses <sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.61%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Other Expenses <sup>(4)</sup></td><td>&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.14%</span></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt">Total Annual Expenses</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: center; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.72%</span></td><td style="text-align: left; padding-bottom: 2.5pt">&#160;</td></tr>
</table>



<p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">&#160;</span></p>
<div></div>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<div><div><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt"></span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
                                         will be charged a $2.50 service charge and pay brokerage charges if you direct Computershare
                                         Inc. and Computershare Trust Company, N.A., as agent for the Common Shareholders (the
                                         &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment
                                         account.</span></td>
</tr></table></div> </div>
<div><div><p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stated
                                         as annualized percentages of average net assets attributable to Common Shares for the six-month fiscal year ended August 31, 2024 (annualized).</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
                                         and Other Related Expenses reflect actual expenses and fees for leverage incurred by
                                         the Fund for the six-month fiscal year ended August 31, 2024 (annualized). The types of leverage used by the Fund
                                         during the six-month fiscal year ended August 31, 2024 (annualized) are described in the Fund Leverage and the
                                         Notes to Financial Statements sections of the Fund&#8217;s annual report. Actual Interest and Other
                                         Related Expenses incurred in the future maybe higher or lower. If short-term market interest
                                         rates rise in the future, and if the Fund continues to maintain leverage, the cost of
                                         which is tied to short-term interest rates, the Fund&#8217;s interest expenses on its
                                         short-term borrowings can be expected to rise in tandem. The Fund&#8217;s use of leverage
                                         will increase the amount of management fees paid to the Fund&#8217;s adviser and sub-advisor(s).</span></td>
</tr></table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
                                         Expenses is based on estimated amounts for the current fiscal year. Expenses attributable
                                         to the Fund&#8217;s investments, if any, in other investment companies are currently
                                         estimated not to exceed 0.01%. See &#8220;Investment Objective and Policies&#8212;Other
                                         Investment Companies&#8221; in the SAI.</span></td>
</tr></table></div></div>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&#160;</p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Example
</b></span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following example illustrates the expenses, including the transaction fee (referred to as the &#8220;Maximum Sales Charge&#8221; in
the Shareholder Transaction Expenses table above), if any, that a common shareholder would pay on a $1,000 investment that is held
for the time periods provided in the table. The example assumes that all dividends and other distributions are reinvested in the
Fund and that the Fund&#8217;s Annual Expenses, as provided above, remain the same. The example also assumes a 5% annual return.
Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less
than the hypothetical 5% return shown in the example.</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1
    Year</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10
    Years</b></span></td><td style="font-weight: bold; text-align: center; padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</span></td><td style="text-align: left; width: 1%">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="text-align: left; width: 1%">$</td><td style="text-align: right; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">403</span></td><td style="text-align: left; width: 1%">&#160;</td></tr>
</table>



<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The example should not
be considered a representation of future expenses. Actual expenses may be greater or less than those shown above.</b></span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt">&#160;&#160;</span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_3"></span>FINANCIAL HIGHLIGHTS </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial highlights table is intended to
help you understand the Fund&#8217;s financial performance for the periods presented. Certain information reflects financial results
for a single Common Share of the Fund. Effective March 1, 2024, the Fund's fiscal and tax year end changed from February 28/29
to August 31. The information for the fiscal years or periods, as applicable, ended August 31, 2024, February 29, 2024, February
28, 2023, February 28, 2022, February 28, 2021 and February 29, 2020 has been audited by KPMG LLP, an independent registered public
accounting firm. The report of KPMG LLP is included in the Fund&#8217;s August 31, 2024 annual report, which is incorporated by
reference herein.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; visibility: hidden; vertical-align: bottom">
    <td style="text-align: center; padding-bottom: 1pt; padding-left: 0.25in; width: 29%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 7%">&#160;(d)</td><td style="padding-bottom: 1pt; text-align: center; width: 2%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td><td style="text-align: center; padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="text-align: center; width: 1%">&#160;</td><td style="text-align: center; width: 3%">&#160;</td><td style="padding-bottom: 1pt; text-align: center; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-left: 0.125in; text-indent: -0.125in"><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="2" style="text-align: center; vertical-align: bottom"><b>Six Months<br/>
    Ended <br/>
    August 31</b></td><td><b>&#160;</b></td><td><b>&#160;</b></td>
    <td colspan="39" style="text-align: center; vertical-align: bottom"><b>Year Ended February 28/29</b></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; padding-left: 0.125in; text-align: center; vertical-align: bottom; text-indent: -0.125in">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2024(d)</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom"/><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2024</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2023</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2022</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2021</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2020</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2019</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2018</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2017</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2016</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center; vertical-align: bottom">2015</td><td style="padding-bottom: 1pt; font-weight: bold; text-align: center; vertical-align: bottom">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.25in; width: 29%">Beginning Common
    Share Net Asset Value ("NAV")</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 7%">12.68</td><td style="padding-bottom: 1pt; text-align: left; width: 2%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">12.33</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">14.50</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">15.07</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">15.56</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">14.18</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">14.11</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">14.26</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">15.01</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">15.02</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td><td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left; width: 1%">$</td><td style="border-bottom: Black 1pt solid; text-align: right; width: 3%">14.15</td><td style="padding-bottom: 1pt; text-align: left; width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Investment Operations:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Net Investment Income (Loss)(a)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.34</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.47</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.61</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.56</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.52</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.63</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.68</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.76</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.79</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Net Realized/Unrealized Gain (Loss)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.11</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.40</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(2.12</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.58</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.53</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.34</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.04</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.13</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.68</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.03</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.87</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.375in">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.28</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.74</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(1.65</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.03</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.08</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1.90</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.56</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.50</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">0.79</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">1.66</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Less Distributions to Common Shareholders:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">From Net Investment Income</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.21</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.38</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.52</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.60</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.57</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.52</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.52</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.64</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.75</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.80</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.79</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">From Net Realized Gains</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.375in">Return of Capital</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.14</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.01</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.375in">Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.35</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.39</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.52</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.60</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.57</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.52</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.52</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.64</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.75</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.80</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(0.79</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in">Common Share:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Shelf Offering Costs</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.01</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Premium per Share Sold through Shelf Offering</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">**</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Discount per Share Repurchased and Retired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">**</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.02</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-bottom: 2.5pt; text-indent: -0.125in; padding-left: 0.25in">Ending NAV</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12.61</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12.68</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">12.33</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14.50</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15.07</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15.56</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14.18</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14.11</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">14.26</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15.01</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">15.02</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: -0.125in; padding-left: 0.25in">Ending Share Price</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.66</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">10.83</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">11.30</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.78</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15.17</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.89</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">12.46</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">13.69</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">14.22</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15.74</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">14.37</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Common Share Total Returns:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Based on NAV(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.22</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6.17</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(11.40</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.09</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.62</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.60</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.29</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.44</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.07</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.45</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">12.01</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Based on Share Price(b)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11.08</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(0.56</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(14.48</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.49</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13.67</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.89</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.09</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.69</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(5.03</td><td style="text-align: left">)%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15.59</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">18.94</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.25in">Common Share Supplemental
    Data/Ratios Applicable to Common Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.25in">Ending Net Assets (000)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">146,174</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">146,928</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">143,013</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">167,972</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">174,401</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">180,024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">164,080</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">165,024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">165,141</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">173,767</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">173,648</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Ratios to Average Net Assets</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.375in">Expenses(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.72</td><td style="text-align: left; white-space: nowrap">%*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.85</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.68</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.52</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.75</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.32</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.61</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.03</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.91</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.51</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.56</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Net Investment Income (Loss)(c)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.70</td><td style="text-align: left">%*</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.80</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.65</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.98</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.06</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.76</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.73</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.35</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">4.54</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.12</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.37</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Portfolio Turnover Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">25</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">6</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">11</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Adjustable Rate MuniFund Term Preferred (&#8220;AMTP&#8221;)
    Shares at the End of Period:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Aggregate Amount Outstanding (000)(e)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Asset Coverage Per $100,000 Share(f)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">265,542</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">266,396</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">261,963</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">290,229</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">297,509</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">303,878</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">285,822</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Variable Rate MuniFund Preferred (&#8220;VMTP&#8221;)
    Shares at the End of Period:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Aggregate Amount Outstanding (000)(e)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">79,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">79,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -0.125in; padding-left: 0.375in">Asset Coverage Per $100,000 Share<span>(f)</span></td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">286,891</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">287,022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">319,959</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">319,808</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 0.5in; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="vertical-align: bottom; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on average shares outstanding.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Return Based
    on Common Share NAV is the combination of changes in common share NAV, reinvested dividend income at Common Share NAV and
    reinvested capital gains distributions at NAV, if any. The last dividend declared in the period, which is typically paid on
    the first business day of the following month, is assumed to be reinvested at the ending NAV. The actual reinvest price for
    the last dividend declared in the period may often be based on the Fund&#8217;s market price (and not its NAV), and therefore
    may be different from the price used in the calculation. Total returns are not annualized.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Return Based
    on Common Share Price is the combination of changes in the market price per share and the effect of reinvested dividend income
    and reinvested capital gains distributions, if any, at the average price paid per share at the time of reinvestment. The last
    dividend declared in the period, which is typically paid on the first business day of the following month, is assumed to be
    reinvested at the ending market price. The actual reinvestment for the last dividend declared in the period may take place
    over several days, and in some instances may not be based on the market price, so the actual reinvestment price may be different
    from the price used in the calculation. Total returns are not annualized.</span></td></tr>
<tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226; Net Investment
    Income (Loss) ratios reflect income earned and expenses incurred on assets attributable to preferred shares issued by the
    Fund, where applicable.</span><br/>
    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226; The expense ratios reflect, among other things,
    all interest expenses and other costs related to preferred shares and/or the
    interest expense deemed to have been paid by the Fund on the floating rate certificates issued by the special purpose trusts
    for the self-deposited inverse floaters held by the Fund, where applicable,
    as follows:</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.5in">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold">Ratios of Interest Expense to Average Net Assets Applicable to Common
    Shares</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: left">Period Ended August 31:</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 43%; text-align: left">2024(d)</td><td style="width: 1%; text-align: left"/><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">2.61</td><td style="width: 1%; text-align: left; white-space: nowrap">%*</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Year
    Ended February 28/29:</span></b></span></td><td style="padding-bottom: 1pt; font-weight: bold; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2024</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2.74</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.57</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.48</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2021</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.68</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2020</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.25</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2019</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.39</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2018</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.95</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2017</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.87</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">2016</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.49</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">2015</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0.50</td><td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the six
    months ended August 31, 2024. Prior to March 1, 2024, the Fund's fiscal year end was February 28/29th.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Amount Outstanding: Aggregate amount
    outstanding represents the principal amount outstanding or liquidation preference as of the end of the relevant fiscal year.</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asset Coverage Per $100,000: Asset coverage
    per $100,000 is calculated by subtracting the Fund&#8217;s liabilities and indebtedness not represented by senior securities
    from the Fund&#8217;s total assets, dividing the result by the aggregate amount of the Fund&#8217;s senior securities representing
    indebtedness then outstanding (if applicable), plus the aggregate of the involuntary liquidation preference of the outstanding
    preferred shares, if applicable, and multiplying the result by 100,000.</span></td></tr>
<tr>
    <td style="vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Annualized.</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Value rounded
    to zero.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_4"></span>TRADING AND NET ASSET VALUE INFORMATION </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-size: 10pt">The
following table shows for the periods indicated: (i) the high and low sales prices for Common Shares reported as of the end of
the day on the NYSE, (ii) the corresponding NAV per share, and (iii) the premium/(discount) to NAV per share at which the Common
Shares were trading as of such date. The Fund&#8217;s Common Shares have historically traded both at premiums and discounts in
relation to the Fund&#8217;s NAV per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount
to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might
be taken to reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of
such shares in the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion
of the Fund to an open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of
these actions, or that share repurchases or tender offers will actually reduce market discount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: left">&#160;</td>
<td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td>
    <td style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing
    Market Price per</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NAV
    per Common Share</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Premium/(Discount)</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Share</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    Date of Market Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    Date of Market Price</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fiscal
    Quarter Ended</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">High</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Low</span></td><td style="padding-bottom: 1pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 33%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    2025</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.70</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.28</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.17</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.09</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.35</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6.70</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.29</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.54</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.49</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.35</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6.56</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.77</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.68</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.73</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7.54</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13.38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.55</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.76</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.33</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13.40</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14.44</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2024</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.94</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.57</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.63</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.39</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13.38</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14.69</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.47</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.26</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.36</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.20</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15.29</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17.32</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">August 2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.82</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.09</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14.13</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15.05</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.30</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.56</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.63</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.22</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10.53</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13.58</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">February 2023</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.16</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.96</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.37</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6.25</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9.78</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)%</span></td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2022</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.94</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.61</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.54</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.71</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.16</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.85</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)%</span></td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-size: 10pt">The
net asset value per Common Share, the market price, and percentage of premium/(discount) to net asset value per Common Share on
April 8, 2025, $11.27, $12.01 and 6.57%, respectively. As of April 8,
2025, the Fund had 11,597,297 Common Shares outstanding and net assets applicable to Common Shares of $130,710,725.</span></p>

<p style="margin: 0pt 0"><span style="font-size: 10pt">&#160;</span>&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_5"></span>THE FUND </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund is a diversified, closed-end management investment company registered under the
                                         1940 Act. The Fund was organized as a Minnesota corporation on September 15, 1992 and
                                         commenced investment operations on November 19, 1992, but was reorganized as a Massachusetts
                                         business trust on August 24, 2012. The Fund&#146;s Common Shares are listed on the NYSE
                                         under the symbol &#147;NAZ.&#148; Preferred Shares and/or Rights issued by the Fund may
                                         also be listed on a securities exchange.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The following
provides information about the Fund&#146;s outstanding Common Shares and Preferred Shares as of April 8, 2025:</p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Title of Class</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/>Authorized</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount&#160;Held<br/>by&#160;the&#160;Fund&#160;or<br/>for
    its Account</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Amount<br/>Outstanding</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 61%">Common Shares</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,597,297</span></td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Preferred Shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlimited</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">883</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">AMTP Series 2028</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">883</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">883</span></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_6"></span>USE
 OF PROCEEDS </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise specified in a prospectus supplement, the net proceeds from any offering will be invested in accordance with the Fund&#8217;s
investment objectives and policies as stated below. The Fund currently anticipates that it will be able to invest substantially all of
the net proceeds in investments that meet the Fund&#8217;s investment objectives and policies within approximately three months of the
receipt of such proceeds. Pending investment, it is anticipated that the proceeds will be invested in short-term or long-term securities
issued by the U.S. Government and its agencies or instrumentalities or in high-quality, short-term money market instruments. See &#147;Use of Leverage.&#148;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_7"></span>THE
FUND&#146;S INVESTMENTS </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
Objectives and Policies </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#146;s most recent <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a> on Form N-CSR entitled &#147;Shareholder Update&#151;Current Investment
Objectives, Investment Policies and Principal Risks of the Funds&#151;Investment Objectives&#148; and &#147;&#151;Investment Policies,&#148;
as such investment objectives and investment policies may be supplemented from time to time, which is incorporated by reference herein,
for a discussion of the Fund&#146;s investment objectives and policies.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio
Composition and Other Information </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please
refer to the section of the Fund&#146;s most recent <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a> on Form N-CSR entitled &#147;Shareholder Update&#151;Current Investment
Objectives, Investment Policies and Principal Risks of the Funds&#151;Investment Policies&#151;Portfolio Contents,&#148; as such portfolio
contents may be supplemented from time to time, which is incorporated by reference herein, for a discussion of the investments principally
included in the Fund&#146;s portfolio. More detailed information about the Fund&#146;s portfolio investments are contained in the SAI
under &#147;The Fund&#146;s Investments.&#148;</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Portfolio
                                            Turnover </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                                                                                                                                            Fund may engage in portfolio trading when considered appropriate, but short-term trading will not be used as the primary means of
                                                                                                                                                            achieving the Fund&#146;s investment objective. For the fiscal period ended August 31, 2024 and fiscal year ended February 29, 2024,
                                                                                                                                                            the Fund&#8217;s portfolio turnover rate was 9% and 11%, respectively. However, there are no limits on the Fund&#146;s rate of
                                                                                                                                                            portfolio turnover, and investments may be sold without regard to length of time held when, in Nuveen Asset Management&#146;s
                                                                                                                                                            opinion, investment considerations warrant such action. A higher portfolio turnover rate would result in correspondingly greater
                                                                                                                                                            brokerage commissions and other transactional expenses that are borne by the Fund. Although these commissions and expenses are not
                                                                                                                                                            reflected in the Fund&#146;s &#8220;Annual Expenses,&#8221; they will be reflected in the Fund&#146;s total return. In addition,
                                                                                                                                                            high portfolio turnover may result in the realization of net short-term capital gains by the Fund which, when distributed to
                                                                                                                                                            shareholders, will be taxable as ordinary income. See &#147;Tax Matters.&#148;</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
                                            Policies </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
                                            investment policies specifically identified in the SAI as such are considered fundamental
                                            and may not be changed without shareholder approval. See &#147;Investment Restrictions&#148;
                                            in the SAI.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_8"></span>USE OF LEVERAGE</b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Fund uses leverage to pursue its investment objectives. The Fund may use leverage to the
                                            extent permitted by the 1940 Act. The Fund may source leverage through a number of methods
                                            including through issuing Preferred Shares, entering into reverse repurchase agreements (effectively
                                            a borrowing), and investing in residual interest certificates of tender option bond trusts,
                                            also called inverse floating rate securities, that have the economic effect of leverage because
                                            the Fund&#8217;s investment exposure to the underlying bonds held by the trust have been
                                            effectively financed by the trust&#8217;s issuance of floating rate certificates. See &#147;The
                                            Fund&#146;s Investments&#151;Portfolio Composition&#151;Inverse Floating Rate Securities and Floating
                                            Rate Securities&#148; and &#147;Investment Restrictions&#148; in the SAI. For a discussion
                                            of risks, see &#147;Portfolio Level Risks&#151;Inverse Floating Rate Securities Risk&#148;
                                            and &#147;Fund Level and Other Risks&#151;Reverse Repurchase Agreement Risk,&#148; as each
                                            such risk is contained in the section of the Fund&#146;s most recent <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a> on Form N-CSR entitled &#147;Shareholder Update&#151;Current Investment Objectives,
                                            Investment Policies and Principal Risks of the Funds&#151;Principal Risks of the Funds.&#148;
                                            The Fund may also use certain derivatives and other instruments that have the economic effect
                                            of leverage by creating additional investment exposure.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
the Fund employs leverage through its outstanding AMTP Shares which have seniority over the Common Shares.</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may issue &#8220;senior securities&#8221; as defined under the 1940 Act. &#8220;Senior securities&#8221; include (i) the issuance
of Preferred Shares; (ii) borrowings (including loans from financial institutions); and (iii) the issuance of debt securities. &#8220;Senior
securities&#8221; have seniority over the Common Shares in regard to the income and assets of the Fund.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
not currently employed by the Fund as a form of leverage, reverse repurchase agreements involve the sale of securities held by
the Fund with an agreement to repurchase the securities at an agreed-upon price, date and interest payment. Selling a portfolio
security and agreeing to buy it back under a reverse repurchase agreement is economically equivalent to borrowing.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund may use derivatives, such as interest rate swaps with varying terms, in order to hedge duration risk or manage the interest rate
expense associated with all or a portion of its leverage. Interest rate swaps are bi-lateral agreements whereby parties agree to exchange
future payments, typically based upon the differential of a fixed rate and a variable rate, on a specified notional amount. Interest
rate swaps can enable the Fund to effectively convert its variable leverage expense to fixed, or vice-versa. For example, if the Fund
issues leverage having a short-term floating rate of interest, the Fund could use interest rate swaps to hedge against a rise in the
short-term benchmark interest rates associated with its outstanding leverage. In doing so, the Fund would seek to achieve lower leverage
costs, and thereby enhance Common Share distributions, over an extended period, which would be the result if short-term market interest
rates on average exceed the fixed interest rate over the term of the swap. To the extent the fixed swap rate is greater than short-term
market interest rates on average over the period, overall costs associated with leverage will be greater (and thereby reduce distributions
to Common Shareholders) than if the Fund had not entered into the interest rate swap(s).</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund also may borrow for temporary or emergency purposes as permitted by the 1940 Act. The Fund, along with certain other funds
managed by Nuveen Fund Advisors (the &#8220;Participating Funds&#8221;), are parties to a committed unsecured credit facility (the
&#8220;Facility&#8221;) provided by a group of lenders, under which Participating Funds may borrow for temporary purposes only. Outstanding
balances drawn by the Fund, or any other Participating Fund, will bear interest at a variable rate and is the liability of such
Fund. The Facility is not intended for sustained levered investment purposes. A large portion of the Facility&#8217;s capacity (and
corresponding annual costs, excluding interest cost) is currently allocated by Nuveen Fund Advisors to a small number of
Participating Funds, which does not include the Fund. The Facility has a 364-day term and will expire in June 2025 unless extended
or renewed. Because participation in the Facility creates a conflict of interest in determining which Participating Funds may draw
upon the Facility at any point in time, Participating Funds have been allocated different first priority portions of the committed
amount of the Facility based primarily on the expected likelihood and extent of the need to borrow under the Facility. There is not
assurance that the Fund will use leverage. The Fund&#8217;s use of leverage may not work as planned or achieve its
goals.</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
pursuit of its investment objectives, the Fund may reduce or increase the amount and type of leverage based upon changes in
market conditions and composition of the Fund&#8217;s holdings. The Fund&#8217;s leverage ratio will vary from time to time
based upon such changes in the amount of leverage used and variations in the value of the Fund&#8217;s holdings. So long as
the net income received from the Fund&#8217;s investments purchased with leverage proceeds exceeds the then current expense
of any leverage, the investment of the proceeds of leverage will generate more net income than if the Fund had not leveraged
itself. Under these circumstances, the excess net income will be available to pay higher distributions to Common
Shareholders. However, if the net income received from the Fund&#8217;s portfolio investments purchased with the proceeds
of leverage is less than the current expense of any leverage, the Fund may be required to utilize other Fund assets to make
interest or dividend payments on its leveraging instruments which may result in a decline in Common Share NAV and reduced net
investment income available for distribution to Common Shareholders.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Fund pays a management fee to Nuveen Fund Advisors (which in turn pays a portion of such fee to Nuveen Asset Management) based on a percentage
of Managed Assets. Managed Assets include the proceeds realized and managed from the Fund&#8217;s use of most types of leverage (excluding
the leverage exposure attributable to the use of futures, swaps and similar derivatives). Because Managed Assets include the Fund&#8217;s
net assets as well as assets that are attributable to the Fund&#8217;s investment of the proceeds of its leverage, it is anticipated
that the Fund&#8217;s Managed Assets will be greater than its net assets. Nuveen Fund Advisors and Nuveen Asset Management are responsible
for using leverage to pursue the Fund&#8217;s investment objectives. Nuveen Fund Advisors and Nuveen Asset Management will base their
decision regarding whether and how much leverage to use for the Fund, and the terms of that leverage, on their assessment of whether
such use of leverage is in the best interests of the Fund. However, a decision to employ or increase leverage will have the effect, all other things being equal, of increasing Managed Assets and in turn Nuveen Fund Advisors&#8217; and
Nuveen Asset Management&#8217;s management fees. Thus, Nuveen Fund Advisors and Nuveen Asset Management have a conflict of interest
in determining whether to use or increase leverage, including the use of the Facility. Nuveen Fund Advisors and Nuveen Asset Management
will seek to manage that conflict by using leverage only when they determine that it would be in the best interests of the
Fund and its Common Shareholders, and by periodically reviewing with the Board of Trustees the Fund&#8217;s performance and the Fund&#8217;s
degree of overall use of leverage and the impact of the use of leverage on that performance.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
 1940 Act generally defines a &#8220;senior security&#8221; as any bond, debenture, note, or similar obligation or instrument constituting
 a security and evidencing indebtedness, and any stock of a class having priority over any other class as to distribution of assets or
 payment of dividends; however, the term does not include any promissory note or other evidence of indebtedness issued in consideration
 of any loan, extension, or renewal thereof, made for temporary purposes and in an amount not exceeding five percent of the value of
 the Fund&#8217;s total assets. A loan shall be presumed to be for temporary purposes if it is repaid within 60 days and is not extended
 or renewed.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 1940 Act, the Fund is not permitted to issue &#8220;senior securities&#8221; that are Preferred Shares if, immediately after the
issuance of Preferred Shares, the asset coverage ratio with respect to such Preferred Shares would be less than 200%. With respect to
any such Preferred Shares, asset coverage means the ratio which the value of the total assets of the Fund, less all liabilities and indebtedness
not represented by senior securities, bears to the aggregate amount of senior securities representing indebtedness of the Fund plus the
aggregate liquidation preference of such Preferred Shares.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 1940 Act, the Fund is not permitted to issue &#8220;senior securities representing indebtedness&#8221; if, immediately after the
issuance of such senior securities representing indebtedness, the asset coverage ratio with respect to such senior securities would be
less than 300%. &#8220;Senior securities representing indebtedness&#8221; include borrowings (including loans from financial institutions)
and debt securities. &#8220;Senior securities representing indebtedness&#8221; also include other derivative investments or transactions,
such as reverse repurchase agreements, to the extent the Fund has not fully covered, segregated or earmarked cash or liquid assets in
accordance with the 1940 Act, the rules thereunder, and applicable positions of the SEC and its staff. With respect to any such senior
securities representing debt, asset coverage means the ratio which the value of the total assets of the Fund, less all liabilities and
indebtedness not represented by senior securities (as defined in the 1940 Act), bears to the aggregate amount of such borrowing represented
by senior securities issued by the Fund.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Fund issues senior securities and the asset coverage with respect to such senior securities declines below the required ratios discussed
above (as a result of market fluctuations or otherwise), the Fund may sell portfolio securities when it may be disadvantageous to do
so.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
types of leverage used by the Fund may result in the Fund being subject to certain covenants, asset coverage or other portfolio composition
limits by its lenders, debt or preferred securities purchasers, rating agencies that may rate the debt or preferred securities, or reverse
repurchase counterparties. Such limitations may be more stringent than those imposed by the 1940 Act and may impact whether the Fund
is able to maintain its desired amount of leverage. At this time Nuveen Fund Advisors does not believe that any such potential investment
limitations will impede it from managing the Fund&#8217;s portfolio in accordance with its investment objectives and policies.</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="margin-top: 0pt; text-indent: 0.5in; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Utilization
of leverage is a speculative investment technique and involves certain risks to the Common Shareholders, including increased variability
of the Fund&#8217;s net income, distributions and NAV in relation to market changes. See &#8220;Leverage Risk,&#8221; as such risk is
contained in the section of the Fund&#8217;s most recent <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a> on Form N-CSR entitled &#8220;Shareholder Update&#8212;Current
Investment Objectives, Investment Policies and Principal Risks of the Funds&#8212;Principal Risks of the Funds&#8212;Fund Level and Other
Risks.&#8221; There is no assurance that the Fund will use leverage or that the Fund&#8217;s use of leverage will work as planned or
achieve its goals.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Effects of Leverage </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Please refer to the section of the Fund&#146;s most recent <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a>
on Form N-CSR entitled &#147;Shareholder Update&#151;Current Investment Objectives, Investment Policies and Principal Risks of the Funds&#151;Effects of Leverage,&#148; as such may be supplemented from time to time, which is incorporated by
reference herein, for a discussion of the effects of leverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_9"></span>RISK
 FACTORS </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
                                            is inherent in all investing. Investing in any investment company security involves risk,
                                            including the risk that you may receive little or no return on your investment or even that
                                            you may lose part or all of your investment. Please refer to the section of the Fund&#146;s
                                            most recent <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a> on Form N-CSR entitled &#147;Shareholder Update&#151;Current Investment
                                            Objectives, Investment Policies and Principal Risks of the Funds&#151;Principal Risks of
                                            the Funds,&#148; as such principal risks may be supplemented from time to time, which is
                                            incorporated by reference herein, for a discussion of the principal risks you should consider
                                            before making an investment in the Fund. Any additional risks applicable to a particular offering
                                            of Securities will be set forth in the related prospectus supplement.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="toc780884_10"></span>MANAGEMENT
                                            OF THE FUND </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trustees
                                            and Officers </b></span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Board of Trustees is responsible for the management of the Fund, including supervision of
                                            the duties performed by Nuveen Fund Advisors and Nuveen Asset Management. The names and business
                                            addresses of the trustees and officers of the Fund and their principal occupations and other
                                            affiliations during the past five years are set forth under &#147;Management of the Fund&#148;
                                            in the SAI.</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment
                                            Adviser, Sub-Adviser and Portfolio Managers </b></span></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investment
Adviser.</i>&#160;Nuveen Fund Advisors, LLC, the Fund&#146;s investment adviser, is responsible for overseeing the Fund&#146;s
overall investment strategy and implementation. Nuveen Fund Advisors offers advisory and investment management services to a broad
range of investment company clients. Nuveen Fund Advisors has overall responsibility for management of the Fund, oversees the
management of the Fund&#146;s portfolio, manages the Fund&#146;s business affairs and provides certain clerical, bookkeeping and
other administrative services. Nuveen Fund Advisors is located at 333 West Wacker Drive, Chicago, Illinois 60606. Nuveen Fund
Advisors is an indirect subsidiary of Nuveen, the investment management arm of TIAA. TIAA is a life insurance company founded
in 1918 by the Carnegie Foundation for the Advancement of Teaching and is the companion organization of College Retirement Equities
Fund. As of March 31, 2025, Nuveen managed approximately $1.3 trillion in assets, of which approximately
$147.1 billion was managed by Nuveen Fund Advisors.</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Sub-Adviser.</i>&#160;Nuveen
Asset Management, LLC, located at 333 West Wacker Drive, Chicago, Illinois 60606, serves as the Fund&#146;s sub-adviser pursuant to a
sub-advisory agreement between Nuveen Fund Advisors and Nuveen Asset Management (the &#147;Sub-Advisory Agreement&#148;). Nuveen Asset
Management, a registered investment adviser, is a wholly owned subsidiary of Nuveen Fund Advisors. Nuveen Asset Management oversees day-to-day
investment operations of the Fund. Pursuant to the Sub-Advisory Agreement, Nuveen Asset Management is compensated for the services it
provides to the Fund with a portion of the management fee Nuveen Fund Advisors receives from the Fund. Nuveen Fund Advisors and Nuveen
Asset Management retain the right to reallocate investment advisory responsibilities and fees between themselves in the future.</span></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Portfolio
                                         Managers.</i> Nuveen Asset Management is responsible for the execution of specific investment
                                         strategies and day-to-day investment operations of the Fund. Nuveen Asset Management
                                         manages the Nuveen funds using a team of analysts and portfolio managers that focuses
                                         on a specific group of funds. The day-to-day operation of the Fund and the execution
                                         of its specific investment strategies is the primary responsibility of Stephen J. Candido
                                         and Michael S. Hamilton, the designated portfolio managers of the Fund. Mr. Candido has
                                         served as portfolio manager of the Fund since October 2023 and Mr. Hamilton has served
                                         as portfolio manager of the Fund since January 2011.&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Stephen
J. Candido, CFA, Managing Director at Nuveen Asset Management, is a portfolio manager for high yield municipal strategies at Nuveen,
managing high yield funds and institutional accounts. He also has responsibility for tax-exempt open-end funds and closed-end funds that
allocate to both investment grade and high yield municipals. Stephen started working in the investment industry in 1996 when he joined
Nuveen in the unit trust division. Prior to his current role, he was a vice president and senior research analyst specializing in high
yield sectors including land secured credits, project finance and housing. Stephen was also an assistant vice president for Nuveen&#8217;s
global structured products team beginning in 2005. He also served as the manager of the fixed income unit trust product management and
pricing group starting in 2001 and prior to that held positions as an equity research analyst and fixed income pricing analyst. Stephen
graduated with a B.S. in Finance from Miami University and an M.B.A. in Finance from the University of Illinois at Chicago. He holds
the Chartered Financial Analyst designation and is a member of the CFA Institute and the CFA Society of Chicago.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Michael
                                            S. Hamilton, Managing Director and Portfolio Manager at Nuveen Asset Management, manages
                                            tax-exempt fixed income portfolios. He began working in the investment industry when he joined
                                            the firm in 1989. He became a portfolio manager in 1992, and was previously a fixed income
                                            fund manager and trader. Mr. Hamilton graduated with a B.A. from the College of Idaho and
                                            an M.B.A. from Western Washington University. Mr. Hamilton is a member of the CFA Institute
                                            and Portland Society of Financial Analysts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Additional information about the Portfolio Managers&#8217; compensation, other accounts managed by the Portfolio Managers and the Portfolio
Managers&#8217; ownership of securities in the Fund is provided in the SAI. The SAI is available free of charge by calling (800) <span style="white-space: nowrap">257-8787</span> or by visiting the Fund&#146;s website at www.nuveen.com. The
information contained in, or that can be accessed through, the Fund&#146;s website is not part of this Prospectus or the SAI, except to the extent specifically incorporated by reference herein or in the SAI. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Investment Management and <span style="white-space: nowrap">Sub-Advisory</span>
Agreements </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Investment Management
Agreement.</i>&#8195;Pursuant to an investment management agreement between Nuveen Fund Advisors and the Fund (the &#147;Investment Management Agreement&#148;), the Fund has agreed to pay an annual management fee for the services and facilities
provided by Nuveen Fund Advisors, payable on a monthly basis, based on the sum of a fund-level fee and a complex-level fee, as described below. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Fund-Level Fee.</i>&#8195;The annual fund-level fee for the Fund, payable monthly, is calculated according to the following schedule: </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 92%; border-collapse: collapse; margin-right: auto">


<tr>
<td style="border-bottom: Black 1pt solid; vertical-align: bottom; white-space: nowrap"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
                                         Daily Managed Assets*</b></span></p></td>
<td style="padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td colspan="2" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><br/>
<span style="font-family: Times New Roman, Times, Serif"><b>Fund Level</b></span><br/>
<span style="font-family: Times New Roman, Times, Serif"><b>Fee Rate</b></span></span></td>
<td style="padding-bottom: 1pt; vertical-align: bottom"><span style="font-size: 10pt">&#160;</span></td></tr>


<tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 90%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                         the first $125&#160;million</span></p></td>
<td style="vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right; width: 6%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.4500%</span></td>
<td style="white-space: nowrap; vertical-align: bottom; width: 1%"/></tr>
<tr>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                the next $125&#160;million</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.4375%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr style="background-color: #cceeff">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                the next $250&#160;million</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.4250%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                the next $500&#160;million</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">0.4125%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr style="background-color: #cceeff">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                the next $1&#160;billion</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">0.4000%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr>
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                the next $3&#160;billion</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">0.3750%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
<tr style="background-color: #cceeff">
<td style="vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
                                managed assets over $5&#160;billion</span></p></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
<td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-size: 10pt">0.3625%</span></td>
<td style="white-space: nowrap; vertical-align: bottom"/></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Complex-Level
Fee.</i>&#8195;The overall complex-level fee, payable monthly, begins at a maximum rate of 0.1600% of the Fund&#8217;s
average daily managed assets, with breakpoints for eligible complex-level assets above $124.3 billion. Therefore, the maximum management
fee rate for the Fund is the Fund-level fee plus 0.1600%. The current overall complex-level fee schedule is as follows:</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; padding-right: 0; padding-left: 0"><b>Complex-Level
    Asset Breakpoint Level*</b></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; width: 50%; padding-right: 0; padding-left: 0"><b>Complex-Level
    Fee</b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For the first $124.3 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1600%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For the next $75.7 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1350%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For the next $200 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1325%</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0">For eligible assets over $400 billion</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 0; padding-left: 0">0.1300%</td></tr>
  </table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>

<!-- Field: Rule-Page --><div style="text-align: left; margin-top: 3pt; margin-bottom: 3pt"><div style="border-top: Black 1pt solid; font-size: 1pt; width: 20%">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%; vertical-align: top; text-align: left">*</td>
<td style="text-align: left; vertical-align: top">See &#8220;Investment Adviser, Sub-Adviser and Portfolio Managers&#8221; in the
SAI for more detailed information about the complex-level fee and eligible complex-level assets.</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">As
                                         of March 31, 2025, the complex-level fee rate for the Fund was 0.1580%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In addition to the fee of Nuveen Fund Advisors, the Fund pays all other
costs and expenses of its operations, including compensation of its trustees (other than those affiliated with Nuveen Fund Advisors and Nuveen Asset Management), custodian, transfer agency and dividend disbursing expenses, legal fees, expenses of
independent auditors, expenses of repurchasing shares, expenses associated with any borrowings, expenses of issuing any Preferred Shares, expenses of preparing, printing and distributing shareholder reports, notices, proxy statements and reports to
governmental agencies, and taxes, if any. All fees and expenses are accrued daily and deducted before payment of dividends to investors. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A discussion regarding
the basis for the Board of Trustees&#8217; most recent approval of the Investment Management Agreement for the Fund may be found in
the Fund&#146;s annual report to shareholders dated August 31, 2024.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Sub-Advisory
Agreement. </i>Pursuant to the Sub-Advisory Agreement, Nuveen Asset Management will receive from Nuveen Fund Advisors a management
fee equal to 38.4615% of Nuveen Fund Advisors&#8217; net management fee from the Fund. Nuveen Fund Advisors and Nuveen Asset Management
retain the right to reallocate investment advisory responsibilities and fees between themselves in the future.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A discussion regarding
the basis for the Board&#8217;s decision to approve the Sub-Advisory Agreement for the Fund may be found in the Fund&#8217;s annual
report to shareholders dated August 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Control Persons and Principal Holders of Common Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of April 1, 2025, no
shareholders owned of record, or were known by the Fund to own of record or beneficially, five percent or more of any class of
shares of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>



<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_11"></span>NET ASSET VALUE </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund&#146;s NAV per Common Share is determined as of the close of trading (normally 4:00&#160;p.m. Eastern time) on each day the NYSE is
open for business. NAV is calculated by taking the market value of the Fund&#146;s total assets, less all liabilities, and dividing by the total number of Common Shares outstanding. The result, rounded to the nearest cent, is the NAV per share. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund utilizes independent pricing services approved by its valuation designee to value
                                         portfolio instruments at their market value. Independent pricing services typically value
                                         non-equity portfolio instruments utilizing a range of market-based inputs and assumptions,
                                         including readily available market quotations obtained from broker-dealers making markets
                                         in such instruments, cash flows and transactions for comparable instruments. In valuing
                                         municipal securities, the pricing services may also consider, among other factors, the
                                         yields or prices of municipal securities of comparable quality, type of issue, coupon,
                                         maturity and rating and the obligor&#146;s credit characteristics considered relevant
                                         by the pricing service or Nuveen Fund Advisors. In pricing certain securities, particularly
                                         less liquid and lower quality securities, the pricing services may consider information
                                         about a security, its issuer or market activity provided by Nuveen Fund Advisors or Nuveen
                                         Asset Management.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If a price cannot be obtained from a pricing service or other <span style="white-space: nowrap">pre-approved</span> source, or if the Fund&#146;s valuation designee deems such price to be unreliable, or if a significant event occurs after the close of the local market but prior to the time at which the Fund&#146;s
NAV is calculated, a portfolio instrument will be valued at its fair value as determined in good faith by the Fund&#146;s valuation designee. The Fund&#146;s valuation designee may determine that a price is unreliable in various circumstances. For
example, a price may be deemed unreliable if it has not changed for an identified period of time, or has changed from the previous day&#146;s price by more than a threshold amount, and recent transactions and/or broker dealer price quotations differ
materially from the price in question. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                            Board of Trustees has designated Nuveen Fund Advisors as the Fund&#146;s valuation designee
                                            pursuant to Rule 2a-5 under the 1940 Act and delegated to Nuveen Fund Advisors the day-to-day
                                            responsibility of making fair value determinations. All fair value determinations made by
                                            Nuveen Fund Advisors are subject to review by the Board of Trustees. As a general principle,
                                            the fair value of a portfolio instrument is the amount that an owner might reasonably expect
                                            to receive upon the instrument&#146;s current sale. A range of factors and analysis may be
                                            considered when determining fair value, including relevant market data, interest rates, credit
                                            considerations and/or issuer specific news. However, fair valuation involves subjective judgments,
                                            and it is possible that the fair value determined for a portfolio instrument may be materially
                                            different from the value that could be realized upon the sale of that instrument.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_12"></span>DISTRIBUTIONS </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund pays
regular monthly cash distributions to Common Shareholders (stated in terms of a fixed cents per Common Share dividend distribution
rate which may be set from time to time). The Fund intends to distribute all or substantially all of its net investment income
each year through its regular monthly distributions and to distribute realized capital gains at least annually. In addition, in
any monthly period, to maintain its declared per common share distribution amount, the Fund may distribute more or less than its
net investment income during the period. In the event the Fund distributes more than its net investment income during any yearly
period, such distributions may also include realized gains and/or a return of capital.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">To the extent that a distribution includes a return of capital the NAV per share may erode. A return of capital may occur, for example, when
some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund&#146;s investment performance and should not be confused with &#147;yield&#148; or &#147;income.&#148;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If the Fund&#146;s distribution includes anything other than net investment income, the Fund will
provide a notice to Common Shareholders of its best estimate of the distribution sources at the time of the distribution. These estimates may not match the final tax characterization (for the full year&#146;s distributions) contained in the Common
Shareholders&#146; <span style="white-space: nowrap">1099-DIV</span> forms after the end of the year. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">While the Fund intends to distribute all realized capital gains at least annually, the Fund may elect to retain all or a portion of any net
capital gain (which is the excess of net long-term capital gain over net short-term capital loss) otherwise allocable to Common Shareholders and pay U.S. federal income tax on the retained gain. As provided under U.S. federal income tax law, Common
Shareholders of record as of the end of the Fund&#146;s taxable year will include their share of the retained net capital gain in their income for the year as a long-term capital gain (regardless of their holding period in the common shares), and
will be entitled to an income tax credit or refund for the federal income tax deemed paid on their behalf by the Fund. If the Fund&#146;s total distributions during a given year is an amount that exceeds the Fund&#146;s current and accumulated
earnings and profits, the excess would be treated by Common Shareholders as return of capital for federal income tax purposes to the extent of the Common Shareholder&#146;s basis in their shares and thereafter as capital gain. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Distributions
                                         will be reinvested in additional shares under the Fund&#146;s Dividend Reinvestment Plan
                                         unless a shareholder elects to receive cash. The Fund reserves the right to change its
                                         distribution policy and the basis for establishing the rate of its monthly distributions
                                         at any time and may do so without prior notice to Common Shareholders.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_13"></span>DIVIDEND REINVESTMENT PLAN </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Please refer to the section of the Fund&#146;s most recent <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm">annual report</a> on Form N-CSR entitled &#147;Shareholder Update&#151;Dividend
Reinvestment Plan,&#148; which is incorporated by reference herein, for a discussion of the Fund&#146;s dividend reinvestment plan. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_14"></span>PLAN OF DISTRIBUTION </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities from time to time on an immediate, continuous or delayed basis, in one or more offerings under this
Prospectus and a related prospectus supplement, on terms to be determined at the time of the offering. The Fund may offer and sell such Securities directly to one or more purchasers, to or through underwriters, through dealers or agents that the
Fund designates from time to time, or through a combination of these methods. Sales of Securities may be made in transactions that are deemed to be &#147;at the market&#148; as defined in Rule 415 under the Securities Act of 1933, as amended (the
&#147;1933 Act&#148;), including sales made directly on the NYSE or sales made to or through a market maker other than on an exchange. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The prospectus supplement relating to any offering of Securities will describe the terms of such offering, including, as applicable: </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the names of any agents, underwriters or dealers; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any sales loads, underwriting discounts and commissions or agency fees and
other items constituting underwriters&#146; or agents&#146; compensation;</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any discounts, commissions, fees or concessions allowed or reallowed or paid to dealers or agents; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the public offering or purchase price of the offered Securities, the estimated net proceeds the Fund will receive from the sale and the use of proceeds; and </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any securities exchange on which the offered Securities may be listed. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The prospectus supplement relating to any Rights offering will set forth the number of Common Shares issuable upon the exercise of each Right
(or number of Rights) and the other terms of such Rights offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Direct Sales </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities directly to, and solicit offers from, institutional investors or others who may be deemed to be
underwriters as defined in the 1933 Act for any resales of Securities. In this case, no underwriters or agents would be involved. The Fund may use electronic media, including the Internet, to sell offered Securities directly. The Fund will describe
the terms of any of those sales in a prospectus supplement. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>By Agents </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities through an agent or agents
designated by the Fund from time to time. An agent may sell Securities it has purchased from the Fund as principal to other dealers for resale to investors and other purchasers, and may reallow all or any portion of the discount received in
connection with the purchase from the Fund to the dealers. After the initial offering of Securities, the offering price (in the case of Securities to be resold at a fixed offering price), the concession and the discount may be changed. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>By Underwriters </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If any underwriters are involved in the offer and sale of Securities,
such Securities will be acquired by the underwriters and may be resold by them, either at a fixed public offering price established at the time of offering or from time to time in one or more negotiated transactions or otherwise, at prices related
to prevailing market prices determined at the time of sale. Unless otherwise set forth in the applicable prospectus supplement, the obligations of the underwriters to purchase Securities will be subject to conditions precedent and the underwriters
will be obligated to purchase all Securities described in the prospectus supplement if any are purchased. Any initial public offering price and any discounts or concessions allowed or <span style="white-space: nowrap">re-allowed</span> or paid to
underwriters may be changed from time to time. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with
an offering of Common Shares, if a prospectus supplement so indicates, the Fund may grant the underwriters an option to purchase additional Common Shares at the public offering price, less the underwriting discounts and commissions, within 45 days
from the date of the prospectus supplement, to cover any overallotments. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>By
Dealers </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer and sell Securities from time to
time through one or more dealers who would purchase the securities as principal. The dealers then may resell the offered Securities to the public at fixed or varying prices to be determined by those dealers at the time of resale. The Fund will set
forth the names of the dealers and the terms of the transaction in the prospectus supplement. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>General </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Any underwriters, dealer or agent participating in an offering of Securities may be deemed to be an &#147;underwriter,&#148; as that term is
defined in the 1933 Act, of Securities so offered and sold, and any discounts and commission received by them, and any profit realized by them on resale of the offered Securities for whom they act as agent, may be deemed to be underwriting discounts
and commissions under the 1933 Act. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Underwriters, dealers and
agents may be entitled, under agreements entered into with the Fund, to indemnification by the Fund against some liabilities, including liabilities under the 1933 Act. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund may offer to sell Securities either at a fixed price or at prices that may vary, at market prices prevailing at the time of sale, at
prices related to prevailing market prices or at negotiated prices. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">To facilitate an offering of Common Shares in an underwritten transaction and in accordance with industry practice, the underwriters may engage
in transactions that stabilize, maintain, or otherwise affect the market price
of the Common Shares or any other Security. Those transactions may include overallotment, entering stabilizing bids, effecting syndicate covering transactions, and reclaiming selling concessions
allowed to an underwriter or a dealer. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">An overallotment in connection with an offering creates a short position in the Common Shares for the underwriter&#146;s own account. </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">An underwriter may place a stabilizing bid to purchase the Common Shares for the purpose of pegging, fixing, or maintaining the price of the Common Shares. </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">Underwriters may engage in syndicate covering transactions to cover overallotments or to stabilize the price of the Common Shares by bidding for, and purchasing, the Common Shares or any other Securities in the open
market in order to reduce a short position created in connection with the offering. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The managing underwriter may impose a penalty bid on a syndicate member to reclaim a selling concession in connection with an offering when the Common Shares originally sold by the syndicate member are purchased in
syndicate covering transactions or otherwise. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Any of
these activities may stabilize or maintain the market price of the Securities above independent market levels. Underwriters are not required to engage in these activities and may end any of these activities at any&#160;time. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with any Rights offering, the Fund may also enter into a
standby underwriting arrangement with one or more underwriters pursuant to which the underwriter(s) will purchase Common Shares remaining unsubscribed for after the Rights offering. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Unless otherwise indicated in the prospectus supplement, each series of
offered Preferred Shares will be a new issue of securities for which there currently is no market. Any underwriters to whom Preferred Shares are sold for public offering and sale may make a market in such Preferred Shares as permitted by applicable
laws and regulations, but such underwriters will not be obligated to do so, and any such market making may be discontinued at any time without notice. Accordingly, there can be no assurance as to the development or liquidity of any market for the
Preferred Shares. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Underwriters, agents and dealers may engage in
transactions with or perform services, including various investment banking and other services, for the Fund and/or any of the Fund&#146;s affiliates in the ordinary course of business. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The maximum amount of compensation to be received by any Financial
Industry Regulatory Authority (&#147;FINRA&#148;) member or independent broker-dealer will not exceed the applicable FINRA limit for the sale of any securities being offered pursuant to Rule 415 under the Securities Act. We will not pay any
compensation to any underwriter or agent in the form of warrants, options, consulting or structuring fees or similar arrangements. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">To the extent permitted under the 1940 Act and the rules and regulations promulgated thereunder, the underwriters may from time to time act as
a broker or dealer and receive fees in connection with the execution of the Fund&#146;s portfolio transactions after the underwriters have ceased to be underwriters and, subject to certain restrictions, each may act as a broker while it is an
underwriter. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A prospectus and accompanying prospectus supplement
in electronic form may be made available on the websites maintained by underwriters. The underwriters may agree to allocate a number of Securities for sale to their online brokerage account holders. Such allocations of Securities for Internet
distributions will be made on the same basis as other allocations. In addition, Securities may be sold by the underwriters to securities dealers who resell Securities to online brokerage account holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b><span id="toc780884_15"></span>DESCRIPTION OF SHARES </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Common Shares </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
Declaration of Trust authorizes the issuance of an unlimited number of Common Shares. The Common Shares have a par value of $0.01 per
share and, subject to the rights of holders of any Preferred Shares, have equal rights to the payment of dividends and the distribution
of assets upon liquidation. The Common Shares when issued, are fully paid and, subject to matters discussed in &#147;Certain Provisions
in the Declaration of Trust and By-Laws,&#148; non-assessable, and have no preemptive or conversion rights or rights to cumulative voting.
A copy of the Declaration of Trust is filed with the SEC as an exhibit to the Fund&#146;s registration statement of which this Prospectus
is a part.&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Each whole Common Share has one vote with respect to matters submitted for a vote by the Fund&#146;s Common Shareholders and on which the
shareholder is entitled to vote, and each fractional share shall be entitled to a proportional fractional vote consistent with the requirements of the 1940 Act and the rules promulgated thereunder, and will vote together as a single class. Whenever
the Fund incurs borrowings and/or Preferred Shares are outstanding, Common Shareholders will not be entitled to receive any cash distributions from the Fund unless all interest on such borrowings has been paid and all accumulated dividends on
Preferred Shares have been paid, unless asset coverage (as defined in the 1940 Act) with respect to any borrowings would be at least 300% after giving effect to the distributions and asset coverage (as defined in the 1940 Act) with respect to
Preferred Shares would be at least 200% after giving effect to the distributions. See &#147;&#151;Preferred Shares&#148; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Common Shares
are listed on the NYSE and trade under the ticker symbol &#147;NAZ.&#148; The Fund intends to hold annual meetings of shareholders
so long as the Common Shares are listed on a national securities exchange and such meetings are required as a condition to such
listing. The Fund does not issue share certificates.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Unlike open-end funds, closed-end funds like the Fund do not provide
daily redemptions. Rather, if a shareholder determines to buy additional Common Shares or sell shares already held, the shareholder may conveniently do so by trading on the exchange through a broker or otherwise. Common shares of closed-end
investment companies may frequently trade on an exchange at prices lower than NAV. Common shares of closed-end investment companies like the Fund have during some periods traded at prices higher than NAV and have during other periods traded at
prices lower than NAV. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Because the market value of the Common
Shares may be influenced by such factors as distribution levels (which are in turn affected by expenses), call protection, dividend stability, portfolio credit quality, NAV, relative demand for and supply of such shares in the market, general market
and economic conditions, and other factors beyond the control of the Fund, the Fund cannot assure you that Common Shares will trade at a price equal to or higher than NAV in the future. The Common Shares are designed primarily for long-term
investors, and investors in the Common Shares should not view the Fund as a vehicle for trading purposes. See &#147;Repurchase of Fund Shares; Conversion to Open-End Fund.&#148; </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>Preferred Shares </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund&#146;s Declaration of Trust authorizes the issuance of an unlimited number of Preferred
                                         Shares in one or more classes or series, with rights as determined by the Board of Trustees,
                                         by action of the Board of Trustees without the approval of the Common Shareholders. As
                                         of April 8, 2025, there were 883 AMTP Shares outstanding.
                                         The AMTP Shares have various rights that were approved by the Board of Trustees without
                                         the approval of Common Shareholders, which are specified in the Fund&#8217;s statement
                                         establishing and fixing the rights and preferences with respect to the AMTP Shares (the
                                         &#8220;Statement&#8221;).  The discussion below generally describes the rights of
                                         the holders of Preferred Shares, including rights generally applicable to the holders
                                         of the Fund&#146;s outstanding AMTP Shares, although the terms of any Preferred Shares
                                         that may be issued by the Fund may be the same as, or different from, the terms described
                                         below, subject to the applicable Statement, applicable law and the Declaration of Trust.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Under
                                            the 1940 Act, the Fund is not permitted to issue &#147;senior securities&#148; that are Preferred
                                            Shares if, immediately after the issuance of Preferred Shares, the asset coverage ratio would
                                            be less than 200%. See &#147;Use of Leverage.&#148; Additionally, the Fund will generally
                                            not be permitted to purchase any of its Common Shares or declare dividends (except a dividend
                                            payable in Common Shares) or other distributions on its Common Shares unless, at the time
                                            of such purchase or declaration, the asset coverage ratio with respect to such Preferred
                                            Shares, after taking into account such purchase or distribution, is at least 200%. Preferred
                                            Shares issued by the Fund have priority over the Common Shares.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">For so long as any Preferred Shares are outstanding, the Fund will not:
(1) declare or pay any dividend or other distribution (other than a dividend or distribution paid in Common Shares) in respect of the Common Shares, (2) call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares,
or (3) pay any proceeds of the liquidation of the Fund in respect of the Common Shares, unless, in each case, (A) immediately thereafter, the Fund shall be in compliance with the 200% asset coverage limitations set forth under the 1940 Act after
deducting the amount of such dividend or other distribution or redemption or purchase price or liquidation proceeds and (B) all cumulative dividends and other distributions of shares of all series of Preferred Shares of the Fund due on or prior to
the date of the applicable dividend, distribution, redemption, purchase or acquisition shall have been declared and paid. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Distribution Preference </i></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund&#146;s Preferred Shares have complete priority over the Common Shares as to distribution of assets. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Liquidation Preference </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In the event of any voluntary or involuntary liquidation, dissolution
or winding up of the affairs of the Fund, holders of Preferred Shares would be entitled to receive a preferential liquidating distribution (expected to equal the original purchase price per share plus accumulated and unpaid dividends thereon,
whether or not earned or declared) before any distribution of assets is made to Common Shareholders. After payment of the full amount of the liquidating distribution to which they are entitled, holders of Preferred Shares will not be entitled to any
further participation in any distribution of assets by the Fund. A consolidation or merger of the Fund with or into another entity or a sale of all or substantially all of the assets of the Fund shall not be deemed to be a liquidation, dissolution
or winding up of the Fund. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Voting Rights </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with any issuance of Preferred Shares, the Fund must
comply with Section&#160;18(i) of the 1940&#160;Act, which requires, among other things, that Preferred Shares be voting shares and have equal voting rights with Common Shares. Except with respect to certain matters affecting only the holders of the
Preferred Shares and except as discussed further below, holders of Preferred Shares vote together with Common Shareholders as a single class on matters submitted to Fund shareholders. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">In connection with the election of the Fund&#146;s trustees, holders of
Preferred Shares, voting as a separate class, are entitled to elect two of the Fund&#146;s trustees, and the remaining trustees are elected by Common Shareholders and holders of Preferred Shares, voting together as a single class. In addition, if at
any time dividends on the Fund&#146;s outstanding Preferred Shares are unpaid in an amount equal to two full years&#146; dividends thereon, the holders of all outstanding Preferred Shares, voting as a separate class, would be entitled to elect a
majority of the Fund&#146;s trustees until all dividends in arrears have been paid or declared and set apart for payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
 Statement with respect to the Fund&#146;s Preferred Shares sets forth certain voting and consent rights of the holders of such Shares,
 including with respect to certain actions that would affect the preferences, rights, or powers of such class or series or the authorization
 or issuance of any class or series ranking prior to the Preferred Shares. Except as may otherwise be required by law, the Fund&#146;s
 Declaration of Trust requires that (1)&#160;the affirmative vote of the holders of at least two-thirds of the Fund&#146;s Preferred
 Shares outstanding at the time, voting as a separate class, would be required to approve any conversion of the Fund from a closed-end
 to an open-end investment company and (2)&#160;the affirmative vote of the holders of at least two-thirds of the outstanding Preferred
 Shares, voting as a separate class, would be required to approve any plan of reorganization (as such term is used in the 1940 Act) adversely
 affecting such shares; provided however, that such separate class vote would be a majority vote if the action in question has previously
 been approved, adopted or authorized by the affirmative vote of two-thirds of the total number of trustees fixed in accordance with
 the Declaration of Trust or the By-laws. The affirmative vote of the holders of a majority of the outstanding Preferred Shares, voting
 as a separate class, would be required to approve any action not described in the preceding sentence requiring a vote of security holders
 under Section&#160;13(a) of the 1940 Act including, among other things, changes in the Fund&#146;s investment objectives or changes
 in the investment restrictions described as fundamental policies under &#147;Investment Restrictions&#148; in the SAI. The class or
 series vote of holders of Preferred Shares described above would in each case be in addition to any separate vote of the requisite percentage
 of Common Shares and Preferred Shares necessary to authorize the action in question.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The foregoing voting provisions would not apply with respect to the
Fund&#146;s Preferred Shares if, at or prior to the time when a vote was required, such shares have been (1)&#160;redeemed or (2)&#160;called for redemption and sufficient funds would have been deposited in trust to effect such redemption. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><i>Redemption, Purchase and Sale of Preferred Shares </i></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The terms of the Preferred Shares may provide that they are redeemable
by the Fund at certain times, in whole or in part, at the liquidation preference of such share plus accumulated dividends, that the Fund may tender for or purchase Preferred Shares and that the Fund may subsequently resell any shares so tendered for
or purchased. Any redemption or purchase of Preferred Shares by the Fund would reduce the leverage applicable to Common Shares, while any resale of such shares by the Fund would increase such leverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_16"></span>RIGHTS OFFERINGS </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                         Fund may in the future, and at its discretion, choose to make offerings of Rights to
                                         its shareholders to purchase Common Shares. Rights may be issued independently or together
                                         with any other offered security and may or may not be transferable by the person purchasing
                                         or receiving the rights. In connection with a Rights offering to shareholders, the Fund
                                         would distribute certificates or other documentation evidencing the Rights and a prospectus
                                         supplement to the Fund&#146;s shareholders as of the record date that the Fund sets for
                                         determining the shareholders eligible to receive Rights in such Rights offering. Any
                                         such future Rights offering will be made in accordance with the 1940 Act and, to the
                                         extent such Rights are transferable, will comply with applicable interpretations of the
                                         SEC or its staff, as such interpretations may be modified in the future, which currently
                                         require that: (i) the Fund&#146;s Board of Trustees make a good faith determination that
                                         such offering would result in a net benefit to existing shareholders; (ii) the offering
                                         fully protects shareholders&#146; preemptive rights and does not discriminate among shareholders
                                         (except for the possible effect of not offering fractional rights); (iii) management
                                         uses its best efforts to ensure an adequate trading market in the Rights for use by shareholders
                                         who do not exercise such Rights; and (iv) the ratio of such transferable Rights offering
                                         does not exceed one new share for each three rights held.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The applicable prospectus supplement would describe the following terms
of the Rights (to the extent each is applicable) in respect of which this Prospectus is being delivered: </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the period of time the offering would remain open; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the underwriter or distributor, if any, of the Rights and any associated underwriting fees or discounts applicable to purchases of the Rights; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the title of such Rights; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the exercise price for such Rights (or method of calculation thereof); </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the number of such Rights issued in respect of each share; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the number of Rights required to purchase a single share;</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the extent to which such Rights are transferable and the market on which they may be traded if they are transferable; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">if such Rights are transferable, a discussion regarding
the Board of Trustees' basis for determining that such offering would result in a net benefit to existing shareholders;</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance or exercise of such Rights; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the date on which the right to exercise such Rights will commence, and the date on which such right will expire (subject to any extension); </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">the extent to which such Rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">termination rights the Fund may have in connection with such Rights offering;
and</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">any other terms of such Rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such Rights. </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">A certain number of Rights would entitle the holder of the Right(s) to
purchase for cash such number of shares at such exercise price as in each case is set forth in, or be determinable as set forth in, the prospectus supplement relating to the Rights offered thereby. Rights would be exercisable at any time up to the
close of
business on the expiration date for such Rights set forth in the prospectus supplement. After the close of business on the expiration date, all unexercised Rights would become void. Upon
expiration of the Rights offering and the receipt of payment and the Rights certificate or other appropriate documentation properly executed and completed and duly executed at the corporate trust office of the Rights agent, or any other office
indicated in the prospectus supplement, the Common Shares purchased as a result of such exercise will be issued as soon as practicable. To the extent permissible under applicable law, the Fund may determine to offer any unsubscribed offered
securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth in the applicable prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_17"></span>CERTAIN PROVISIONS IN THE DECLARATION OF
TRUST AND <span style="white-space: nowrap">BY-LAWS</span> </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>General</i>. The By-laws of the Fund provide that by becoming a shareholder of the Fund, each shareholder shall be deemed to have agreed to
be bound by the terms of the Declaration of Trust and By-laws. However, neither the Declaration of Trust nor the By-laws purport to require the waiver of a shareholder&#146;s rights under the federal securities laws. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Shareholder and Trustee Liability</i>. Under Massachusetts law,
shareholders could, under certain circumstances, be held personally liable for the Fund&#146;s obligations. However, the Declaration of Trust contains an express disclaimer of shareholder liability for the Fund&#146;s debts or obligations and
requires that notice of such limited liability be given in each agreement, obligation or instrument entered into or executed by the Fund or the trustees. The Declaration of Trust further provides for indemnification out of the Fund&#146;s assets and
property for all loss and expense of any shareholder held personally liable for the Fund&#146;s obligations. Thus, the risk of a shareholder incurring financial loss on account of shareholder liability is limited to circumstances in which the Fund
would be unable to meet its obligations. The Fund believes that the likelihood of such circumstances is remote. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Declaration of
Trust provides that the Fund&#146;s obligations are not binding upon the Fund&#146;s trustees individually, but only upon the
Fund&#146;s assets and property, and that the trustees shall not be liable for errors of judgment or mistakes of fact or law.
Nothing in the Declaration of Trust, however, protects a trustee against any liability to which the trustee would otherwise be
subject by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct
of the trustee&#146;s office. &#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Anti-Takeover
Provisions</i>. The Declaration of Trust and By-laws include provisions that could limit the ability of other entities or persons to
acquire control of the Fund or to convert the Fund to open-end status. The By-laws require the Board of Trustees be divided into
three classes with staggered terms. See &#147;Management of the Fund&#148; in the SAI. This provision of the By-laws could delay for
up to two years the replacement of a majority of the Board of Trustees. When Preferred Shares are issued, holders of Preferred
Shares, voting as a separate class, are entitled to elect two of the Fund&#146;s trustees. In addition, the Declaration of Trust
requires a vote by holders of at least two-thirds of the Common Shares and, if issued, Preferred Shares, voting together as a single
class, except as described below, to authorize (1) a conversion of the Fund from a closed-end to an open-end investment company, (2)
a merger or consolidation of the Fund, or a series or class of the Fund, with any corporation, association, trust or other
organization or a reorganization of the Fund, or a series or class of the Fund, (3) a sale, lease or transfer of all or
substantially all of the Fund&#146;s assets (other than in the regular course of the Fund&#146;s investment activities), (4) in
certain circumstances, a termination of the Fund, or a series or class of the Fund or (5) a removal of trustees by shareholders, and
then only for cause, unless, with respect to (1) through (4), such transaction has already been authorized by the affirmative vote
of two-thirds of the total number of trustees fixed in accordance with the Declaration of Trust or the By-laws, in which case the
affirmative vote of the holders of at least a majority of the Fund&#146;s Common Shares and, if issued, Preferred Shares outstanding
at the time, voting together as a single class, would be required; provided, however, that where only a particular class or series
is affected (or, in the case of removing a trustee, when the trustee has been elected by only one class), only the required vote by
the applicable class or series will be required. However, approval of shareholders would not be required for any transaction,
whether deemed a merger, consolidation, reorganization or otherwise whereby the Fund issues shares in connection with the
acquisition of assets (including those subject to liabilities) from any other investment company or similar entity. In the case of
the conversion of the Fund to an open-end investment company, or in the case of any of the foregoing transactions constituting a
plan of reorganization that adversely affects the holders of any outstanding Preferred Shares, the action in question also would
require the affirmative vote of the holders of at least two-thirds of the Preferred Shares outstanding at the time, voting as a
separate class, unless such transaction has already been authorized by the affirmative vote of two-thirds of the total number of
trustees fixed in accordance with the Declaration of Trust or the By-laws, in which case the affirmative vote of the holders of at
least a majority of the Fund&#146;s Preferred Shares outstanding at the time would be required. None of the foregoing provisions may
be amended except by the vote of at least two-thirds of the Common Shares and any preferred shares voting together as a single
class. The votes required to approve the conversion of the Fund from a closed-end to an open-end investment company or to approve
transactions constituting a plan of reorganization which adversely affects the holders of preferred shares are higher than those
required by the 1940 Act. The Board of Trustees believes that the provisions of the Declaration of Trust relating to such higher
votes are in the best interest of the Fund and its shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>


<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Procedural Requirements on Derivative Actions, Exclusive
Jurisdiction and Jury Trial Waiver</i>. The By-laws of the Fund contain certain provisions affecting potential shareholder claims against the Fund, including procedural requirements for derivative actions, an exclusive forum provision, and the
waiver of shareholder rights to a jury trial. Massachusetts is considered a &#147;universal demand&#148; state, meaning that under Massachusetts corporate law a shareholder must make a demand on the company before bringing a derivative action (i.e.,
a lawsuit brought by a shareholder on behalf of the company). The By-laws of the Fund provide detailed procedures for the bringing of derivative actions by shareholders which are modeled on the substantive provisions of the Massachusetts corporate
law derivative demand statute. The procedures are intended to permit legitimate inquiries and claims while avoiding the time, expense, distraction, and other harm that can be caused to the Fund or its shareholders as a result of spurious shareholder
demands and derivative actions. Among other things, these procedures: </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">provide that before bringing a derivative action, a shareholder must make a written demand to the Fund; </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">establish a 90-day review period, subject to extension in certain circumstances, for the Board of Trustees to evaluate the shareholder&#146;s demand; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">establish a mechanism for the Board of Trustees to submit the question of whether to maintain a derivative action to a vote of shareholders; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">provide that if the Fund does not notify the requesting shareholder of the rejection of the demand within the applicable review period, the shareholder may commence a derivative action; </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">establish bases upon which a trustee will not be considered to be not independent for purposes of evaluating a derivative demand; and </td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">provide that if the trustees who are independent for purposes of considering a shareholder demand determine in good faith within the applicable review period that the maintenance of a derivative action is not in the
best interest of the Fund, the shareholder shall not be permitted to maintain a derivative action unless the shareholder first sustains the burden of proof to the court that the decision of the trustees not to pursue the requested action was not a
good faith exercise of their business judgment on behalf of the Fund. </td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">These procedures may be more restrictive than procedures for bringing derivative suits applicable to other investment companies. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The By-laws also
                                                                           require that actions by shareholders against the Fund, except for actions under the U.S. federal securities laws, be brought only in
                                                                           a certain federal court in Massachusetts, or if not permitted to be brought in federal court, then in the Business Litigation
                                                                           Session of the Massachusetts Superior Court in Suffolk County (the &#147;Exclusive Jurisdictions&#148;), and that the right to jury
                                                                           trial be waived to the fullest extent permitted by law. Other investment companies may not be subject to similar restrictions. The
                                                                           designation of Exclusive Jurisdictions may make it more expensive for a shareholder to bring a suit than if the shareholder were
                                                                           permitted to select another jurisdiction. In the event a shareholder selects another jurisdiction to bring its suit and the venue
                                                                           for such suit is subsequently changed back to an Exclusive Jurisdiction through the legal process, then such shareholder shall be
                                                                           required to reimburse all expenses incurred by the Fund or any other person in effecting such change of venue back to the Exclusive
                                                                           Jurisdiction. Also, the designation of Exclusive Jurisdictions and the waiver of jury trials limit a shareholder&#146;s ability to
                                                                           litigate a claim in the jurisdiction and in a manner that may be more favorable to the shareholder. It is possible that a court may
                                                                           choose not to enforce these provisions of the Fund&#146;s By-laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"><i>Preemptive
Rights</i>. The Declaration of Trust provides that Common Shareholders shall have no right to acquire, purchase or subscribe for any
shares or investments of the Fund, other than such right, if any, as the Fund&#146;s Board of Trustees in its discretion may determine. As of the
date of this Prospectus, no preemptive rights have been granted by the Board of Trustees.</p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Reference should be made to the Declaration of Trust and By-laws on
file with the SEC for the full text of these provisions. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;
</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_18"></span>REPURCHASE OF FUND SHARES; CONVERSION TO <span style="white-space: nowrap">OPEN-END</span> FUND </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                            Fund is a closed-end investment company and as such its shareholders will not have the right
                                            to cause the Fund to redeem their shares. Instead, the Common Shares will trade in the open
                                            market at a price that will be a function of several factors, including dividend levels (which
                                            are in turn affected by expenses), NAV, call protection, dividend stability, portfolio credit
                                            quality, relative demand for and supply of such shares in the market, general market and
                                            economic conditions and other factors. Because shares of closed-end investment companies
                                            may frequently trade at prices lower than NAV, the Fund&#146;s Board of Trustees has currently
                                            determined that, at least annually, it will consider action that might be taken to reduce
                                            or eliminate any material discount from NAV in respect of Common Shares, which may include
                                            the repurchase of such shares in the open market or in private transactions, the making of
                                            a tender offer for such shares at NAV, or the conversion of the Fund to an open-end investment
                                            company. The Fund cannot assure you that its Board of Trustees will decide to take any of
                                            these actions, or that share repurchases or tender offers will actually reduce market discount.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">If
                                         the Fund converted to an open-end investment company, it would be required to redeem
                                         all Preferred Shares, including AMTP Shares, then outstanding (requiring in turn that
                                         it liquidate a portion of its investment portfolio), and the Common Shares would no longer
                                         be listed on the NYSE or elsewhere and it would likely have to significantly reduce any
                                         leverage it is then employing, which may require a repositioning of its investment portfolio,
                                         which may in turn generate substantial transaction costs, which would be borne by Common
                                         Shareholders, and may adversely affect Fund performance and Fund distributions. In contrast
                                         to a closed-end investment company, shareholders of an open-end investment company may
                                         require the company to redeem their shares at any time (except in certain circumstances
                                         as authorized by the 1940 Act or the rules thereunder) at their NAV, less any redemption
                                         charge that is in effect at the time of redemption. The Fund currently expects that any
                                         such redemptions would be made in cash. The Fund may charge sales or redemption fees
                                         upon conversion to an open-end fund. In order to avoid maintaining large cash positions
                                         or liquidating favorable investments to meet redemptions, open-end investment companies
                                         typically engage in a continuous offering of their shares. Open-end investment companies
                                         are thus subject to periodic asset in-flows and out-flows that can complicate portfolio
                                         management. The Board of Trustees may at any time propose conversion of the Fund to an
                                         open-end investment company depending upon its judgment as to the advisability of such
                                         action in light of circumstances then prevailing.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Before
                                            deciding whether to take any action if the Common Shares trade below NAV, the Fund&#146;s
                                            Board of Trustees would consider all relevant factors, including the extent and duration
                                            of the discount, the liquidity of the Fund&#146;s portfolio, the impact of any action that
                                            might be taken on the Fund or its shareholders, and market considerations. Based on these
                                            considerations, even if the Fund&#146;s shares should trade at a discount, the Board of Trustees
                                            may determine that, in the interest of the Fund and its shareholders, no action should be
                                            taken.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_19"></span>TAX MATTERS </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following information is meant
as a general summary for U.S. shareholders. This summary does not discuss the tax consequences of an investment in Rights or Preferred
Shares. Please see the SAI for additional information. Investors should rely on their own tax adviser for advice about the particular
federal, state and local tax consequences to them of investing in the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund has elected and intends to
qualify each year to be treated as a regulated investment company (&#8220;RIC&#8221;) under Subchapter M of the Internal Revenue
Code of 1986, as amended. In order to qualify for treatment as a RIC, the Fund must satisfy certain requirements regarding the
sources of its income, the diversification of its assets and the distribution of its income. As a RIC, the Fund is not expected
to be subject to federal income tax. The Fund primarily invests in municipal securities issued by states, cities and local authorities
and certain possessions and territories of the United States (such as Puerto Rico or Guam) or municipal securities whose income
is otherwise exempt from regular federal and Arizona income taxes. To qualify to pay exempt-interest dividends, which are treated
as items of interest excludable from gross income for federal income tax purposes, at least 50% of the value of the total assets
of the Fund must consist of obligations exempt from regular income tax as of the close of each quarter of the Fund&#8217;s taxable
year. If the proportion of taxable investments held by the Fund exceeds 50% of the Fund&#8217;s total assets as of the close of
any quarter of any Fund taxable year, the Fund would not for that taxable year satisfy the general eligibility test that would
otherwise permit it to pay exempt-interest dividends. A shareholder treats an exempt-interest dividend as interest on state and
local bonds exempt from regular federal income tax. Federal income tax law imposes an alternative minimum tax. Interest on certain
municipal securities, such as certain private activity bonds, is included as an item of tax preference in determining the amount
of a taxpayer&#8217;s alternative minimum taxable income. To the extent that the Fund receives income from such municipal securities,
a portion of the dividends paid by the Fund, although exempt from regular federal income tax, will be taxable to shareholders
whose tax liabilities are determined under the federal alternative minimum tax. The Fund will annually provide a report indicating
the percentage of the Fund&#8217;s income attributable to municipal securities and the percentage includable in federal alternative
minimum taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition to exempt-interest
dividends, the Fund may also distribute to its shareholders amounts that are treated as long-term capital gain or ordinary income
(which may include short-term capital gains). These distributions are generally subject to regular federal income tax, whether
or not reinvested in additional shares. Net capital gain distributions (the excess of net long-term capital gain over net short-term
capital loss) that are properly reported to fund shareholders as capital dividends are generally taxable at rates applicable to
long-term capital gains regardless of how long a shareholder has held its shares. Long-term capital gains are currently taxable
to non-corporate shareholders at rates of up to 20%. Distributions of net short-term capital gains for a taxable year in excess
of net long-term capital losses for such taxable year generally will be taxable at ordinary income rates to a shareholder receiving
such distributions. The Fund does not expect that any part of its distributions to shareholders from its investments will qualify
for the dividends-received deduction available to corporate shareholders or as &#8220;qualified dividend income,&#8221; which is
taxable to non-corporate shareholders at preferential U.S. federal income tax rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A 3.8% Medicare contribution
tax generally applies to all or a portion of the net investment income of a shareholder who is an individual and not a nonresident
alien for U.S. federal income tax purposes and who has adjusted gross income (subject to certain adjustments) that exceeds a threshold
amount ($250,000 if married filing jointly or if considered a &#8220;surviving spouse&#8221; for federal income tax purposes, $125,000
if married filing separately, and $200,000 in other cases). This 3.8% tax also applies to all or a portion of the undistributed
net investment income of certain shareholders that are estates and trusts. For these purposes, interest, dividends, and certain
capital gains are generally taken into account in computing a shareholder&#8217;s net investment income, but exempt-interest dividends
are not taken into account.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a RIC, the Fund will not
be subject to federal income tax in any taxable year provided that it meets certain requirements. As described in &#8220;Distributions&#8221;
above, the Fund may retain for investment some (or all) of its net capital gain. If the Fund retains any net capital gain or taxable
net investment income, it will be subject to tax at the regular corporate rate on the amount retained. If the Fund retains any
net capital gain, it may designate the retained amount as undistributed capital gains in a notice to its shareholders who, if subject
to federal income tax on long-term capital gains, (i) will be required to include in income for federal income tax purposes, as
long-term capital gain, their share of such undistributed amount; (ii) will be deemed to have paid their proportionate shares of
the tax paid by the Fund on such undistributed amount and will be entitled to credit that amount of tax against their federal income
tax liabilities, if any; and (iii) will be entitled to claim refunds to the extent the credit exceeds such liabilities. For federal
income tax purposes, the tax basis of shares owned by a shareholder of the Fund will be increased by an amount equal to the difference
between the amount of undistributed capital gains included in the shareholder&#8217;s gross income and the tax deemed paid by the
shareholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Dividends declared by the
Fund in October, November or December, payable to shareholders of record in such a month, and paid during the following January
will be treated as having been received by shareholders in the year the distributions were declared.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each shareholder will receive an annual
statement summarizing the U.S. federal income tax status of all distributions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The repurchase, sale or exchange of Common
Shares normally will result in capital gain or loss to holders of Common Shares who hold their shares as capital assets. Generally,
a shareholder&#8217;s gain or loss will be long-term capital gain or loss if the shares have been held for more than one year
even though the increase in value in such Common Shares may be at least partly attributable to tax-exempt interest income. Present
law taxes both long-term and short-term capital gains of corporations at the rates applicable to ordinary income. For non-corporate
taxpayers, however, long-term capital gains are currently taxed at rates of up to 20%. Short-term capital gains and other ordinary
income are taxed to non-corporate taxpayers at ordinary income rates. If a shareholder sells or otherwise disposes of Common Shares
before holding them for six months, any loss on the sale or disposition will be treated as a long-term capital loss to the extent
of any amounts treated as distributions to the Common Shareholder of long-term capital gain (including any amount credited to
the shareholder as undistributed capital gain) or (2) disallowed to the extent of exempt-interest dividends received by a Common
Shareholder. Any loss realized by a shareholder on the disposition of shares held 6 months or less is disallowed to the extent
of the amount of exempt-interest dividends received by the shareholder with respect to Common Shares. Any loss realized on a sale
or exchange of shares of the Fund will be disallowed to the extent those shares of the Fund are replaced by substantially identical
shares of the Fund (including shares acquired by reason of participation in the Plan) within a period of 61 days beginning 30
days before and ending 30 days after the date of disposition of the original shares, or to the extent the shareholder enters into
a contract or option to repurchase shares within such period. In that event, the basis of the replacement shares of the Fund will
be adjusted to reflect the disallowed loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any interest on indebtedness
incurred or continued to purchase or carry the Fund&#8217;s shares to which exempt-interest dividends are allocated is not deductible.
Under certain applicable rules, the purchase or ownership of shares may be considered to have been made with borrowed funds even
though such funds are not directly used for the purchase or ownership of the shares. In addition, if you receive social security
or certain railroad retirement benefits, you may be subject to U.S. federal income tax on a portion of such benefits as a result
of receiving investment income, including exempt-interest dividends and other distributions paid by the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Fund
may be required to withhold (as &#8220;backup withholding&#8221;) U.S. federal income tax from distributions (including exempt-interest
dividends) and repurchase proceeds payable to a shareholder if the shareholder fails to provide the Fund with his or her correct
taxpayer identification number or to make required certifications, or if the shareholder has been notified by the IRS that he or
she is subject to backup withholding. The backup withholding rate is 24%. Backup withholding is not an additional tax; rather,
it is a way in which the IRS ensures it will collect taxes otherwise due. Any amounts withheld may be credited against a shareholder&#8217;s
U.S. federal income tax liability.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Fund may invest in municipal
securities that pay interest that is taxable under the federal alternative minimum tax. If you are, or as a result of investment
in the Fund would become, subject to the federal alternative minimum tax, the Fund may not be a suitable investment for you. In
addition, distributions of taxable ordinary income (including any net short-term capital gain) will be taxable to shareholders
as ordinary income (and not eligible for favorable taxation as &#8220;qualified dividend income&#8221;), and capital gain dividends
will be taxable as long-term capital gains.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Arizona Tax Matters.</i> The Fund&#8217;s
regular monthly dividends will not be subject to Arizona personal income tax to the extent they are paid out of income earned
on obligations that, when held by individuals, pay interest that is exempt from taxation by Arizona under Arizona law (e.g., obligations
of Arizona and its political subdivisions) or federal law, so long as at the close of each quarter of the Fund&#8217;s taxable
year at least 50% of the value of the Fund&#8217;s total assets consists of such obligations and the Fund designates such tax-exempt
distributions pursuant to certain written notice requirements to its shareholders. The portion of the Fund&#8217;s monthly dividends
that is attributable to income other than as described in the preceding sentence will be subject to the Arizona income tax. The
Fund expects to earn no or only a minimal amount of such non-exempt income. If you are an individual Arizona resident, you will
be subject to Arizona personal income tax to the extent the Fund distributes any realized capital gains, or if you sell or exchange
shares and realize a capital gain on the transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><i>Other State and Local Tax Matters</i>.
While exempt-interest dividends are exempt from regular federal and Arizona income taxes, they may not be exempt from other state
or local income or other taxes. Some states exempt from state income tax that portion of any exempt-interest dividend that is
derived from interest a regulated investment company receives on its holdings of securities of that state and its political subdivisions
and instrumentalities. Therefore, the Fund will report annually to its shareholders the percentage of interest income the Fund
earned during the preceding year on tax-exempt obligations and the Fund will indicate, on a state-by-state basis, the source of
this income. Shareholders are advised to consult with their own tax advisors for more detailed information concerning Arizona
tax matters or the tax laws of their state and locality of residence. Please refer to the SAI for more detailed information.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_20"></span>CUSTODIAN AND TRANSFER AGENT </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The
                                            custodian of the assets of the Fund is State Street Bank and Trust Company, located at One
                                            Congress Street, Suite&#160;1, Boston, Massachusetts 02114-2016 (the &#147;Custodian&#148;).
                                            The Custodian performs custodial, fund accounting and portfolio accounting services. The
                                            Fund&#146;s transfer, shareholder services and dividend paying agent with respect to the
                                            Fund&#146;s Common Shares is Computershare Inc. and Computershare Trust Company, N.A., located
                                            at 150 Royall Street, Canton, Massachusetts 02021. The transfer agent, tender and dividend
                                            paying agent and calculation agent for any Preferred Shares, will be identified in the applicable
                                            prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<h5 style="text-align: left; margin-top: 0pt; margin-bottom: 10pt"><a href="#toc">Table of Contents</a></h5>

 <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_21"></span>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">KPMG
                                                                           LLP (&#8220;KPMG&#8221;) an independent registered public accounting firm, served as independent registered public accounting firm
                                                                           to the Fund for the fiscal years ended February 28, 2015 through August 31, 2024. The principal business address of KPMG is 200 East
                                                                           Randolph Street, Chicago, IL 60601.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<p style="text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PricewaterhouseCoopers
LLP (&#8220;PwC&#8221;), an independent registered public accounting firm, has been engaged to serve as independent registered
public accounting firm to the Fund for the current fiscal year. The principal business address of PwC is One North Wacker Dr,
Chicago, IL 60606.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_22"></span>LEGAL MATTERS </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Certain legal
matters in connection with the offering will be passed upon for the Fund by Stradley Ronon Stevens &amp; Young, LLP, located at
2005 Market Street, Suite 2600, Philadelphia, Pennsylvania. Stradley Ronon Stevens &amp; Young, LLP may rely as to certain matters
of Massachusetts law on the opinion of Morgan, Lewis &amp; Bockius LLP. Any additional legal opinions will be described in a prospectus supplement.</p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_23"></span>AVAILABLE
INFORMATION </b></p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Fund is subject to the informational
requirements of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;) and the 1940 Act and is required to file reports, proxy statements and other information with the SEC. Reports, proxy statements, and other information
about the Fund can be inspected at the offices of the NYSE. </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">This
Prospectus does not contain all of the information in the Fund&#146;s Registration Statement, including amendments, exhibits, and schedules. Statements in this Prospectus about the contents of any contract or other document are not necessarily
complete and, in each instance, reference is made to the copy of the contract or other document filed as an exhibit to the Registration Statement, each such statement being qualified in all respects by this reference. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Additional information about the Fund and the Securities can be found
in the Fund&#146;s Registration Statement (including amendments, exhibits, and schedules) on Form <span style="white-space: nowrap">N-2</span> filed with the SEC. The SEC maintains a website (http://www.sec.gov) that contains the Fund&#146;s
Registration Statement, other documents incorporated by reference, and other information the Fund has filed electronically with the SEC, including proxy statements and reports filed under the Exchange Act. </p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="toc780884_24"></span>INCORPORATION BY REFERENCE </b></p>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The documents listed below, and any reports and other documents
subsequently filed with the SEC pursuant to Section&#160;30(b)(2) of the 1940 Act and Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the termination of the offering will be incorporated by reference into this Prospectus and deemed
to be part of this Prospectus from the date of the filing of such reports and documents: </p> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The Fund&#146;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/892992/000199937125004231/naz-n2a_041525.htm">SAI</a>, dated April 17,
2025;</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>
<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The Fund&#146;s <a href="http://www.sec.gov/Archives/edgar/data/892992/000119312524253805/d892918dncsr.htm"><span style="text-decoration: underline">annual
report</span></a> on Form N-CSR for the fiscal year ended August 31, 2024;</td></tr></table> <p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>





<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="page-break-inside: avoid">
<td style="width: 4%">&#160;</td>
<td style="width: 2%; vertical-align: top; text-align: left">&#9679;</td>
<td style="width: 1%; vertical-align: top">&#160;</td>
<td style="text-align: left; vertical-align: top">The description of the Common Shares contained in the Fund&#146;s Registration
Statement on Form 8-A (File&#160;No.&#160;001-11510) filed with the SEC on November 6,1992, including any amendment or report filed for the purpose of updating
such description prior to the termination of the offering registered hereby.</td></tr></table>
<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The information incorporated by reference is considered to be part of
this Prospectus, and later information that the Fund files with the SEC will automatically update and supersede this information. Incorporated materials not delivered with the Prospectus may be obtained, without charge, by calling (800) <span style="white-space: nowrap">257-8787,</span> by writing to the Fund at 333 West Wacker Drive, Chicago, Illinois 60606, or from the Fund&#146;s website (<span style="text-decoration: underline">http://www.nuveen.com</span>).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div>

    <!-- Field: /Page -->


</div>



<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>naz-20250418.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6spw7xRiXhun8uCbn1MSauAKbP9w5dzGelBtm99HTnK3yco78q0eS7jPykGYTwO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:naz="http://nuveen.com/20250418" elementFormDefault="qualified" targetNamespace="http://nuveen.com/20250418">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="naz-20250418_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="naz-20250418_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="naz-20250418_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2024" schemaLocation="https://xbrl.sec.gov/cef/2024/cef-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2024" schemaLocation="https://xbrl.sec.gov/cef/2024/cef-2024_pre.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="naz_CommonStockAdjustedForOfferingMember" name="CommonStockAdjustedForOfferingMember" abstract="true" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>naz-20250418_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#SecurityOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#AddressTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#RiskOnly" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="naz-20250418.xsd#naz_CommonStockAdjustedForOfferingMember" xlink:label="loc_nazCommonStockAdjustedForOfferingMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_nazCommonStockAdjustedForOfferingMember" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>naz-20250418_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="naz-20250418.xsd#naz_CommonStockAdjustedForOfferingMember" xlink:label="naz_CommonStockAdjustedForOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="naz_CommonStockAdjustedForOfferingMember" xlink:to="naz_CommonStockAdjustedForOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="naz_CommonStockAdjustedForOfferingMember_lbl" xml:lang="en-US">Common Stock Adjusted for Offering [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="naz_CommonStockAdjustedForOfferingMember" xlink:to="naz_CommonStockAdjustedForOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="naz_CommonStockAdjustedForOfferingMember_doc" xml:lang="en-US">Common Stock Adjusted for Offering.</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>naz-20250418_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2Cover" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#N2Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/cef/role/N2" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#N2" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2024/cef-2024.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="naz-20250418.xsd#naz_CommonStockAdjustedForOfferingMember" xlink:label="loc_nazCommonStockAdjustedForOfferingMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_nazCommonStockAdjustedForOfferingMember" order="100" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>nuveenlogo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 nuveenlogo.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  G * # 1$
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M&D&(-?HC.'_A^?#XYRIZ3TRK;G*4_-;K^J;RKGA">.>>>5..:KS\DIX^?/\
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0>B)>B)>B)>B)>B)>B+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>logo_img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo_img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !K -L# 2(  A$! Q$!_\0
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M+RPNM)\57AM-1F=/(FCC;R6&#\IV\K@]#SQUH ]PHK@KSP3XI-D#8?$'54O
M,YN((7C8_P"Z%! _$UD>!_B!K@\97'@CQC!$-6C!:WNH1M6< ;N1TY7D$8Z'
M(S0!ZI113)98X(7EE<)&BEF8G  ')- #Z*\6^'_Q)N];^*VKV5\TT=AJ48DT
MV*4$ *@^4J#_ 'URWN17M- !17G?Q7AUW3O#-[XAT3Q%>V,MG&K-;*$,3KN
M)Y7(;GU[=*H?#K3M>\3^#;+6]5\8ZP9KL.1'!Y2*@#%1U0DGB@#U.BN#O_#W
MCG3(FGT#Q;_:#KS]DU:W0A_82(%(/X5'X(^)L?B+4I] UFQ;2/$5N2)+5S\L
MF.I0G\\>G()H ] HKQSXS7/B7PGIZ:_HWBB^ABGN1"]FRHR)E204.W('R]#G
MK7>> [+5+?PS:W6L:S=:E>7D,<[F8*%BRN=JA0..>^: .GHHKP_XPWGBOP6U
MEJ&C^*M0%M?7#1M!*L;")NHVG;G'7@YZ=: /<**XBT\%ZV]G"UQX]UYIB@+F
M-8%7..P,9X_&J.FZ+XHT3X@V4-SXFU'5M(NK2<N)D"^2Z[<9*C'.>.G0T >B
MT5X1\3;OQUX#NK2[M?%-_/H5S((WEDBB:6!NX)"X/&2#[8KVK1WBDT:R>"]>
M]B:%62YD(+2@CAB0 ,GV% %VBO)_B"/%=IXGTG3_  OXFO!>:M,Y:TD2-X[>
M)0,N#MR%'OG->E:98SV.FP6UQJ%Q>S1KA[B; :0^I   H YCQ_\ #/2/'MJC
M7):UU"%=L-W&,D#KAA_$OM^1KPV^^%'Q%\%WC7.A2S7$:'*S:;,58CW3(/X<
MU])^']?L?$ND1ZGISLT#LR8==K*RD@@CL<BM2@#YW\&?'+6=,U6+1_&L#-'N
M$;73Q>7-"?5UQR/7@'ZU]#+L?$B[6W#AASD?6O.?C/X4TW6_ FH:E- @U#3H
MC-#< 8; ZJ3W!&>/6MOX87<]]\,] GN'+RFU"ECU(4E1^@% '2:A_P @RZ_Z
MXO\ R->3_LY_\B/J?_83?_T7'7K&H?\ (,NO^N+_ ,C7D_[.?_(CZG_V$W_]
M%QT >PUXC^T9_P @_P -?]?C_P EKVZO$/VCU#Z9X<0]&NY ?^^5H ]N+!4W
M,0 !R2:\BM=/'B[X]CQ#IY$FDZ-;"%[M#E)9L,-JG^+&_G''RU>\3_!O2K[P
MU/;Z//J%OJ"19B9[Z61)& ^ZRLQ&#TXQBF?!;QE_:VA/X;U"-+;5]'_=-"$"
M%XP<;L#N#P?P/>@#U.N*^(=Q+J$%AX2LI"EUKDIBE9>L=JO,S?E\O_ J[0G
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M._\ DHWA[_K_ (O_ $(5]J74$5S:303HLD4B%71AD,",$&OBOX=_\E&\/?\
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MIXHHX(EBAC2.-1A410 ![ 5SGC+P/H_C729;34+=!<;3Y%VJCS(6[$'T]N]
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M8FLZ'?Z9)@)=P/"2>VX$9KR+X#:XVGC5?!&I_N=0L;AY(HWX+#.' ^A&?HU
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4F /7!/K7<HH5 J@!0, #L* /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="10">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 18, 2025</div></th>
<th class="th"><div>Apr. 14, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0000892992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">424B5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Nuveen Arizona Quality Municipal Income  Fund<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><div id="xdx_801_ecef--ShareholderTransactionExpensesTableTextBlock_dU_gL1STETTB-DVDSMW_zE5OaxVhJPke" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%">
  <tr>
    <td style="width: 94%"></td>
    <td style="vertical-align: bottom; width: 4%"></td>
    <td></td>
    <td></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: #cceeff">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">Shareholder Transaction Expenses </div></div><span id="xdx_906_ecef--BasisOfTransactionFeesNoteTextBlock_c20250418__20250418_zMvvcOQCKtS9">(as a percentage of offering price)</span><div style="letter-spacing: 0px; top: 0px; display: inline"></div></div></td>
    <td style="vertical-align: bottom">&#160;&#160;</td>
    <td style="vertical-align: bottom"></td>
    <td style="vertical-align: bottom"></td>
    <td style="vertical-align: bottom"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em">Maximum Sales Charge</div></td>
    <td style="vertical-align: bottom">&#160;&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_987_ecef--SalesLoadPercent_dp_c20250418__20250418_fKg_____zTjtjQmXxTug" style="vertical-align: bottom; text-align: right">1.00%</td>
    <td style="white-space: nowrap; vertical-align: bottom"><sup>*</sup>&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: #cceeff">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em">Offering Costs<div style="font-size: 75%; vertical-align: top; display: inline; font-size: 8.3px">(1) </div></div></td>
    <td style="vertical-align: bottom">&#160;&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_984_ecef--OtherTransactionExpensesPercent_dp_c20250418__20250418_fKDEp_zDpNuVt0D1X3" style="vertical-align: bottom; text-align: right">0.49%</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em">Dividend Reinvestment Plan Fees<div style="font-size: 75%; vertical-align: top; display: inline; font-size: 8.3px">(2) </div></div></td>
    <td style="vertical-align: bottom">&#160;&#160;</td>
    <td style="vertical-align: bottom">$</td>
    <td id="xdx_98C_ecef--DividendReinvestmentAndCashPurchaseFees_pp2p0_c20250418__20250418_fKDIp_z9cJXEp4Pe99" style="vertical-align: bottom; text-align: right">2.50</td>
    <td style="white-space: nowrap; vertical-align: bottom">&#160;</td></tr>
  </table>

<div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F04_z0HYTuXwT2p3" style="width: 2%; vertical-align: top; text-align: left">*</td>
    <td style="vertical-align: top; text-align: left; width: 98%">
        <div id="xdx_F1E_zwFGXYf0Jnc1" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">
    The maximum sales charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters in an offering that is not made at-the-market, the applicable prospectus supplement will set forth any other applicable sales load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering. </div></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; display: none; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F08_zhChSEFH60Nf" style="width: 4%; vertical-align: top; text-align: left">(1)</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F19_zDBcWxvIeML6" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Assuming
        a Common Share offering price of $11.79
        (the closing price of the Common Shares on the NYSE on April 14, 2025). </div></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; display: none; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F08_zRmKNlk0Fm4g" style="width: 4%; vertical-align: top; text-align: left">(2)</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F15_zfKUWE2NZFvg" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account.</div></td></tr>
  </table>



<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td style="width: 4%; vertical-align: top; text-align: left">(1)</td>
    <td style="vertical-align: top; text-align: left">
        <div style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span id="xdx_906_ecef--OtherTransactionFeesNoteTextBlock_c20250418__20250418_z6YgRTEszduc">Assuming
        a Common Share offering price of <span id="xdx_90C_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z02esFTRIWml">$11.79</span>
        (the closing price of the Common Shares on the NYSE on April 14, 2025). </span></div></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td style="width: 4%; vertical-align: top; text-align: left">(2)</td>
    <td style="vertical-align: top; text-align: left">
        <div style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account. </div></td></tr>
  </table> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><div id="xdx_808_ecef--AnnualExpensesTableTextBlock_dU_gL1AETTB-TW_zOYuGDr7ExJ6"></div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%">
  <tr>
    <td></td>
    <td style="vertical-align: bottom"></td>
    <td></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: White">
    <td style="vertical-align: top; width: 82%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 5%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom; width: 11%"><span style="font-family: Times New Roman, Times, Serif"><b>As a Percentage of Net Assets Attributable to Common Shares<sup>(3)</sup></b></span></td>
    <td style="vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: White">
    <td style="vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"><div style="font-weight: bold; display: inline"><span style="font-family: Times New Roman, Times, Serif">Annual Expenses</span></div></div></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td style="vertical-align: bottom"></td>
    <td style="vertical-align: bottom"></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: rgb(204,238,255)">
    <td style="text-align: left; vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 20pt; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif">Management Fees</span></div></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td id="xdx_987_ecef--ManagementFeesPercent_dp_c20250418__20250418_fKDMp_zfUN1oQiP816" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.97%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="text-align: left; vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 20pt; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif">Interest
        and Other Related Expenses <sup>(4)</sup></span></div></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td id="xdx_98C_ecef--InterestExpensesOnBorrowingsPercent_dp_c20250418__20250418_fKDMpKDQp_zzoXe64zI6I4" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">2.61%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255); page-break-inside: avoid">
    <td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt; vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Other Expenses <sup>(5)</sup></span></div></td>
    <td style="padding-bottom: 1pt; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td id="xdx_988_ecef--OtherAnnualExpensesPercent_dp_c20250418__20250418_fKDMpKDUp_zRn8W0NsUF8i" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.14%</span></td>
    <td style="padding-bottom: 1pt; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="text-align: left; vertical-align: top">
        <div style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -1em"><span style="font-family: Times New Roman, Times, Serif">Total Annual Expenses</span></div></td>
    <td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;&#160;</span></td>
    <td id="xdx_980_ecef--TotalAnnualExpensesPercent_dp_c20250418__20250418_fKDMp_znySGzqOK879" style="vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif">3.72%</span></td>
    <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
  </table>

<div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%">&#160;</div>



<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F06_zx07KqSG6T4j" style="width: 4%; vertical-align: top; text-align: left">(3)</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F1B_ztsskV1elOlg" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">
        Stated as annualized percentages of average net assets attributable to Common Shares for the six-month fiscal year ended August 31,
        2024 (annualized).</div></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F00_zOB1JzvPsoB5" style="width: 4%; vertical-align: top; text-align: left">(4)</td>
    <td id="xdx_F10_zlLMyWzYPXH9" style="vertical-align: top; text-align: left">Interest and Other Related Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month fiscal year ended August 31, 2024 (annualized). The types of leverage used by the Fund during the six-month fiscal year ended August 31, 2024 (annualized) are described in the Fund Leverage and the Notes to Financial Statements sections of the Fund's annual report. Actual Interest and Other Related Expenses incurred in the future maybe higher or lower. If short-term market interest rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates, the Fund&#146;s interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund&#8217;s use of leverage will increase the amount of management fees paid to the Fund&#8217;s adviser and sub-advisor(s).</td></tr>
</table>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td id="xdx_F04_zZc5hFyPmWd6" style="width: 4%; vertical-align: top; text-align: left">(5)</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F14_z96hsuJvXrke" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">
    <span id="xdx_90D_ecef--OtherExpensesNoteTextBlock_c20250418__20250418_zmVchX1UmQih">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#8217;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#8220;The Fund&#8217;s Investments&#8212;Other Investment Companies&#8221; in the SAI. </span></div></td></tr>
  <tr style="page-break-inside: avoid">
    <td style="vertical-align: top; text-align: left">&#160;</td>
    <td style="vertical-align: top; text-align: left">&#160;</td></tr>
  </table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">0.97%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">2.61%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[6]</sup></td>
<td class="nump">0.14%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">3.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><div id="xdx_809_ecef--ExpenseExampleTableTextBlock_dU_zrESIo3FGNH1" style="font: bold 10pt Times New Roman, Times, Serif; display: inline">Example </div><div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The following example illustrates the expenses including the applicable transaction fees (referred to as the &#8220;Maximum Sales Charge&#8221; in the fee table above), if any, and estimated offering costs, that a Common Shareholder would pay on a $1,000 investment that is held for the time periods provided in the table. The example assumes that all dividends and other distributions are reinvested in the Fund and that the Fund&#8217;s Annual Total Expenses, as provided above, remain the same. The example also assumes a transaction fee of 1.00%, as a percentage of the offering price, and a 5% annual return.<div style="font-size: 75%; vertical-align: top; display: inline; font-size: 9.1px">1</div> </div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 60%">
  <tr>
    <td></td>
    <td style="vertical-align: bottom; width: 25%"></td>
    <td></td>
    <td style="vertical-align: bottom; width: 25%"></td>
    <td></td>
    <td style="vertical-align: bottom; width: 25%"></td></tr>
  <tr style="font: 8pt Times New Roman, Times, Serif; page-break-inside: avoid">
    <td style="border-bottom: #000000 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">1&#160;Year</div></div></td>
    <td style="vertical-align: bottom; padding-bottom: 0.5pt">&#160;</td>
    <td style="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">3&#160;Years</div></div></td>
    <td style="vertical-align: bottom; padding-bottom: 0.5pt">&#160;</td>
    <td style="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">5&#160;Years</div></div></td>
    <td style="vertical-align: bottom; padding-bottom: 0.5pt">&#160;</td>
    <td style="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center"><div style="letter-spacing: 0px; top: 0px; display: inline"><div style="font-weight: bold; display: inline">10&#160;Years</div></div></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: #cceeff">
    <td id="xdx_98A_ecef--ExpenseExampleYear01_c20250418__20250418_fKDEp_zuIuIR6z1VJ4" style="vertical-align: bottom; text-align: center">$52</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_983_ecef--ExpenseExampleYears1to3_c20250418__20250418_fKDEp_z04Xyt8cWdgg" style="vertical-align: bottom; text-align: center">$127</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_98E_ecef--ExpenseExampleYears1to5_c20250418__20250418_fKDEp_zdRw44Fs9R7l" style="vertical-align: bottom; text-align: center">$204</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td id="xdx_98F_ecef--ExpenseExampleYears1to10_c20250418__20250418_fKDEp_zGaCCLJzEUlf" style="vertical-align: bottom; text-align: center">$406</td></tr>
  </table>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"><div style="font-weight: bold; display: inline">The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those shown above. </div></div>

<div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</div>

<div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%">&#160;</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="page-break-inside: avoid">
    <td style="width: 2%; vertical-align: top; text-align: left"><div id="xdx_F0E_zX9gNnjs15O1" style="font-size: 75%; vertical-align: top; display: inline; font-size: 9.1px">(1)</div>&#160;</td>
    <td style="vertical-align: top; text-align: left">
        <div id="xdx_F13_zlfieIQghqla" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">
    The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example. </div></td></tr>
  </table>

<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt">&#160;</div>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></div>



<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">$ 52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">$ 406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><div id="xdx_804_ecef--PurposeOfFeeTableNoteTextBlock_dU_zzkWLXa6cqS3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The
purpose of the table and the example below is to help you understand all fees and expenses that you, as a shareholder of Common
Shares (&#8220;Common Shareholder&#8221;), would bear directly or indirectly. The table shows the expenses of the Fund as a
percentage of the average net assets applicable to Common Shares, and not as a percentage of total assets or Managed Assets (as defined in the accompanying prospectus).</div>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">(as a percentage of offering price)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionFeesNoteTextBlock', window );">Other Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Assuming
        a Common Share offering price of <span id="xdx_90C_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z02esFTRIWml">$11.79</span>
        (the closing price of the Common Shares on the NYSE on April 14, 2025). <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherExpensesNoteTextBlock', window );">Other Expenses, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#8217;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#8220;The Fund&#8217;s Investments&#8212;Other Investment Companies&#8221; in the SAI. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><div id="xdx_808_ecef--SharePriceTableTextBlock_dU_zeFXUFAqjOjh" style="text-align: center; font-weight: bold; display: inline"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="trading"></span>TRADING AND NET ASSET VALUE INFORMATION</span></div><div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The following table shows for the periods indicated: (i)&#160;the high and low sales prices for the Common Shares reported as of the end of the day on the NYSE, (ii)&#160;the corresponding NAV per share, and (iii)&#160;the premium/(discount) to NAV per share at which the Common Shares were trading as of such date. The Fund&#8217;s Common Shares have historically traded both at premiums and discounts in relation to the Fund&#8217;s NAV per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might be taken to reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of such shares in the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion of the Fund to an open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of these actions, or that share repurchases or tender offers will actually reduce market discount.</div>

<table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%">
  <tr style="border-bottom: Black 1pt solid; display: none; visibility: hidden; vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 0pt">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_488_ecef--HighestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMj3CmfwFjti" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_481_ecef--LowestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zDkzjJ0gZfR7" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_48E_ecef--HighestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3ShTHTlK4ab" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_481_ecef--LowestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0aTUt17m3d9" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_483_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zuuuYg3cHfU1" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td id="xdx_485_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsVaUze4oI8" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold">&#160;</td>
    <td colspan="7" style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold">&#160;</td>
    <td colspan="7" style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif">&#160;</td>
    <td colspan="7" style="white-space: nowrap; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; text-align: left">&#160;</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Closing Market Price<br/>per Common Share</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">NAV per Common Share<br/>on Date of Market Price</td>
    <td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; padding-bottom: 0pt">&#160;</td>
    <td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; text-align: center">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Premium/(Discount) on</b></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Date of Market Price</b></p></td></tr>
  <tr style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 0pt">Fiscal Quarter End</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;High&#8199;&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;Low&#8199;&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;High&#8199;&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;Low&#8199;&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;High&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#8195;Low&#8199;</b></span></td>
    <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">&#160;</td></tr>
  <tr id="xdx_41C_20241201__20250228_z5MFGj29r6Tl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">February 2025</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.70</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">11.28</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.17</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.09</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">4.35</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(6.70</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_413_20240901__20241130_zqukCJjPhKb9" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">November 2024</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.29</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">11.54</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.49</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.35</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(1.60</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(6.56</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_410_20240601__20240831_z3JFofs0Jxjf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; font-family: Times New Roman, Times, Serif; text-align: left">August 2024</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="width: 5%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">11.77</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="width: 5%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">10.68</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="width: 9%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.73</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="width: 9%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.33</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="width: 3%; font-family: Times New Roman, Times, Serif; text-align: right">(7.54</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="width: 3%; font-family: Times New Roman, Times, Serif; text-align: right">(13.38</td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_410_20240301__20240531_zZe2ZswQmNyd" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">May 2024</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">11.05</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">10.55</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.76</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.33</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(13.40</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(14.44</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_419_20231201__20240229_zOpZ67B6tENb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">February 2024</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">10.94</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">10.57</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.63</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.39 </td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(13.38</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(14.69</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_412_20230901__20231130_zkO84MC4UCd5" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">November 2023</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">10.47</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">9.26</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.36</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">11.20</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(15.29</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(17.32</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_41A_20230601__20230831_zwayjvCbwBwd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">August 2023</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">10.82</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">10.27</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.60</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.09</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(14.13</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(15.05</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_41F_20230301__20230531_zNfI1G5BuW4g" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">May 2023</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">11.30</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">10.56</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.63</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.22</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(10.53</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(13.58</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_419_20221201__20230228_zvAsuNSZxD9c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">February 2023</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.15</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">11.16</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.96</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.37</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(6.25</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(9.78</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  <tr id="xdx_41F_20220901__20221130_z3obWbHxBRU3" style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">November 2022</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">13.94</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">11.61</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">12.54</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">$</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right">11.71</td>
    <td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">11.16</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td>
    <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: right">(0.85</td>
    <td style="font-family: Times New Roman, Times, Serif; text-align: left">)%</td></tr>
  </table>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in">The NAV per Common
Share, the market price and percentage of premium/(discount) to NAV per Common Share on April 14, 2025 was <span id="xdx_902_eus-gaap--NetAssetValuePerShare_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zu8rIqtPAI7g">$11.31</span>, <span id="xdx_90D_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zULm9teFsU01">$11.79</span>, <span id="xdx_90E_ecef--LatestPremiumDiscountToNavPercent_c20250414__20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zakmU9T7oUm7">
4.24%</span>, respectively. As of April 14, 2025, the Fund had <span id="xdx_90E_ecef--OutstandingSecurityNotHeldShares_c20250414__20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkXYJWALFg68">
11,597,297</span> Common Shares outstanding, and net assets applicable to Common Shares of $131,117,293. See &#8220;Repurchase of Fund
Shares; Conversion to Open-End Fund&#8221; in the accompanying prospectus.</div>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.28<span></span>
</td>
<td class="nump">$ 11.54<span></span>
</td>
<td class="nump">$ 10.68<span></span>
</td>
<td class="nump">$ 10.55<span></span>
</td>
<td class="nump">$ 10.57<span></span>
</td>
<td class="nump">$ 9.26<span></span>
</td>
<td class="nump">$ 10.27<span></span>
</td>
<td class="nump">$ 10.56<span></span>
</td>
<td class="nump">$ 11.16<span></span>
</td>
<td class="nump">$ 11.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.70<span></span>
</td>
<td class="nump">12.29<span></span>
</td>
<td class="nump">11.77<span></span>
</td>
<td class="nump">11.05<span></span>
</td>
<td class="nump">10.94<span></span>
</td>
<td class="nump">10.47<span></span>
</td>
<td class="nump">10.82<span></span>
</td>
<td class="nump">11.30<span></span>
</td>
<td class="nump">12.15<span></span>
</td>
<td class="nump">13.94<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidNav', window );">Lowest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.09<span></span>
</td>
<td class="nump">12.35<span></span>
</td>
<td class="nump">12.33<span></span>
</td>
<td class="nump">12.33<span></span>
</td>
<td class="nump">12.39<span></span>
</td>
<td class="nump">11.20<span></span>
</td>
<td class="nump">12.09<span></span>
</td>
<td class="nump">12.22<span></span>
</td>
<td class="nump">12.37<span></span>
</td>
<td class="nump">11.71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidNav', window );">Highest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.17<span></span>
</td>
<td class="nump">$ 12.49<span></span>
</td>
<td class="nump">$ 12.73<span></span>
</td>
<td class="nump">$ 12.76<span></span>
</td>
<td class="nump">$ 12.63<span></span>
</td>
<td class="nump">$ 12.36<span></span>
</td>
<td class="nump">$ 12.60<span></span>
</td>
<td class="nump">$ 12.63<span></span>
</td>
<td class="nump">$ 12.96<span></span>
</td>
<td class="nump">$ 12.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.35%<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
<td class="num">(7.54%)<span></span>
</td>
<td class="num">(13.40%)<span></span>
</td>
<td class="num">(13.38%)<span></span>
</td>
<td class="num">(15.29%)<span></span>
</td>
<td class="num">(14.13%)<span></span>
</td>
<td class="num">(10.53%)<span></span>
</td>
<td class="num">(6.25%)<span></span>
</td>
<td class="nump">11.16%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.70%)<span></span>
</td>
<td class="num">(6.56%)<span></span>
</td>
<td class="num">(13.38%)<span></span>
</td>
<td class="num">(14.44%)<span></span>
</td>
<td class="num">(14.69%)<span></span>
</td>
<td class="num">(17.32%)<span></span>
</td>
<td class="num">(15.05%)<span></span>
</td>
<td class="num">(13.58%)<span></span>
</td>
<td class="num">(9.78%)<span></span>
</td>
<td class="num">(0.85%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LatestPremiumDiscountToNavPercent', window );">Latest Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,597,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=naz_CommonStockAdjustedForOfferingMember', window );">Common Stock Adjusted for Offering [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetAssetValuePerShare', window );">NAV Per Share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityNotHeldShares', window );">Outstanding Security, Not Held [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,797,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The maximum sales charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters in an offering that is not made at-the-market, the applicable prospectus supplement will set forth any other applicable sales load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#8220;Plan Agent&#8221;), to sell your Common Shares held in a dividend reinvestment account.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Assuming
        a Common Share offering price of $11.79
        (the closing price of the Common Shares on the NYSE on April 14, 2025).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Stated as annualized percentages of average net assets attributable to Common Shares for the six-month fiscal year ended August 31,
        2024 (annualized).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Interest and Other Related Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month fiscal year ended August 31, 2024 (annualized). The types of leverage used by the Fund during the six-month fiscal year ended August 31, 2024 (annualized) are described in the Fund Leverage and the Notes to Financial Statements sections of the Fund's annual report. Actual Interest and Other Related Expenses incurred in the future maybe higher or lower. If short-term market interest rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates, the Fund&#146;s interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund&#8217;s use of leverage will increase the amount of management fees paid to the Fund&#8217;s adviser and sub-advisor(s).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top"><span id="xdx_90D_ecef--OtherExpensesNoteTextBlock_c20250418__20250418_zmVchX1UmQih">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#8217;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#8220;The Fund&#8217;s Investments&#8212;Other Investment Companies&#8221; in the SAI. </span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#8217;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LatestPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LatestPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherExpensesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherExpensesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityNotHeldShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityNotHeldShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetAssetValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478494/946-205-50-7<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478494/946-205-50-7<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetAssetValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=naz_CommonStockAdjustedForOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=naz_CommonStockAdjustedForOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( #9YDEI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( #9YDEH_;^KT\P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%.PS ,AE\%Y=XZ[3K$HJZ739Q 0F(2B%N4
M>%M$TT2)4;NWIPU;!X('X!C[S^?/DFOEA7(!GX+S&,A@O!ELVT6A_)H=B;P
MB.J(5L9\3'1C<^^"E30^PP&\5._R@%!R?@L626I)$B9@YF<B:VJMA HHR84S
M7JL9[S]"FV!: ;9HL:,(15X :Z:)_C2T-5P!$XPPV/A50#T34_5/;.H .R>'
M:.94W_=YOTBY<8<"7A\?GM.ZF>DBR4[A^"L:02>/:W:9_++8;'?WK"EYN<QX
ME15WNV(E^$I4U=OD^L/O*FR=-GOSSXR7WXPO@DT-O^ZB^0102P,$%     @
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M3@H\W/[O#;#"Q([A[8N_ 5!+ P04    "  V>9):T*+3%>8:   )W0  &
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;.V=6W/B2I+'W_D4%9[N&7O"QDC<
M3-\BW#87 =+I.=TS&R<<_2!#V6@;$*N+W9Y/OY55$KI0"-SG'_NR,S%],%#Y
MJWM2JLS*^O#L!S_"!><1^[E:KL./)XLHVKR[O QG"[YRP[J_X6OQS8,?K-Q(
MO T>+\--P-VY%%HM+\U&HW.Y<KWUR:</\K,OP:</?APMO37_$K P7JW<X.4S
M7_K/'T^,D_2#W[W'140?7'[ZL'$?^5<>_7/S)1#O+K>4N;?BZ]#SURS@#Q]/
MKHUW3KM! C+%OSS^'.;^9E25>]__06^L^<>3!I6(+_DL(H0K7I[X#5\NB23*
M\3\)]&2;)PGF_T[I UEY49E[-^0W_O*_O'FT^'AR=<+F_,&-E]'O_O.()Q5J
M$V_F+T/Y7_:<I&V<L%D<1OXJ$18E6'EK]>K^3!HB)V T]PB8B8!9$MB;0S,1
M:)9S:.T1:"4"K;) >X] .Q%H'YM#)Q'H'"O0302ZQ[;252)P=6P.O42@=ZR
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MA=)L*,U!T8H:(7,[-BK='"LU0N5C137VKJE7(TJJ6WRL:+1ZY24#U#L92AM
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M2K.A- =%*RH$,U,(E9[U>H4@EF&T2-<%!/]\@+=/*RBI7DXKB+5=62U #\1
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M9D%I8RAM J5-H30;2G-0M**"R%S6S>H+&W9#H+Q&.U2S7QM85JLJH [M4-H
M2AM":2,HS8+2QE#:!$J;0FDVE.:@:$55D3FTF\<XM&=.1L>IB%]PLOU/4(%7
M!170.]] '?VAM &4-H321E":!:6-H;0)E#:%TFPHS4'1BGHS<_0WE;/POE.!
M0[[F=,_MK8R[LTF]$W-W;56?$#21GLVW4%H?2AM :4,H;02E65#:&$J;0&E3
M*,V&TAP4K7CI?>;EWSP0Q5X^#7V1#T''>?@? !:=^/.;S>DJ*75AIXWI&:U6
MWK%3[TSY^WJ/"[EI3/OIZOH7^7P6:F_@"),87RKV6[)%32&XDS_GRL$^O6KE
M7&23Y#/SQ9(IW/AK>7S N?X7%4KMP*M-:Y$R22I:?>7%J\O3N5C4T7+OC!96
M!1%RI%:!N79+^,P#>2!!9J1*&<8BY5Q47!- JW0_B/M$;1)&?D >T&*%1R0*
MR>;3?3516KBMK_=,K4?%PBR@V&:DY74+S4+ILU)0R"]:. JJZ!FJ$U<KSZA<
M,!G72Y:%R3,.23EH'S\M1=I*A>!G*J_/OAO,U89@'$9<5C3,+6/GG&*1R:U_
MLI&<4QY+[LK8;>3*OZ1E<7*%4.I^SY*= VE468EA))WS(_<'ETT@:A338W[
M^-(3:')#ISN':+4<4%BY;;$? G^5%IS&"$7FVYICMH8-U=WDOJY.H:C@9F(X
MIF'>TWX.58,EK>"+1X$T4IPTS=#P?J+"Y(X[)*';5NX/&C,4NY!%%%8ON>A)
M3H4\6U18E/><I0\AOEBR!V'R"[^UZ-#)E[4LP 5-D9VGB9?=<4!^_6+TDC%+
M'4@1XV"W[V0WS/G,FZNG&M'DZCHGF3D=#TAK)0LH.&K29(TE[3_Y*B90=69
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M/':C$Q)Z:>>[M+OC#[]6RER^"]R](I_V>M;1/G3<8)CKV*/(+N]$P00C7[Q
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MVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA])
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ -GF26F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( #9YDEH_;^KT\P   "L"   1              "
M <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( #9YDEJ97)PC$ 8
M )PG   3              "  >4!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ -GF26M"BTQ7F&@  "=T  !@              ("!)@@  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( #9YDEJH .\L( ,
M .P1   -              "  4(C  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(   0K      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>15</ContextCount>
  <ElementCount>33</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="naz_424b5-041825.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>naz-20250418.xsd</File>
    <File>naz-20250418_def.xml</File>
    <File>naz-20250418_lab.xml</File>
    <File>naz-20250418_pre.xml</File>
    <File doctype="424B5" isUsgaap="true" original="naz_424b5-041825.htm">naz_424b5-041825.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>nuveenlogo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="10">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="83">http://xbrl.sec.gov/cef/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "naz_424b5-041825.htm": {
   "nsprefix": "naz",
   "nsuri": "http://nuveen.com/20250418",
   "dts": {
    "schema": {
     "local": [
      "naz-20250418.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/cef/2024/cef-2024.xsd",
      "https://xbrl.sec.gov/cef/2024/cef-2024_pre.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "naz-20250418_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "naz-20250418_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "naz-20250418_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "naz_424b5-041825.htm"
     ]
    }
   },
   "keyStandard": 33,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 1,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 15,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 196,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2024": 83,
    "http://fasb.org/us-gaap/2024": 10,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-04-18",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naz_424b5-041825.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-04-18",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "naz_424b5-041825.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllCoregistrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AllCoregistrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Coregistrants [Member]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r176",
      "r177",
      "r182"
     ]
    },
    "naz_CommonStockAdjustedForOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://nuveen.com/20250418",
     "localname": "CommonStockAdjustedForOfferingMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock Adjusted for Offering [Member]",
        "documentation": "Common Stock Adjusted for Offering."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r82",
      "r83",
      "r84",
      "r85",
      "r86",
      "r87",
      "r179",
      "r180",
      "r181",
      "r187",
      "r190",
      "r191"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CoregistrantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "CoregistrantAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Coregistrant [Axis]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r3",
      "r4",
      "r6",
      "r7",
      "r13",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r178",
      "r183",
      "r184",
      "r185",
      "r188",
      "r189"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r13",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r75",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r178",
      "r183",
      "r184",
      "r185",
      "r188",
      "r189"
     ]
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r163"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r163"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]",
        "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability."
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r160",
      "r161",
      "r162"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r111"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share",
        "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r63",
      "r64",
      "r66",
      "r67",
      "r70",
      "r88"
     ]
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r160",
      "r161",
      "r162"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference",
        "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r5",
      "r177",
      "r186"
     ]
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r136",
      "r142"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r142"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r135",
      "r142"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r74",
      "r176",
      "r177",
      "r182"
     ]
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2024",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001999371-25-004421-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001999371-25-004421-xbrl.zip
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MFM:3T^?:AQ>/ -RHTP#W_-WF(6ZQ%#+@^DS([!026J2X=K\+FK*$0>P03>4
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M?2Y%@1?-BHXAI*JRXU5KAJ]_ %!+ P04    "  V>9):O^$R0=L"  !G#@
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MS/G&[M<M0;2P!FU2TR#^BRZU<E;<I=C#L<^I5$GU9WT[\AM02P,$%     @
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ME[ #,+*L?MB'I5EMIL$F %!P[ PU(]#N>E:[IR4V!V,/M19#ZC2!YFP;M+H
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MK "^:X_UTJN+ZAA]RX8GID AY=5&!_W.6SRN+2?D&JF#B5/(S._@[)0:CHJ
M463(?Z8&>UM&^P8L%S@KBFW7=KWW&IU7V5%@I1C+&2SG VSAWQ"+:,#2/VBG
M W)#O<>M7@B#!^NO(*-.<*I_MF$)HRYU3A:;&52Q24 :)*.F*6?_0$(C/3F"
ML=B"<^ZFR%G^/4BQ.V/HKV)>!5X;"# "Q\_$++-QQAA*7;8(633%X%F HG X
M9GJ@&^/6<D'L$I]KJX'0?)J3HA4 OY@3#HA"2B^8<- 61-0"MV]8#BA4?2R
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M!(A,G@Y+H(UEFT<7)2YELFS&MQA*YA04\0N%A4/R3[^UWH%>CHF PV('G?#
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M+WR0C'4Z9^YB#A=S8VEQH<965EQHO!"8,[:[9,)XHB#36CCL'(IF3[%[!BQ
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MO&HQ9I^Q8)'-(5 03*I8@W$\AI3E!#U?KH#H;D D1;0K5U/2S@0KQ),5<(M
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M."+^2X<=#0DHL^ED2VH_<%2[83=C$SA$FWF! :AM>>X-"&N3@;X)R+[K67"
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M G2C$YYA3A(H;;O<+)"+G43*XTK8C'E$D*M>WRR4-_5"8ZLZZ>DLAEC!8K;
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M_.0+VA?-J%\+U6RMJ6;)5%/-[QQ0BHMEV-/IYG= @TVQI==",=MKBEDRQ=1
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M5SPZ/?WS\.2+=G'9O-P_3E[)7F5GI*5N+U49 LLEB*+.&#4H8+DUUC9\T6)
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MP@Q0:Z26PR8A?"'#FJ%T!7\,1YV:KPMC._;GSJ"S),<T51BATJ3:^EH,LJ<
MQI(W6S^.*ZC$]ZN20RCBIM0,1)G$;NE F]_6>BL+.V?1SFWP\GYV$5K/FV%@
ML:DJKY#5IQZ"07PT1>%<"I8I! F5TBJV4N:*^5A^@^I01.'5 05)F+G?H>J'
M#$]@FQL\LM<"],I 5/LRZ] 9[B;@YA7!C"'AO%[%[K1CERH@6FGC"HCVSE=
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MZIQN S;@OMVP2:TAB58[%CP*-HZVJ(O'/=T@9EBU3?F)-M<-:8L(M\"TP+3
MM,"TP&RE&U_FU/]&[GJXPCX/_MP;;CKTL=]($GJY82A.&\GJFX9B#S2H)NT9
M]S<-2+?3;2 E;QZ*TRT@#509&NS)IL$ C6$+MN2H<]Q 8=CX.>G6N"T>X9B<
M=(X;5"S>.('V&\6PO]QBS:E\\QC&N\W?0,!TJWW,'H6HFW0(WSA1[X$Z?MRD
M<O[& 8'CU:0$]D-< %L@'/1.&AGR'F!7FL@&#R"B-#'D/00VFC0&?@#B.-D"
M=/3..Q?-Y8.U:S[C*$P/;@3"@F\'-;4@[F/,N\QFLT!@)Q4WH*G?N:E[^-5-
M_2BQ!_ ; #\,1+F%V.935'=< VZ!:8%I@6F!>5; ;$T9(!73+%)[D"0B3>R]
M;K=[1Z6KF;OOU.EMA]_QU+FHMJM_#$".G&YO&R(X3L^<B[-M\$R?'3O'FZX2
MT B0\Z[3[6\#L9X>.]TFG:DV#\C)MF#DQ.D=;P.-G!TY9TU,! \!R&D3V\UV
M^I_X/I+Z%"A1 P#%O1+&U;2%]W@+3 M,"TP+3 O,,]:DI/_J_<^9"!.1[(TV
M[;,ZZMPNI;^V;_""/DAF[DB\LL/H)G9G+]Z\W'29@:/.^19X1>OR.Q_!(-ZH
MP^_FH6C267?S.W*T!;BHRWQ^#"B:N(TV3Q<76X +."/; 44#[_NF/%?WU)E0
M0_H87HLD1>\4_#F*IL+>^SU*DOW-7T;]SEF3 *E-WSO]1HV[-Q\A=;H%O/:H
M<[$%M]]QI]O\3&U25MH.*+: XQ_7M)MZ#"A.MB"*\ 1XZC9 T23W:9N#]V19
MTRA.QU'@1_:W+ XC@,S^ZJ9WS+UMC+UMB'G9 N&EOP6'>AM"Y+: PV[!5;,-
M%-G;AI.Y!>2P6VC8-KUFX/U7EJ045(>7B?TI"_T/,*O]3<13^TLLQB*.A6?O
M8;6Y?O?UX-.W+_1G[_4^@<(!>+:;VNE$V._AS6AL?Q&Q'WEM-FX+3 M,"TP+
M3 O, SJ3[G(92O?2X.HJ%E=X#PZF5&C[CRR%VY'C]RAH;T]L,&[O_-PYZFY!
M %(+1PM'"T=S.!ZD+G0+R(,!LCU*FKJ7,#;/?AO)<#U0K^Q?>MVN S<2*V![
MXPU>2_W3$^?D> MBEONGI\[1Q184.>N?]IR+TRT()^]?=)U^D[(%FP?DS#EI
MDK:Z:4".ND?.^394)^R?GSCGVU"#;K=Y<0O(3BA0;$W\TXW]&EMBU8SX9VM&
M;(%I@6F!:8%I@7E@,^*F=+3'M1WNMDS3 M("\JP!V193YK; <7:!QJW=A&,K
M%;2FEL1?DYD;OB%[(OWU#,Y>"T@+2 O(ZO;-4^>\27;3Y@$Y<[K;8&@]ZETX
M%TV*!#X$(.=-*JY6;ZU#B@5\8\%_O\[4BUCU[Y7=Z\Y2^YL_%8G]6=S87Z.I
M&SK\A6-?BM@?O[:G;GSEP_#X:/?%&[I,S%$.QN[4#^:OEH\#+ZK+9_;F<0%1
M&%HS.#P0QUV.1!!@!C'<UG]_T7U!G^7M39^KDPUBWPT<^Y\BN!8H6< T;I@<
MR+EN?"^=X)/=ER!C<*<RD"\"=Y:(5[;ZZP6)*!6"*\LJ:333(W8[)%D0^A+_
MOP5#4]>K[([HKHS]XLV>6Q!$;@-7B5:5<=8'$950)CBBT':E')6P^3K*5?Y.
M07ZZ320$-"\HMOE@B!XN1?0&$6IV\+$+V"W4!OT\^-/V$W(/C*+IT ^QBDV(
M;H+1Q VO8$H_Q%_PC42]X=BQ\"EM4WBVYU_[("9[\"!E;[II=0;8/)K=>&WD
MSGR$\,KUPP0&2=+8'V8X.?DK:!9_#&_.._8W@"YPDS2?RQ.CP$77!T"'L,_(
MI^%@Y8#1A!8TGR$E!',0V7VLS4WSXZ-C/X:1AEGBAR*!F=TYKI9^@4,<W:!A
M":!/)PZ.XR9)-H5YTL@>"A-^Z5,1NK,V@^F.T@Q6I1ZT9U@+'$:.]?Q-%@*<
M#:%*18BS#E5Y<7P 73\DK9R]3I !_A!JDCW LAU&J>VG"0*T[R#>\:58  ""
M(,"!84C/'X_AZS"UQW$TY9EID"S)80'\C;* "*(C.T+%W!'*QHW%J=PPA.4"
MV7EK.)F;/(BE&V<KSR+5C;_]-.*OA8T'FI%G4^ZW+6!W1RF^M_B@$@CX0K-#
MJ4ZCHRA?,6D) YXR Q!^)@6\F%!@EG=^G F">QSI^Q[G,DLJ'FD3Q;5GFU+6
MX6"M=JI3]P=\#MP13T\)AXE 7 8(?,*'%MY+D)G"-L#--Q()O8LGKLP/3# =
M>(GWI@92WJ?R^2<@MH@'/.SM/'JLVYF\]*>O[6(!! *@4 3!CKFJ''#P $^T
MO&.%&X=(L$ I0M;NP9\RB@9  8H+HKHIGU]5W7NF(P:D9.7#<8!/PSGN-<V.
MUPN>.8&'6)<&UQL[C \EFM:."CQA<C&E5<.1@!-\94=XE0&D<#H3A]E7$,"Z
M4P 63I_&!**%GQU%28K#  'SH:]@ )X]Y"-, Y8'@Y,L)+^8 ,.#HP-7,K$?
MQAGA2[.B( *X = 8_54C)/<QX"\M(]I.9F($NH8]R^)9!).D<09P\E&4_"01
MP?C $_"SG])IA-.3R"G@+WLB@@(,U3V3&$HD'\0NCI7#J?72;5,&<QW.U-G*
M.MW*("_4V[0V=HKJ':],&WG)Q'N[Z;F)0+/81E'F.V8[@!>UQ@R '5'V]Q?]
M%TO>E&4IX4[\J&A;EONJ+U59VQ# ""9:#=B&5OL[M41X\88CF3"N"8[((+N"
M4V0?]5Z502PW ^_AO7(+W$O?OG4_[CC41GT<DL"/CU[6H;+?[1_O>?MEB)75
MH^Z=P]H'ZW'38+@%.%.OE,%>4A9KR2RWU)9[C,X>ZQ0K?AT6!Z.Y0!B-Z$*%
M"0%B$0<@*K]X\V\0(@A</CX?Q##.W'AN]\\/^Q?Y93%\4W)9K7:JFF]TXW.V
MJ<B8V@5MCT^2S^AFS>"-,=A?N0'WQB.+"#\;3AYHC)]>YV2+.X,3JC;LVFF,
MJFZCKFT/3TH;]L&M@)\F!4$?E90V'%&RPJEK4E#HP4FI24V9!\+/T8J@/#0I
M]3:<8K3"J;O82E+:<+>&%?!SON477&_#&8VK7' /=NI6(:45Z7N#^#FY4RA@
M'E2QO=:K78I V*BEW;M#P,$Z ?B@[*K^3_:#HDLH05^/:3IR;-2Q.NB)P^<C
M^Y,;CR:V_-[1UM;_E=AC/P& [3EHT3B*?>,F)1TZG6RY3Y0R)ZJ;LL89EF5O
MO++S7UWZE1UB1GY'+&:Q2$28)LH[%8[\&6"=GR\\"_L5^']EOL<N4S;TBW D
MT 0N/8*"$R#QSU@$XMI%!UZ^C]N^7>.-;]?B,.97;!X&-L,_TNPS,\[93[2S
MD#T=239,8W=$'I%*Y$+@NT,_\%-?^FLPU'H(+Y(3%[V*>N_E8"+$(YF(41;3
M6T7'96'LE-R4[ -SV"FK8( ALR!5CA.W1("*. JC56;.08-1I=?( !X&" N4
MN8>.<VU4WW?L69 EI?GEQ'YX'04 "/*0!=0LGS0FX*TH.;;879\[@PC)4UB[
M/POF56S(3:P_ <TNDTV2_M\>]_(8W-'#W=POM$94+<55K?5[?9/_Z089D!5*
MI#+&!>[0_Q9Q5(>W[97?MB9$]W\<'-@??!%XK^POP'1?PU-_9<@& *C^:YO0
M#7_:!P=RIX'9J5FEA*BLV;\%H"R@3=M.HL#WM),3SNXK^Q1-W?(+]<(I.13N
MC H>N!+",4*.'E<F8^^%L5RUT-?VM_D,UCB(X;X8O;8_NU/!R/@<X;+/S9<.
MU5OX"Z+PUT- 2!4U,WC]8!@+]\?!D$+C7MEN<./.DY6Q8FQ[3DK%>4WX$&[:
MK*=(\_GR[S&:0395$JDC)</IY7O 6J/1V7GW_/SX_Q[KP_3MZ^#=Q\__L >?
MW]F?WW^S!Y>7\.^?@]^_O[<_?O[PQ]=/@V\?__ALL[.K 'XCH!8&&\[>V)O%
MA$I0DS$*]]W*NTQ9H<%"X.-$6'D8'JO%R22Z272<"T?&8?221Z$R<$KV_'WZ
M:>)?34AL@=?MQ T ?HI/XY?-R$D2R:*88OA*PKZ%?U)0(,?H?/[WY7L'II!S
MC"*0F9)9I*-X\QA&%IG@2?DH2%A3/YL>[GF@,:"TN(^76^$5C"#D<$5\089.
M2 AO,#H'Y&&:B*%,,G@2)#P97EB0.HO+H]BCB9^D42Q#('$DE(RC=(*S2N!8
MEE8 (E8M"GY"&3*-JK)M ?H<"A#D0Y3!8538%5R3H' J#"PN G;C!P'#@E"X
M"@[4QA04EL22#"@<9VFFYOHM<F/2R+YA )2@A8(6@6%L80J+] 0<\*F/H6[I
MQ$TI]#00&&G),8?!',3<E($816'BPX6'L8^T7'C!GJ*%R1H*BKHD%,"*,I2B
M06D/_"D&V&+4[!SH':;"F"P%-NL6$G"D$1E06UB_BD[%J$K038,,\,""]2R+
M1[ 8E-<MVF<5<<=8B&8 C@S=!%A\%/']:P0&D!DFO(;$D1&>/TC!!7D>CB Z
M\.%O$/;I&)ACJ[!Y>;0 (Q@T!@-9AEZ#2( 3BP <<#"PCA =1=.9CK<WZ0"C
M9H%ZYU'&:$4ZJ.X=;8,G1KY'D4,4Z(JHY4.8"%NOB@"$<?C0Y,A*Z!=CB7)0
M#F<%@I"[)Q&GMJJSIIML[>QOJR+;T&ZX@3 VZ]YQ;,U"9=1MWXZP@1&:Q_.U
MN[M[([2[^Y1'V'PL[@/G9:W7IEV=8#G"'B3E3(<*GRX.W5Z@[*X-O+=!E"CK
M\2<6J+ZH=++M0%>[400>R/3:VV)J']N!JG:3"+PORCKP3ED'M@-).\3T<^ML
M32#X8Y%P7O+IP<!91M>W&?4?_A8IY0?=*UF@W>9MW6:YQ>^DK]J4%]H=;W=\
M>W;\KM?=/?&_[AOR T4E$9#_7^;&L+><IK7-J-_VP];?WL/V3YBJW=HGN;6_
M1S?MSC[)G6T/[9/=VO;0/M6=;0_MD]W:+3^T#U#;XZB^ML<:U1*9X$+S][N8
M;5N+\*5U/A[H_!@521ZRC. #+?V7Y:L^KZ^6LK[Y>_W.6;?=_>>Z^[U._[S=
M_>>Z^_T.YJ&WN_]<=Q\[TK:[_RB[WV3I&R>!X\[1(TM^+]O-?ZS-WSM]=,EO
M_^6:-*O&Y3+6&,T378OI4,0V5W.K1>.#T]"#'I;'N!PW?2/V%]V([5;NUE;V
M.B?MJ7P:6]FGNDOM5CZ)K5PH<+9;N1%I<K,B9*]SNDB$?$"YL=W+]:@#)Z>/
MOY</6UUPC:5EN/18JPP\F;NJUSE;9!QMMW*WMI)++[=;^02VLM\Y.VJW\HEL
MY5&[E4](@#Q[')-+JPQL0K$[ZAP]QI6YRQZ!3^Z\E?^?SO74ZW1;6]73V,IN
MYZ3=RJ>QE2#_/X:5JMW*5O[?B:U\7)GQN/4&/)7-/.X<;X$VMZON@+R#2*L0
M/)7[JMNY:+?RJ6SE2>O;>1I;V>^<ME+D4]G*HS;0ZRG)D-MA1&XW<TT*P>EC
MG,Y=]@B8.0+M)?4T+JENY[@5'9_$5EYT^JTI^4GL)$J.[58^C:WL=?J/841^
MVEOYF'+CR>,DU;5*P"8V\ZQSU'_\S=Q5KT">)-!J T_CMNIVSA_C/+1;N8FM
M[+>*W=/8RO[CI"6V6_F@18K:K=Q%"?*XTWL,X:=5!S:CVSU*C/0N^P1DED"K
M #R-^ZG7.6I%C:>QE=W'*8#0;F4;%-1NY9*M[+<6EJ<D,P*;;16 I[*91YV3
M+8CPVE5_@)DET-Y73^6^ZK6YID]C*WN=7JL0/(VM['<NVJU\*EMYU/KIGI ,
M>=I9V'ZJU0=V;"\O.F<[K0X\<HY :^AX&E?449LI_%2VLM<Y[;5;^22VLM^V
MA'@J6]GKG+6G\NG(C8]E:6E5@/6K -W.^<;5N042_V'J#@/QQH+_?IV9HS)P
MMZUEZL97/H"&CW;K8#/7J:>?T7P//.'&9RL1T/WF/$BC&<VKOU -O.D[(@L_
M] 2.VNV<^.%MT'V;""L4J>TF"?Q[[0:9L&>@0KV-IM,HM"\G;BP<.YT(G.\'
M/#*+_1%\XX8>/H<MR]TK84=C^$%,_6QZN.?YR0@TP73?3B/[MK'M*+0&,&9@
MGSO4/MNQ?\'$M3/\WWZGVZ.93CLG9R\=.Q;)3(Q2_UH$\XX]2'!:];+%+R.D
M'T -M2>N9_=ZSLG%F=._."O,">]E:9+"P'YX1>-K*!/;G<T"T'"!^A'\TFMC
M .JHZYSUX/_[)YT%FWIW\E ?9F_LS=*(9!VZX_Q00NE[P%NBT=EY]_S\^/^>
MZ+/R[9_O[0_?/[^S?ST<\GK+R[UEUH7KWOA22\<!"=YN^A]1D@]$87M =''B
MCWWA.?8HB!+A'0CX$4 #^I_"#+8?7HLDI3]'T12P-@>"O?(3P+#P;!@)2#]=
M9?;>Q7'7'HS2COU-4?6-"U087[DA8-(#D@7(/OEA*)(H=6'6>!;%;NH#Q2+1
MBEG*]I >'(S>Q44?:;WY]+ (6,P(YC%6%L$!IAD2G$);7'H7/(-C#[.4H(Q%
M&4XX8.YHDL$I2Y/F4 RSQ(?U)78:8\(73*I2OXZ180"/T-@!DCH^?9V4#BTR
MF0!WP<.7D3]\_O?E^^8 Z(VSD_ET& 4V3G/V^O/@_W3PK_/7]I=8C$6,FZRF
M#+W#*+:_HD20 /TD&?PVG.?,:>K.FP/@!DED#\U%N'8B1EGLISY,)GZ.)FYX
M)3JELW3?8_FPMQ3NX3@*@N@&>+(UBZ-KWX.)_' <Q5,F:7<(;%OC4&VVR<I+
M&P^(KFY-X=*@&^<5KY8D'N"(03!S/1SN[R^Z+^@S<,"1^KPR1H91#/2#5M'
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M['5,>2U%-[2.FD$:Q.SH/%=:-9&I#DAU:*=HP"&>G<>"6(%[H]H78[%7::/
M3@DT5 %@PH7N(6$$:U ]EMP]0F_F^=MLHV7/!OHOJ,@ ![+HRBZJE@M7<0%D
MD4D)WI2EQV+J7X%# $:QRT_,12ZU6]-#SA?-IC+4C[N8R/+L5%V6P9%ZBE5&
MT9-RED@'"1?"5WV)#-':*ER]S)1B53Q4]W,Q71VJ6X11,63HAC\4/;(HG+]8
M:*&JRM/JJZ38.5GU+L_E9]QW-\9>,L 0Z;3EW<]VFEFQ;/?3GV9356U,=C/2
MS=Y57&3N>42\?0"$A-CHT/JH3*M?^;A2Z]H,S@[U+MICQ^F'CY^_#F1!!B61
M8=UW0UXHM*W*#S;7/2O'B]%X<*2 @>BM55[.4B[44+ =F;EII6?#LDH3'?M?
M(H<$B_3!V%89.Z7XPMSKK-HB(PD#7#=T[V*B:23[@5&*<A:D,HP/*[>/4JX&
MI])/$U@B%KPV[NQ=;Z)>+**<WP(+&F?@%W$6B,J=@/?H- LDRT>&3",LL.Q7
M8R39T6VYJA.+KCN@.[=0IJ5@/E"G"(N?0"Z+JC[E+0**W5^TV%, <>)BS31!
MRDG)RRZ=S$XAE%%VV,)N#""12W(B"8($0>G#5TN[H>*;W.C #<TXOQV_90:F
M,"5+(&(KME!&#]4(6NC<,5(YZ'2:U6SR1GLRI>]&#!.?:\KZJOSKL"@X<:!1
MA>;(\4\L0K5:=XTLP%($AHJ\3ZD$8A0&V#&)]P_O2&D%MU7Y./L211HYL J.
M+0VI,E*L8L%))4#2<G43B:DJG^=*X=4<O%0?OQHO8^K>99$R,6-E\^ R&1M6
MC >[==UM'F31IW_<^O1AV?UNZ]/?5![DDGV[-<:PMOS=25XD\OWEVZ\?OU#5
MNS\^V)?_''Q]?[E+22>R?[II\M@AZ!>W8WM'G4UT03AJSV6[+-7_MZSB2LGO
MX4C*W%@7%L5QK%]1GRW/EV01623VN!B?F??J^J7;Z?90+N3>Z!79)U459.G*
M,ZI9HR!>UJ(=GD+\194Q^2T5=NS.I[(ZL:I F<?_%EKAX-C4G9KS_%F3=W7A
M^=*:R%!-9AD,Z8RYJOR<DRS*:YFZ*=V2LD FVXA897HK1;PO6.:;@S"D0E&_
M.0#X;_.#W]V;1(6F8B-CA#M)N&,E/D+8""E836!;XFLATTFN 0P*,968C0UL
MR:K2^/!UA-I*QQK .S.M/M="A)5X_4 U]R#MZOU;$DNQ6-[$'_IZ.TVY&21\
MQ#T/1LV,U"XIDQ8,G)=UM%!BH0#?3OT]O5O*T7L4X4$Z"HI417F=:*8%_,N0
M)NSY5Z(B("RI2W'957JXIIGGHC+T9K40RRSO[">%VNDX+I,3:1SCF)4;57T:
M_ZTIN([BN,P-Q0KB^4L$)C6&2U)MDZ93SNX!Z40=+],-%^F"KHK]ITG2Z$JP
M:$NQ*6C,P^ZL+MIQ_@7'%MO-6=I,Y(?4QQ4DJ#BZ4;74T7!4:QXU^LT[M1@V
M;94F8I2FB>RKIL]7,1M65=^F$ORR&U\DC:P&H$@N0VS&J+@.O6'4AS=8'C"X
MRH*(3>@!'#TM=2(F?QE*,'MUB?F\/?L5(L7E&1#JC'O=V.&HVWTIU>,K  [T
M-R'CZ:(*2]:]U>\*3G7)58#ZJP $"IE014ZYCG)Y!LF5AR*(;AY;C7GXR.W"
M'6GA@>&B0X7ZJ[*GO"<,8U#JC]"$D<RGPRB0"/X\^#^R%U1M\SENP\O5L*="
MI$1PZ"(QCJ.51-1M0O6%+27<%> #K=U5#*ZFR!+Y/\C!H.;"U[5ODWB-SCTE
MA1@>MG#X8NU@W6.+?3K,2]'2PPD!(MGMQM_?04#\P<$H!^C)Q3X;: /%YMA>
M_HU-3Z4Y4MCXRLU.+,_EQF,>22]T[KZZR-)E@J9Y:^E\,4X@R^:+$RS1_D*U
MFN7V!Z 4>G-[(C MA^PCQKBRJ_RU"'WVJG'Q?[QH@7;)F*N*04D*R6L(Y[9&
M([C@K=FSA SP&B>6X=]@RY8RNHQC4G*I!DLL+3E&&6(CVP$C=V6IXL^#/Y=.
M9]=.5]P1NAMDTQ)*1N$&+ F#X1D33T""-&;.!5#YMBPK47[=6@#W3ELJ?Q,C
M-Y.!BM+SIS6>G/]8DAZE5<T/QP$9,LBV1CQ&]P0N->_B. O5S8A+'-C4MH6C
MTGD([&$<)M089X02 1RKE*W:3EZ&7P:!I'/',&++#CFH1]$OL"..+*6&&RJF
M;JCZK'ML;9WK6F:)#MW/5^_H)L_\F=+'!!RK:.J/C%1]QW#GJ;4/Q3R2TA_Z
M;N,H, WP1E#$""Z!*&7OK*"6B!3)7]+74"[C(V2TIV>-D4N E^E8.78RP*^H
M4P&Y^#FU%*=LGRGW2T3TZ Y'EBZQXLBL!55QI39(VFB<2!VT<V<F7B_7 K8]
MD!V5)!-2S7A,R>2KT($:@#%ZG\=_C>8BI0/"JO] +OT>?J961O*NW9'KAXPR
M%?GN2=AE&O>H*73]68\Q1V.T.11YSHX98D0*E[IT8TIA9.F<#0YN4LGTKND4
MOT*?[R$YQ PW764P'>PAW<P@;+A!D3,7F_?8@Q7Z!<$X V "@7WN@$[1/U'A
M(S?XS_GYD3WX].V+ED1R-;+3? ID0>8H=,NJ$ EER$'61W/R"I<@5^&C.0!E
MQ-4@S;'SNTEV>B^VIOV?_W'>[YT!P6JK3_/Y"_V>Z"JB$'_36,B-T%2'FJ2B
MH*8E'%)+B<8 (/#][NM+!3I][KW>[_#F&!UP2 %4MQ]*C[)^3&("&XU7P[UA
M!JV:0/.H&3EZ/KD14R%1H/2CQM/7^+X-(C91"A==@'1U-2G66*@SW*ZR?%<7
MW6*S:R%O6OZBG9QN0GD?GD\1(6$J2Q7F .EZ/BMP&-S2BI':P*TF"\?\-G!O
MM!FKCDD_MI7@P9V=]JTIS">MNQ/=G;W6W=G W;FSHAX%3S9G/[9=,'8:"I#/
M!J4\R J+3)!UB?6!1(0^B6'*JB4E?=W"Z0Y"GYW+?6,G;^:%ETU>NM$0-ZOW
M%3'/HFV7."/;:%>"!(N;<WDLD&K1H&MJ0]]9#?I=\"1*S1EH*U&ARS#IB?KF
M7 D*:?4O;$->]8O#4+$Q9<4HY=&M( QK_1X&1,Y2:JHG^_2M LG,G=.! ;&K
M,-F^-DF5[.R8F%.!C-T!CED<8R4HE&$@5T;54EVV12RF@)+05HPNOP.1.HHJ
M.2J<\R9DS%$51@,U#@73F;Z"SCU/2U5V(3&>FHE2W/BU/#U%M_I.*[4?D/OD
MEO@Z2;#J72L>23A<KZR]WKX^+%31<"XK*4F;5BUUVWM&%S>W\'"QRRPZT:HG
MAN,OB1+K\C@=>Z^_SV8VKJVK;-8._8W5FTS:,LI(<%51>HO<HMAG65:WF)?F
ML."9O:-]O6#=-T1"9,0JF(+Z[;"K(X[1DNCDY0K:>X/] D=/=7MF8U>T^Y?"
M9J<@[N:%./ A]JL53S>9&V0@8UXHM"XD&">S/,Q<396"ET>NTXF]9=,+>U'7
MIR4N8$UC%"7UO=_VR9-J1$048T=J6>C8L+6[5(=.)OE4:=W<(R\CHSY"2/V$
ML6K?I%BET5 F%!Q.B4N9=&?2&U&93/CE'<N=OO(D>;(YO>_M3,@YR(=^H;>V
M1#&)Q[\>^KM=Z>Y;2<^N]]O3F1/IK3>'S%4J'@X5ZK0SB2VTX[\;![9FPW=@
M&0O30,F1>"U#H)#%7T<!<#M,1Z(,FORCP;6("8#**^/7,)^&K3'93+..\=CU
MXP+'<9:9D?( B=K@%6U:HU+&&A2N$&C<N.B!&DD16/I8*,.*L[C+O'B&GG_R
M@\\"C/ W EA<BH:AJSEGP70?P?*MFPD'^G ;=KC"XI KBRK6MF^S#JP*+M8<
M 13P5"/8>B,P28Y&'"%[A3#21M](A4NXC TSK99+0^>U Y=NQ8)0(DQ/&F<Q
MNU7SFI><7+]DH8;,":LBH0/-):ZZ(:<BOF(G@"%Z<8X>"\PAWWL$RYQ+0NET
M+.X,@-F_(, A=: F&&CSN@3!')NO([F^8B7.%8F<5[0CCF/B9']2@*7*B7X*
M#*PNC_UV_9]MMUF24KX=D R]>\D#\6IZYWO^OAD7R%^3!82/E8S!025O&NF
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MNE6+S%(S(4(2Y*.SP2<)**FQH25E[LPM0=%!(6@'.A!1LT)0]R:6//*OQDS
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MV,Q+D;AX<,U&4QDJ'?D&&(]A6=G8&E#I^VF_%R44.9UEH%F004T:1BW:G,.
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MB4WWL@'?UY=\L4D 052K.*$""G6<4C))EM_G>A)G">L$^(;##P+')J<]<(^
M@-V8Z=4'(:[ETLC>Z#W^ *OCS._[7,A9&N [A5[9LQGQYC(^T,6=S2XNBO$7
M_$$^G<<;^ [[U5V<(K9Q"FFAN5G+'G<@/^B]O\_E4"  -Y<"!\ZWA?TDJ(."
M*2F>3EV?Y'[\J?-2VW8[QBNBJ3*VZ2AYI^]S-:.T NGMXM$=6TPS)-<>6,G$
MZMB++8&5FJ1&VE,!/B.S&E,6+QJR[1:DZ7VN):#^BK-TDYR9Z6]F.2[K*+VA
MQ,A0?--[5>N+?F7D?<>U:1T^C#2[U\4XX +Z#"(SV!Z$W*,6B M#U)Q8T7YT
M+ED2)SE.+[$]+0JEJA(>X/L"UDH(OP-O'G'Q7W8]H'S5A(&S,!I221%1LZ[*
M)Y1)URDLW@K[1_-F(/G2*;A-P6%\;/,>E_./@)CV09#U1.=:ZC(IS?C(HX\P
M2C54>S&D+SFYS]6,F>NGE*V39-<J%GZK!X-)<P5U(.<TF6F@^UR 75-:%#XS
M?[AP1,*NLPW+:!%HF.QTC\N1SFVBYJ8Y7"1NGEFUQ0B#GD=2Y/KHTF86PQWL
M;:_S9C!OYODZ;V:UMI</R[*CO!GM^!4QE,T=U6%A':5-NE1[@X4IE>#GA==)
MI?2K9SH!E[%#C]&\\$BR$PNK-M8J32R C,.D]#U1DJK)Y1H!$.#K8?O+$.4&
M))SK<<<HF/CWH$U3#U?7[)?F^X-?EDENBJ:;]5L/VJP]=2VJJRO-]J7^A2(*
M[RPM!(/K M-%7'HSM@C4B!5:%O19.81 CMUKB7+TYP$9>>G[UAZ>?#X]^&7_
M[##^]"Y^]_GX;7SVR_[IX=GK^.#3\3\/3Q%X)#[_M 2TR*>3P^.MP^.WBBU"
M@SVN-KAQK 4A87)V2S8VI8UK8\IZMI$+%] ==P;W2A/!"E?,;0IJ/+B!O'@8
M*VF)>Y0#ETA&;;A@-!$"O%>]%3/,5YJ'0.F32LK >%RR)'4^"=S W,7D*NJ-
M/J;2\J(,\!"U 3WU3P=-?H-B+"M-17.]9V7NZZ &<V<F;?;BX_U_]K#?S%A+
MU"D5QWT;8SUD)8!P*<KI!:A@L,VPJ]EJA_/_9@F/PLGI/D^.A=.(\<'F#D+!
MEQ:Q@QVWM!=?,O*-V^)5.O7"GW18Y,5U-J02]LQ;3RSUY CZ\9N4Z4CEY<5"
MRL8RLU4F@<+PHG2F-]-:,F52 7NMN%4)3$=SM[S%TIEO:-H:^[:]*3NZ>J8F
M,,\%=B&;*H0U1U)<D@)9;*2!8(N(Y$N:RWV;#5=C( B],':=3_.YAVS79FI<
M_0';46M^$UQ=[5_+3;FIMGXU]L&5XDZ#:B5$9 :N5P:5ATW(]9X&56 ](=HO
MG).ZVI6-*3=4&FH;OXV#WB2R$&&^:G';2E,1SFW03X9 %QC(J:B7Z[R8261N
MVD:71#88-Q+-A5+YJ(!NU7.I3!9V(<X";J+J#XQ1"\W6R03@1:)DH4P]/"6M
M_CUGG_Z^LOIHA:VT6?48;$V7JH',ILV*,R]7E_\Z"IAF_:(7=OL?ST]L66,>
M%,!M\*<5;@7%V6K]H3'#.H,A1NR80E$F=R:;!F7M3LAM>JS^FH8@M;? J?/+
M=(4FZ80V0W%123<__A<HH<3]JI0+FKGL2CY!P$("KDW^^TO&="*Q(=2<K-(G
M?4RZQB5YW;.*=QE,K'$QAXVU[%-C7Y@ /BFXA%?2Z[NVJ[=*8V;/IODL6:Q/
M30)^,@ZJ0X=%-74,WM'CH"AS0KC@ UJA8WH=-(!F4Z_SD_J#M 0>?$VQ?7R2
M$[&T82C;3$<YHZZ Y%SA/A9WJ<R]4$>FBN"%!8\KN3YM9; .T*XP!ZC)VEZ\
M*[5V!990M13Y:E&D"KAR-B:'"-P.BJ-N2C$L3([D(&4YX.1PWM>3U8*-(#C*
M2\TNJ7PH("BXI;)0'=O*0E6Y2)OFLE#>J!7;UOO1#6CUM5@@B,)M/DHI>#QK
MA .I&,!)WZ<NM"OT:I_0U7(:1$T<7%"RQ1%B 4@8CG*-7-X)<H0Q386@PI51
MK# !A-(2KDQP;\[G;_U3BLEFMJFWX!:LI(Y/YQ/,.<(SS"^),^:,1 /SF6&U
MB\/.=EDJ:D-^NI\94!NM*\)'=I%:3B\",X4@$^ #6Q=@%8BI,IO*OUQ-#^%L
M,U:W8\?+3^#:X3!UU2$3;S0< /'5,"2R2/=<@086\#/.ZW) <2A[7&Y04JD[
M#/@VHKL[E"R\5"L<@(-/&),Q@]9> -]'8G)2IC<)?"&_?-@*XQL*&JQH) ZY
MYLRDKSM=7G>O#2> +5L"?&HU95>:18MY0:S2FZ5C+.,$%2=!>['I3:$ /2=3
M,!Q]N7IFBN90B^W *V(.U@'KX/4C^E4&=,VFJ]F\U319^%.SN@V$8ELEGRHX
M9/:$S<[Z\1N"P.<1JM7H(ARJ1]D/-EM=MT!T"'%E.W='4MO&Q@&O[%0Q./KD
MS!"3?6E\ XHZR)DXQ_MJIBJ>QSK>6XOW[JSCO1CO?;&.]ZX6[_T#PT6O7+CH
M?/__Q!_WS\\/3\\>?FCGNZ*QGA/ZT!BD/;MIR&K6W'=$*9A&5%.N/OQJ=@VC
M,DH?)<8&6#,,^ZG/N,(GZ>_)UIDT[Y2;I :RT2-! F@/G+(!TMF/3QA+L4K9
M"#[;/^)HA*!L4IM0MPJTA'#@HG2RK$P) TX,@^(VIRF1.BJ>6_P[^@T&",&-
MW_!0=9%DT/88R(%[6A5#='S4U\5Z[C6Y7V@.!G:8,N)_+Y3=[TDZ))8QE*$@
M>YPBAAY=@K>E -+%G)'6$=M5<I*GP!RGOHT/(EAR/Z"&-;'Q7__CY>[N]NO3
MHP/ZV\[K3<G-/IL-P*B>8(NFCZHF'"&'R GRA),Q#XH1,:V=5R^?4R:$P&F%
M)K).DZ+M.#4U5I(8OFL[_V#0O@+2JN!I]:0$."2NA3*E2E3%K!0B9Q\<]G^2
M/$'"!S%X[_R(@<06K=7YK,)1*".C/C\I6&'?!EP:WFUCI39;Z1H_Q:3,X-PS
MRF+'@R#GRO4LSX;9),Q]E\Y*F%F/]P#H9NB;4?*%$"\1_C0B2 R%@RD0:;CR
M29!PO3.XH%GJLEH^YP0%?T9#8S]5+%*KXI,9#%$ <Q@2"/_[67*]26#?;3.\
M)9A"7B8"2GI<Q/0K>B0X.J7@J;HM.*'],OLW\!&S103F[ZD$C?UD+N-L.4U5
MHZ_.Y<G-MHG0D8G"FKC)AGN#@&E&#&6.LV&@;_DNTF)+XV.MDS)AOV?;/^K.
M80F>0Y5C4#TFJ,CJT=?2G*'*6,&V8.]MNV,^G[A#<BW1Z&[#WI33L#,)7M>=
M%XB&G'S%-49X_^'>\1/DCW#^?'DD<"%1IP*;"(P^S!3XBEEO^!VSWI:)1LA.
MS#SQG^S[D(_C_,Q=\G"=%QJ^LD\Z-H OJ'A,82,S3=!-*RG%8E!'3X&"'L.-
MT!>2$ESR,*L>R4GZ:;2_POW\U'C*O9R*^%H."F3-B^Z 90WOF@2(P#E@$5.M
M7H*HE<1Q*3D V\%?SZ[YU2,S";G[4=M-%?3>I#* 41R<%;#B.<^YQ\Y>"A&S
MX,CI2@GY")X?:>=97FM/CRB*:+1&5.<'3\.F8T:U$$['&H0BF=F&S>*"G@G<
MFN\F]5<7MY5;KK4M. I"62(+^+R!&K* Z+&A(/!13-Y?[LQZ+F5%5X!1**.D
M1<P9Z2@]<BLQ*Y-9T.RUTWG03GQPY%9R$!P$%(>CJ*R'VOXAQC Q@+1$A3ZY
M3%LOLZPHF;+X<XT^VGB]"DLS)!.*G&#;&J*.@W[H6ID!G)?NYI9-1$9(>7&
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MP^W_F$RGW%XZ^]GE+3F>H>%4LO! !_*BWK:8,62J0S.^<\AH&O;!G+/E4#G
M$AVZ%?1TFI1Y.HI093$I[5Q8>GNE#J?!W*2Y5+WVBVNS;1W9P)LZ4;[0^B_T
M%&VD_<M^SWX9=2-]0FM7)P7&Z8942C7 25 E!%GL>DUA,+C"A>3>.0?2MR7<
MWUTFT)U#+R4"E5, [:YJP(WSU32\7;F\.?&N136-#CN.8+&WR?C1/I$2X0[*
M:5K"W=*<-4R+"1;1H+I(3[7N!=2$F:D#4$UJ&0]<JP *+IO8:(UBE*@MFP">
M;-:.,%B_U"\(XDA!A(J%RV@%8->(A/DQ;KWS<-!&HI_-N2G91^CE0RUA2S^N
MN5JL\ZO9^JV7K8:=DRIPBSA(:HD$K';A=]&]9YW;ZKQ@C9+>1M2.P%W,VVTP
MA/X*7)-[/IRY>L$/5(=A>"@!#$>_4J_@Q;;PMY0N]9AC&LEN1V'*IS!-1-[Z
MH2<'=<UJ"=09_E RQ^P87&)B:8C4(7]!D6 ZZU7D:D;4#@<M9<I;U<?NJ YT
ME1<"-"(J-G,LKY\1DT#X.7<(W:PXXA)&(/<9?BK1M(IS1#-"WU<]$TO*&USA
M0UN&3K/@H19T<&-&+,-LB-*S'V+H16Z#%YTLF>8F-1>H29(C$]>_-9AO\4:0
M]TN:5U&A(N?.9+[$,,"Q)HY#=;*<J *?1*54\8KKU;18<^MB.ZX1N"TQAA%
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M*%4X A9C7!2+Q4Q!0S8;!=5N5ID36FU:M3SDD4H@+)8*&9P\3Y92P::HP,L
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M""$$\TITXH)SH B!4>G2Q0E&DG!H#")$Y)8%-9@QK,Q"E,WNI/E91&SGV4C
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MMFP0/[PL7&LWVEGN;S2XX5I/ZW2;+8.&@PO:O/P2].RN3]YL>VRDYU"P=,V
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M2P$"% ,4    "  V>9):O^$R0=L"  !G#@  %               @ &7 P
M;F%Z+3(P,C4P-#$X7V1E9BYX;6Q02P$"% ,4    "  V>9):>(-0]L<"   -
M#@  %               @ &D!@  ;F%Z+3(P,C4P-#$X7VQA8BYX;6Q02P$"
M% ,4    "  V>9):/&RV*H0"  !#"@  %               @ &="0  ;F%Z
M+3(P,C4P-#$X7W!R92YX;6Q02P$"% ,4    "  V>9):*MN.[58. 0!A; @
M%               @ %3#   ;F%Z7S0R-&(U+3 T,3@R-2YH=&U02P$"% ,4
M    "  V>9):!$![>;L\  !\SP  #@              @ ';&@$ ;G5V965N
>;&]G;RYJ<&=02P4&      8 !@"" 0  PE<!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>naz_424b5-041825_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:naz="http://nuveen.com/20250418"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="naz-20250418.xsd" xlink:type="simple"/>
    <context id="AsOf2025-04-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
        </entity>
        <period>
            <startDate>2025-04-18</startDate>
            <endDate>2025-04-18</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-14_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-14</instant>
        </period>
    </context>
    <context id="From2024-12-012025-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-05-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012024-02-29_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2023-03-012023-05-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="From2022-12-012023-02-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="From2022-09-012022-11-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="From2025-04-142025-04-14_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-14</startDate>
            <endDate>2025-04-14</endDate>
        </period>
    </context>
    <context id="From2025-04-142025-04-14_custom_CommonStockAdjustedForOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naz:CommonStockAdjustedForOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-14</startDate>
            <endDate>2025-04-14</endDate>
        </period>
    </context>
    <context id="AsOf2025-04-14_custom_CommonStockAdjustedForOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000892992</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naz:CommonStockAdjustedForOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-14</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-04-18" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2025-04-18" id="Fact000004">424B5</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-04-18" id="Fact000005">0000892992</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="AsOf2025-04-18" id="Fact000011">Nuveen Arizona Quality Municipal Income  Fund</dei:EntityRegistrantName>
    <us-gaap:SharePrice
      contextRef="AsOf2025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000012"
      unitRef="USDPShares">11.79</us-gaap:SharePrice>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000013"
      unitRef="USDPShares">11.31</us-gaap:NetAssetValuePerShare>
    <cef:PurposeOfFeeTableNoteTextBlock contextRef="AsOf2025-04-18" id="Fact000015">&lt;div id="xdx_804_ecef--PurposeOfFeeTableNoteTextBlock_dU_zzkWLXa6cqS3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The
purpose of the table and the example below is to help you understand all fees and expenses that you, as a shareholder of Common
Shares (&#x201c;Common Shareholder&#x201d;), would bear directly or indirectly. The table shows the expenses of the Fund as a
percentage of the average net assets applicable to Common Shares, and not as a percentage of total assets or Managed Assets (as defined in the accompanying prospectus).&lt;/div&gt;

</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="AsOf2025-04-18" id="Fact000018">&lt;div id="xdx_801_ecef--ShareholderTransactionExpensesTableTextBlock_dU_gL1STETTB-DVDSMW_zE5OaxVhJPke" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;td style="width: 94%"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 4%"&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: #cceeff"&gt;
    &lt;td style="vertical-align: top"&gt;
        &lt;div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"&gt;&lt;div style="letter-spacing: 0px; top: 0px; display: inline"&gt;&lt;div style="font-weight: bold; display: inline"&gt;Shareholder Transaction Expenses &lt;/div&gt;&lt;/div&gt;&lt;span id="xdx_906_ecef--BasisOfTransactionFeesNoteTextBlock_c20250418__20250418_zMvvcOQCKtS9"&gt;(as a percentage of offering price)&lt;/span&gt;&lt;div style="letter-spacing: 0px; top: 0px; display: inline"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid"&gt;
    &lt;td style="vertical-align: top"&gt;
        &lt;div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"&gt;Maximum Sales Charge&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_987_ecef--SalesLoadPercent_dp_c20250418__20250418_fKg_____zTjtjQmXxTug" style="vertical-align: bottom; text-align: right"&gt;1.00%&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&lt;sup&gt;*&lt;/sup&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: #cceeff"&gt;
    &lt;td style="vertical-align: top"&gt;
        &lt;div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"&gt;Offering Costs&lt;div style="font-size: 75%; vertical-align: top; display: inline; font-size: 8.3px"&gt;(1) &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_984_ecef--OtherTransactionExpensesPercent_dp_c20250418__20250418_fKDEp_zDpNuVt0D1X3" style="vertical-align: bottom; text-align: right"&gt;0.49%&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid"&gt;
    &lt;td style="vertical-align: top"&gt;
        &lt;div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; text-indent: -1em"&gt;Dividend Reinvestment Plan Fees&lt;div style="font-size: 75%; vertical-align: top; display: inline; font-size: 8.3px"&gt;(2) &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;$&lt;/td&gt;
    &lt;td id="xdx_98C_ecef--DividendReinvestmentAndCashPurchaseFees_pp2p0_c20250418__20250418_fKDIp_z9cJXEp4Pe99" style="vertical-align: bottom; text-align: right"&gt;2.50&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td id="xdx_F04_z0HYTuXwT2p3" style="width: 2%; vertical-align: top; text-align: left"&gt;*&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left; width: 98%"&gt;
        &lt;div id="xdx_F1E_zwFGXYf0Jnc1" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;
    The maximum sales charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters in an offering that is not made at-the-market, the applicable prospectus supplement will set forth any other applicable sales load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; display: none; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td id="xdx_F08_zhChSEFH60Nf" style="width: 4%; vertical-align: top; text-align: left"&gt;(1)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;div id="xdx_F19_zDBcWxvIeML6" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;Assuming
        a Common Share offering price of $11.79
        (the closing price of the Common Shares on the NYSE on April 14, 2025). &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; display: none; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td id="xdx_F08_zRmKNlk0Fm4g" style="width: 4%; vertical-align: top; text-align: left"&gt;(2)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;div id="xdx_F15_zfKUWE2NZFvg" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#x201c;Plan Agent&#x201d;), to sell your Common Shares held in a dividend reinvestment account.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;



&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td style="width: 4%; vertical-align: top; text-align: left"&gt;(1)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;div style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span id="xdx_906_ecef--OtherTransactionFeesNoteTextBlock_c20250418__20250418_z6YgRTEszduc"&gt;Assuming
        a Common Share offering price of &lt;span id="xdx_90C_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z02esFTRIWml"&gt;$11.79&lt;/span&gt;
        (the closing price of the Common Shares on the NYSE on April 14, 2025). &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td style="width: 4%; vertical-align: top; text-align: left"&gt;(2)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;div style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#x201c;Plan Agent&#x201d;), to sell your Common Shares held in a dividend reinvestment account. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt; </cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="AsOf2025-04-18" id="Fact000019">(as a percentage of offering price)</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="AsOf2025-04-18"
      decimals="INF"
      id="Fact000020"
      unitRef="Ratio">0.0100</cef:SalesLoadPercent>
    <cef:OtherTransactionExpensesPercent
      contextRef="AsOf2025-04-18"
      decimals="INF"
      id="Fact000021"
      unitRef="Ratio">0.0049</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="AsOf2025-04-18"
      decimals="2"
      id="Fact000022"
      unitRef="USD">2.50</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock contextRef="AsOf2025-04-18" id="Fact000028">&lt;div id="xdx_808_ecef--AnnualExpensesTableTextBlock_dU_gL1AETTB-TW_zOYuGDr7ExJ6"&gt;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%"&gt;
  &lt;tr&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: White"&gt;
    &lt;td style="vertical-align: top; width: 82%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 5%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: bottom; width: 11%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;As a Percentage of Net Assets Attributable to Common Shares&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;
        &lt;div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em"&gt;&lt;div style="font-weight: bold; display: inline"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Annual Expenses&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;div style="font: 10pt/normal Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 20pt; text-indent: -1em"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Management Fees&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecef--ManagementFeesPercent_dp_c20250418__20250418_fKDMp_zfUN1oQiP816" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.97%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;div style="font: 10pt/normal Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 20pt; text-indent: -1em"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest
        and Other Related Expenses &lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecef--InterestExpensesOnBorrowingsPercent_dp_c20250418__20250418_fKDMpKDQp_zzoXe64zI6I4" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2.61%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255); page-break-inside: avoid"&gt;
    &lt;td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt; vertical-align: top"&gt;
        &lt;div style="font: 10pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other Expenses &lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecef--OtherAnnualExpensesPercent_dp_c20250418__20250418_fKDMpKDUp_zRn8W0NsUF8i" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.14%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; white-space: nowrap; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid"&gt;
    &lt;td style="text-align: left; vertical-align: top"&gt;
        &lt;div style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt; text-align: left; text-indent: -1em"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total Annual Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecef--TotalAnnualExpensesPercent_dp_c20250418__20250418_fKDMp_znySGzqOK879" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3.72%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%"&gt;&#160;&lt;/div&gt;



&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td id="xdx_F06_zx07KqSG6T4j" style="width: 4%; vertical-align: top; text-align: left"&gt;(3)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;div id="xdx_F1B_ztsskV1elOlg" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;
        Stated as annualized percentages of average net assets attributable to Common Shares for the six-month fiscal year ended August 31,
        2024 (annualized).&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td id="xdx_F00_zOB1JzvPsoB5" style="width: 4%; vertical-align: top; text-align: left"&gt;(4)&lt;/td&gt;
    &lt;td id="xdx_F10_zlLMyWzYPXH9" style="vertical-align: top; text-align: left"&gt;Interest and Other Related Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month fiscal year ended August 31, 2024 (annualized). The types of leverage used by the Fund during the six-month fiscal year ended August 31, 2024 (annualized) are described in the Fund Leverage and the Notes to Financial Statements sections of the Fund's annual report. Actual Interest and Other Related Expenses incurred in the future maybe higher or lower. If short-term market interest rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates, the Fund&#x92;s interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund&#x2019;s use of leverage will increase the amount of management fees paid to the Fund&#x2019;s adviser and sub-advisor(s).&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td id="xdx_F04_zZc5hFyPmWd6" style="width: 4%; vertical-align: top; text-align: left"&gt;(5)&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;div id="xdx_F14_z96hsuJvXrke" style="font: 8pt/normal Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;
    &lt;span id="xdx_90D_ecef--OtherExpensesNoteTextBlock_c20250418__20250418_zmVchX1UmQih"&gt;Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#x2019;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#x201c;The Fund&#x2019;s Investments&#x2014;Other Investment Companies&#x201d; in the SAI. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="AsOf2025-04-18"
      decimals="INF"
      id="Fact000029"
      unitRef="Ratio">0.0097</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="AsOf2025-04-18"
      decimals="INF"
      id="Fact000030"
      unitRef="Ratio">0.0261</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="AsOf2025-04-18"
      decimals="INF"
      id="Fact000031"
      unitRef="Ratio">0.0014</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="AsOf2025-04-18"
      decimals="INF"
      id="Fact000032"
      unitRef="Ratio">0.0372</cef:TotalAnnualExpensesPercent>
    <cef:OtherTransactionFeesNoteTextBlock contextRef="AsOf2025-04-18" id="Fact000033">Assuming
        a Common Share offering price of &lt;span id="xdx_90C_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z02esFTRIWml"&gt;$11.79&lt;/span&gt;
        (the closing price of the Common Shares on the NYSE on April 14, 2025). </cef:OtherTransactionFeesNoteTextBlock>
    <us-gaap:SharePrice
      contextRef="AsOf2025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000034"
      unitRef="USDPShares">11.79</us-gaap:SharePrice>
    <cef:OtherExpensesNoteTextBlock contextRef="AsOf2025-04-18" id="Fact000038">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#x2019;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#x201c;The Fund&#x2019;s Investments&#x2014;Other Investment Companies&#x201d; in the SAI. </cef:OtherExpensesNoteTextBlock>
    <cef:ExpenseExampleTableTextBlock contextRef="AsOf2025-04-18" id="Fact000040">&lt;div id="xdx_809_ecef--ExpenseExampleTableTextBlock_dU_zrESIo3FGNH1" style="font: bold 10pt Times New Roman, Times, Serif; display: inline"&gt;Example &lt;/div&gt;&lt;div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The following example illustrates the expenses including the applicable transaction fees (referred to as the &#x201c;Maximum Sales Charge&#x201d; in the fee table above), if any, and estimated offering costs, that a Common Shareholder would pay on a $1,000 investment that is held for the time periods provided in the table. The example assumes that all dividends and other distributions are reinvested in the Fund and that the Fund&#x2019;s Annual Total Expenses, as provided above, remain the same. The example also assumes a transaction fee of 1.00%, as a percentage of the offering price, and a 5% annual return.&lt;div style="font-size: 75%; vertical-align: top; display: inline; font-size: 9.1px"&gt;1&lt;/div&gt; &lt;/div&gt;

&lt;div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 8pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 60%"&gt;
  &lt;tr&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 25%"&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 25%"&gt;&lt;/td&gt;
    &lt;td&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 25%"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 8pt Times New Roman, Times, Serif; page-break-inside: avoid"&gt;
    &lt;td style="border-bottom: #000000 1pt solid; vertical-align: bottom; white-space: nowrap; text-align: center"&gt;&lt;div style="letter-spacing: 0px; top: 0px; display: inline"&gt;&lt;div style="font-weight: bold; display: inline"&gt;1&#160;Year&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;div style="letter-spacing: 0px; top: 0px; display: inline"&gt;&lt;div style="font-weight: bold; display: inline"&gt;3&#160;Years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;div style="letter-spacing: 0px; top: 0px; display: inline"&gt;&lt;div style="font-weight: bold; display: inline"&gt;5&#160;Years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 0.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: #000000 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;div style="letter-spacing: 0px; top: 0px; display: inline"&gt;&lt;div style="font-weight: bold; display: inline"&gt;10&#160;Years&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; page-break-inside: avoid; background-color: #cceeff"&gt;
    &lt;td id="xdx_98A_ecef--ExpenseExampleYear01_c20250418__20250418_fKDEp_zuIuIR6z1VJ4" style="vertical-align: bottom; text-align: center"&gt;$52&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_ecef--ExpenseExampleYears1to3_c20250418__20250418_fKDEp_z04Xyt8cWdgg" style="vertical-align: bottom; text-align: center"&gt;$127&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98E_ecef--ExpenseExampleYears1to5_c20250418__20250418_fKDEp_zdRw44Fs9R7l" style="vertical-align: bottom; text-align: center"&gt;$204&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_ecef--ExpenseExampleYears1to10_c20250418__20250418_fKDEp_zGaCCLJzEUlf" style="vertical-align: bottom; text-align: center"&gt;$406&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;&lt;div style="font-weight: bold; display: inline"&gt;The example should not be considered a representation of future expenses. Actual expenses may be greater or less than those shown above. &lt;/div&gt;&lt;/div&gt;

&lt;div style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&#160;&lt;/div&gt;

&lt;div style="border-bottom: #000000 1px solid; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; width: 11%"&gt;&#160;&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="page-break-inside: avoid"&gt;
    &lt;td style="width: 2%; vertical-align: top; text-align: left"&gt;&lt;div id="xdx_F0E_zX9gNnjs15O1" style="font-size: 75%; vertical-align: top; display: inline; font-size: 9.1px"&gt;(1)&lt;/div&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;
        &lt;div id="xdx_F13_zlfieIQghqla" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"&gt;
    The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#x2019;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt"&gt;&#160;&lt;/div&gt;

&lt;div style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/div&gt;



</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="AsOf2025-04-18"
      decimals="0"
      id="Fact000041"
      unitRef="USD">52</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="AsOf2025-04-18"
      decimals="0"
      id="Fact000042"
      unitRef="USD">127</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="AsOf2025-04-18"
      decimals="0"
      id="Fact000043"
      unitRef="USD">204</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="AsOf2025-04-18"
      decimals="0"
      id="Fact000044"
      unitRef="USD">406</cef:ExpenseExampleYears1to10>
    <cef:SharePriceTableTextBlock contextRef="AsOf2025-04-18" id="Fact000047">&lt;div id="xdx_808_ecef--SharePriceTableTextBlock_dU_zeFXUFAqjOjh" style="text-align: center; font-weight: bold; display: inline"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="trading"&gt;&lt;/span&gt;TRADING AND NET ASSET VALUE INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The following table shows for the periods indicated: (i)&#160;the high and low sales prices for the Common Shares reported as of the end of the day on the NYSE, (ii)&#160;the corresponding NAV per share, and (iii)&#160;the premium/(discount) to NAV per share at which the Common Shares were trading as of such date. The Fund&#x2019;s Common Shares have historically traded both at premiums and discounts in relation to the Fund&#x2019;s NAV per share. The Fund cannot predict whether its Common Shares will trade at a premium or discount to NAV in the future. The Board of Trustees has currently determined that, at least annually, it will consider action that might be taken to reduce or eliminate any material discount from NAV in respect of Common Shares, which may include the repurchase of such shares in the open market or in private transactions, the making of a tender offer for such shares at NAV, or the conversion of the Fund to an open-end investment company. The Fund cannot assure you that its Board of Trustees will decide to take any of these actions, or that share repurchases or tender offers will actually reduce market discount.&lt;/div&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-width: 0; font: 10pt Times New Roman, Times, Serif; margin: 0 auto; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="border-bottom: Black 1pt solid; display: none; visibility: hidden; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_488_ecef--HighestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zMj3CmfwFjti" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_481_ecef--LowestPriceOrBid_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zDkzjJ0gZfR7" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_48E_ecef--HighestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3ShTHTlK4ab" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_481_ecef--LowestPriceOrBidNav_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0aTUt17m3d9" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_483_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zuuuYg3cHfU1" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_485_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_dp_hus-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsVaUze4oI8" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="white-space: nowrap; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;Closing Market Price&lt;br/&gt;per Common Share&lt;/td&gt;
    &lt;td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;NAV per Common Share&lt;br/&gt;on Date of Market Price&lt;/td&gt;
    &lt;td style="white-space: nowrap; font-family: Times New Roman, Times, Serif; padding-bottom: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman, Times, Serif; text-align: center"&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Premium/(Discount) on&lt;/b&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Date of Market Price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="border-bottom: Black 1pt solid; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="vertical-align: bottom; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: left; padding-bottom: 0pt"&gt;Fiscal Quarter End&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 0pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#x2003;High&#x2007;&#x2007;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#x2003;Low&#x2007;&#x2007;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#x2003;High&#x2007;&#x2007;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#x2003;Low&#x2007;&#x2007;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#x2003;High&#x2007;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#x2003;Low&#x2007;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41C_20241201__20250228_z5MFGj29r6Tl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;February 2025&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.70&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;11.28&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.17&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.09&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;4.35&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(6.70&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_413_20240901__20241130_zqukCJjPhKb9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;November 2024&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.29&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;11.54&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.49&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.35&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(1.60&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(6.56&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_410_20240601__20240831_z3JFofs0Jxjf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;August 2024&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 5%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;11.77&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 5%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;10.68&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.73&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="width: 9%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.33&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 3%; font-family: Times New Roman, Times, Serif; text-align: right"&gt;(7.54&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 3%; font-family: Times New Roman, Times, Serif; text-align: right"&gt;(13.38&lt;/td&gt;
    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_410_20240301__20240531_zZe2ZswQmNyd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;May 2024&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;11.05&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;10.55&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.76&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.33&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(13.40&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(14.44&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20231201__20240229_zOpZ67B6tENb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;February 2024&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;10.94&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;10.57&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.63&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.39 &lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(13.38&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(14.69&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_412_20230901__20231130_zkO84MC4UCd5" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;November 2023&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;10.47&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;9.26&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.36&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;11.20&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(15.29&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(17.32&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41A_20230601__20230831_zwayjvCbwBwd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;August 2023&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;10.82&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;10.27&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.60&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.09&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(14.13&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(15.05&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41F_20230301__20230531_zNfI1G5BuW4g" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;May 2023&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;11.30&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;10.56&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.63&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.22&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(10.53&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(13.58&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20221201__20230228_zvAsuNSZxD9c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;February 2023&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.15&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;11.16&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.96&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.37&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(6.25&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(9.78&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41F_20220901__20221130_z3obWbHxBRU3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;November 2022&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;13.94&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;11.61&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;12.54&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: right"&gt;11.71&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; color: #212529; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;11.16&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;%&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;(0.85&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;)%&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;div style="font: 10pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0.5in"&gt;The NAV per Common
Share, the market price and percentage of premium/(discount) to NAV per Common Share on April 14, 2025 was &lt;span id="xdx_902_eus-gaap--NetAssetValuePerShare_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zu8rIqtPAI7g"&gt;$11.31&lt;/span&gt;, &lt;span id="xdx_90D_eus-gaap--SharePrice_iI_c20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zULm9teFsU01"&gt;$11.79&lt;/span&gt;, &lt;span id="xdx_90E_ecef--LatestPremiumDiscountToNavPercent_c20250414__20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zakmU9T7oUm7"&gt;
4.24%&lt;/span&gt;, respectively. As of April 14, 2025, the Fund had &lt;span id="xdx_90E_ecef--OutstandingSecurityNotHeldShares_c20250414__20250414__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkXYJWALFg68"&gt;
11,597,297&lt;/span&gt; Common Shares outstanding, and net assets applicable to Common Shares of $131,117,293. See &#x201c;Repurchase of Fund
Shares; Conversion to Open-End Fund&#x201d; in the accompanying prospectus.&lt;/div&gt;

</cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000048"
      unitRef="USDPShares">12.70</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000049"
      unitRef="USDPShares">11.28</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000050"
      unitRef="USDPShares">12.17</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000051"
      unitRef="USDPShares">12.09</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000052"
      unitRef="Ratio">0.0435</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-12-012025-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000053"
      unitRef="Ratio">-0.0670</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000054"
      unitRef="USDPShares">12.29</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000055"
      unitRef="USDPShares">11.54</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000056"
      unitRef="USDPShares">12.49</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000057"
      unitRef="USDPShares">12.35</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000058"
      unitRef="Ratio">-0.0160</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-09-012024-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000059"
      unitRef="Ratio">-0.0656</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000060"
      unitRef="USDPShares">11.77</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000061"
      unitRef="USDPShares">10.68</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000062"
      unitRef="USDPShares">12.73</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000063"
      unitRef="USDPShares">12.33</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000064"
      unitRef="Ratio">-0.0754</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-06-012024-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000065"
      unitRef="Ratio">-0.1338</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000066"
      unitRef="USDPShares">11.05</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000067"
      unitRef="USDPShares">10.55</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000068"
      unitRef="USDPShares">12.76</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000069"
      unitRef="USDPShares">12.33</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000070"
      unitRef="Ratio">-0.1340</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-03-012024-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000071"
      unitRef="Ratio">-0.1444</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000072"
      unitRef="USDPShares">10.94</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000073"
      unitRef="USDPShares">10.57</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000074"
      unitRef="USDPShares">12.63</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000075"
      unitRef="USDPShares">12.39</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000076"
      unitRef="Ratio">-0.1338</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-12-012024-02-29_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000077"
      unitRef="Ratio">-0.1469</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000078"
      unitRef="USDPShares">10.47</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000079"
      unitRef="USDPShares">9.26</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000080"
      unitRef="USDPShares">12.36</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000081"
      unitRef="USDPShares">11.20</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000082"
      unitRef="Ratio">-0.1529</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-09-012023-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000083"
      unitRef="Ratio">-0.1732</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000084"
      unitRef="USDPShares">10.82</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000085"
      unitRef="USDPShares">10.27</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000086"
      unitRef="USDPShares">12.60</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000087"
      unitRef="USDPShares">12.09</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000088"
      unitRef="Ratio">-0.1413</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-06-012023-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000089"
      unitRef="Ratio">-0.1505</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000090"
      unitRef="USDPShares">11.30</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000091"
      unitRef="USDPShares">10.56</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000092"
      unitRef="USDPShares">12.63</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000093"
      unitRef="USDPShares">12.22</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000094"
      unitRef="Ratio">-0.1053</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-03-012023-05-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000095"
      unitRef="Ratio">-0.1358</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000096"
      unitRef="USDPShares">12.15</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000097"
      unitRef="USDPShares">11.16</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000098"
      unitRef="USDPShares">12.96</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000099"
      unitRef="USDPShares">12.37</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000100"
      unitRef="Ratio">-0.0625</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-12-012023-02-28_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000101"
      unitRef="Ratio">-0.0978</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000102"
      unitRef="USDPShares">13.94</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000103"
      unitRef="USDPShares">11.61</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000104"
      unitRef="USDPShares">12.54</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000105"
      unitRef="USDPShares">11.71</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000106"
      unitRef="Ratio">0.1116</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2022-09-012022-11-30_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000107"
      unitRef="Ratio">-0.0085</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000108"
      unitRef="USDPShares">11.31</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000109"
      unitRef="USDPShares">11.79</us-gaap:SharePrice>
    <cef:LatestPremiumDiscountToNavPercent
      contextRef="From2025-04-142025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000110"
      unitRef="Ratio">0.0424</cef:LatestPremiumDiscountToNavPercent>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-04-142025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000111"
      unitRef="Shares">11597297</cef:OutstandingSecurityNotHeldShares>
    <us-gaap:SharePrice
      contextRef="AsOf2025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000112"
      unitRef="USDPShares">11.79</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000113"
      unitRef="USDPShares">11.79</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000114"
      unitRef="USDPShares">11.79</us-gaap:SharePrice>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-04-142025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000115"
      unitRef="Shares">11597297</cef:OutstandingSecurityNotHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="From2025-04-142025-04-14_custom_CommonStockAdjustedForOfferingMember"
      decimals="INF"
      id="Fact000116"
      unitRef="Shares">12797297</cef:OutstandingSecurityNotHeldShares>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-04-14_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000117"
      unitRef="USDPShares">11.31</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="AsOf2025-04-14_custom_CommonStockAdjustedForOfferingMember"
      decimals="INF"
      id="Fact000118"
      unitRef="USDPShares">11.34</us-gaap:NetAssetValuePerShare>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnote id="Footnote000023" xlink:label="Footnote000023" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">
    The maximum sales charge for offerings made at-the-market is 1.00%. If the Common Shares are sold to or through underwriters in an offering that is not made at-the-market, the applicable prospectus supplement will set forth any other applicable sales load and the estimated offering expenses. Fund shareholders will pay all offering expenses involved with an offering. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000023"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnote id="Footnote000024" xlink:label="Footnote000024" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Assuming
        a Common Share offering price of $11.79
        (the closing price of the Common Shares on the NYSE on April 14, 2025). </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000024"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnote id="Footnote000025" xlink:label="Footnote000025" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">You will be charged a $2.50 service charge and pay brokerage charges if you direct ComputerShare as agent for the Common Shareholders (the &#x201c;Plan Agent&#x201d;), to sell your Common Shares held in a dividend reinvestment account.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000025"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnote id="Footnote000035" xlink:label="Footnote000035" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">
        Stated as annualized percentages of average net assets attributable to Common Shares for the six-month fiscal year ended August 31,
        2024 (annualized).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnote id="Footnote000036" xlink:label="Footnote000036" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Interest and Other Related Expenses reflect actual expenses and fees for leverage incurred by the Fund for the six-month fiscal year ended August 31, 2024 (annualized). The types of leverage used by the Fund during the six-month fiscal year ended August 31, 2024 (annualized) are described in the Fund Leverage and the Notes to Financial Statements sections of the Fund's annual report. Actual Interest and Other Related Expenses incurred in the future maybe higher or lower. If short-term market interest rates rise in the future, and if the Fund continues to maintain leverage, the cost of which is tied to short-term interest rates, the Fund&#x92;s interest expenses on its short-term borrowings can be expected to rise in tandem. The Fund&#x2019;s use of leverage will increase the amount of management fees paid to the Fund&#x2019;s adviser and sub-advisor(s).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnote id="Footnote000037" xlink:label="Footnote000037" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span id="xdx_90D_ecef--OtherExpensesNoteTextBlock_c20250418__20250418_zmVchX1UmQih">Other Expenses is based on estimated amounts for the current fiscal year. Expenses attributable to the Fund&#x2019;s investments, if any, in other investment companies are currently estimated not to exceed 0.01%. See &#x201c;The Fund&#x2019;s Investments&#x2014;Other Investment Companies&#x201d; in the SAI. </xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000037"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000032"
          xlink:label="Fact000032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000041"
          xlink:label="Fact000041"
          xlink:type="locator"/>
        <link:footnote id="Footnote000045" xlink:label="Footnote000045" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">
    The example assumes that all dividends and distributions are reinvested at Common Shares NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund&#x2019;s actual rate of return may be greater or less than the hypothetical 5% return shown in the example. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000041"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000042"
          xlink:label="Fact000042"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000042"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000043"
          xlink:label="Fact000043"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000043"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000044"
          xlink:label="Fact000044"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000044"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
